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Introducción 
Regulación global de la expresión de genes de virulencia en bacterias 
patógenas 
La patogenicidad de determinadas bacterias puede entenderse como una respuesta 
de adaptación rápida a los cambios producidos en las condiciones del entorno que las 
rodea. La habilidad para detectar y responder a esos cambios es lo que les conferirá 
cierta ventaja a la hora de colonizar nuevos nichos así como evadir el sistema inmune 
del organismo infectado. En el caso concreto de las bacterias patógenas, estas 
respuestas van unidas a cambios en la expresión de determinados genes que codifican 
factores implicados en virulencia. Normalmente, las bacterias utilizan los sistemas de 
transducción de señales de dos componentes (TCSs) para conectar los estímulos 
ambientales con una respuesta adaptativa concreta. Estos sistemas, que están 
implicados en diversos procesos celulares, se componen de dos proteínas, una histidina 
quinasa (HK) y un regulador de respuesta (RR). La HK es generalmente una proteína 
integral de membrana, encargada de captar y responder a un determinado estímulo 
modificando el estado de fosforilación del RR citosólico. Esta fosforilación provocará 
cambios conformacionales en el regulador el cual, ahora, podrá actuar como un factor 
transcripcional activando o reprimiendo la expresión de determinados genes (para una 
revisión ver Perry et al., 2011). Además de estos sistemas, varios reguladores de 
respuesta denominados stand-alone han sido implicados en la regulación global de la 
expresión de genes de virulencia. En general, el término stand-alone hace referencia a i) 
no están asociados a una HK unida a membrana, ii) su actividad y/o concentración 
intracelular varía en respuesta a estímulos externos y iii) los mecanismos implicados en 
la transducción de dichos estímulos no han sido totalmente definidos (McIver, 2009). 
Dentro de este grupo de reguladores se encuentra la proteína MgaSpn de 
Streptococcus pneumoniae, cuya caracterización molecular ha sido el objetivo principal 
de este trabajo. En este momento, y como consecuencia de nuestra investigación, se 
considera que MgaSpn es un miembro de la familia Mga/AtxA de reguladores de 
respuesta global, que incluye a los reguladores de virulencia Mga (S. pyogenes) y AtxA 
(Bacillus anthracis).  
El regulador global Mga de Streptococcus pyogenes 
S. pyogenes (estreptococo del grupo A; GAS) es una bacteria Gram positiva (G+) 
que provoca un gran número de enfermedades en humanos, algunas de ellas muy 
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graves (Cunningham, 2000). La proteína Mga fue el primer regulador global de 
virulencia del tipo stand-alone descrito en GAS. Este regulador controla la expresión de 
aproximadamente un 10% del genoma bacteriano durante las primeras etapas de la 
infección, afectando directamente la expresión de genes importantes en adherencia, 
internalización y evasión del sistema inmune del hospedador, así como la expresión de 
su propio gen (McIver et al., 1999; Ribardo and McIver, 2006). Además, Mga también 
regula, probablemente de forma indirecta, genes involucrados en el transporte y 
utilización de carbohidratos (Hondorp and McIver, 2007).  
Mga es una proteína de 62 kDa que se une a secuencias localizadas upstream de 
sus promotores diana a través de la región N-terminal, donde se han identificado tres 
motivos implicados en el reconocimiento y unión a DNA: CMD-1, HTH-3 and HTH-4 
(McIver et al., 1995; McIver and Myles, 2002; Vahling and McIver, 2006). Sin embargo, 
no se ha establecido una secuencia consenso que sea reconocida por la proteína Mga. 
En los estudios de interacción proteína-DNA publicados hasta el momento se ha 
utilizado Mga fusionada a la proteína de unión a maltosa (43 kDa) o Mga fusionada a 
una cola de histidinas. En la región central de Mga se han identificado dos dominios que 
presentan homología con los dominios reguladores denominados PRDs 
(Phosphotransferase Regulation Domains). Generalmente, estos dominios contienen 
residuos de histidina que son fosforilados por componentes del sistema de 
fosfotransferasa (PTS; Phosphotransferase System) dependiente de fosfoenolpiruvato. 
Se ha sugerido que el sistema de fosfotransferasa, normalmente implicado en el 
transporte de azúcares, modularía la actividad del regulador Mga vía fosforilación 
(Hondorp et al., 2013). Además, en la región C-terminal de Mga se ha identificado un 
motivo que presenta similitud con una región del componente EIIB de los sistemas PTS. 
Dicho motivo parece estar implicado en la oligomerización de Mga (Hondorp et al., 
2012). No obstante, y a pesar de estos hallazgos, el mecanismo de regulación 
transcripcional mediado por Mga sigue siendo una incógnita.  
El regulador global AtxA de Bacillus anthracis 
La proteína AtxA es un regulador global de B. anthracis (bacteria G+; agente causal 
del ántrax) que activa la expresión de los genes que codifican la toxina del ántrax. Estos 
genes están localizados en el plásmido pXO1. Además, AtxA regula la expresión de 
genes localizados en el cromosoma bacteriano y en el plásmido pXO2 (Fouet, 2010).  
AtxA es una proteína de 56 kDa que presenta dos motivos posiblemente implicados 
en unión a DNA (región N-terminal), dos dominios PRD (región central) y un motivo tipo 
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EIIB (región C-terminal). Se ha demostrado, in silico e in vitro, que las regiones 
promotoras de los genes de la toxina del ántrax poseen curvatura intrínseca como 
característica estructural común (Hadjifrangiskou and Koehler, 2008). Además, se ha 
propuesto que sucesos de fosforilación/desfosforilación en residuos de histidina 
localizados en los dominios PRD modularían la actividad de AtxA (Tsvetanova et al., 
2007). Por otro lado, la región C-terminal parece estar implicada en interacciones AtxA-
AtxA y, por tanto, en la formación de homo-dímeros y oligómeros de orden superior 
(Hammerstrom et al., 2011). Sin embargo, hasta ahora, no hay estudios publicados 
sobre la interacción de AtxA con DNA. 
Streptococcus pneumoniae y factores de virulencia 
S. pneumoniae (el neumococo), es una bacteria G+ componente de la flora normal 
de la nasofaringe, donde reside como comensal de forma asintomática coexistiendo con 
otros microorganismos. Sin embargo, cuando el sistema inmune se debilita, es capaz de 
colonizar diferentes partes del cuerpo humano produciendo diversas enfermedades 
tales como neumonía, sepsis, meningitis, otitis media y procesos invasivos severos 
(Kadioglu et al., 2008). Esta bacteria tiene un gran interés clínico por ser una de las 
mayores causas de morbilidad y mortalidad en todo el mundo debido, principalmente, a 
la aparición de estirpes resistentes a múltiples antibióticos y al escaso conocimiento que 
existe sobre los mecanismos implicados en la regulación de los factores de virulencia. 
Datos recientes de la organización mundial de la salud estiman que la neumonía mata 
anualmente a unos 1,2 millones de niños menores de cinco años, más que el SIDA, la 
malaria y el sarampión juntos, siendo la neumonía causada por neumococo la más 
común (www.who.int/mediacentre/factsheets/fs331/es/).  
S. pneumoniae produce diferentes factores de virulencia que le permiten colonizar 
la nasofaringe e invadir otros nichos, así como protegerse del sistema inmune del 
huésped. Entre los factores de virulencia más estudiados caben destacar la cápsula 
polisacarídica, enzimas líticas como la autolisina (LytA), la neumolisina o hemolisina 
(PLY), y proteínas ancladas a la superficie celular bien a través del motivo LPXTG o 
mediante interacciones no covalentes con la colina (proteínas de unión a colina; CBPs). 
También han sido implicadas en virulencia algunas proteínas relacionadas con el 
transporte de diferentes compuestos, como por ejemplo hierro o manganeso (revisado 
en Mitchell and Mitchell, 2010).  
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En esta Tesis hemos trabajado fundamentalmente con la estirpe no capsulada R6, 
que deriva del aislado clínico D39 (serotipo 2). Los genomas de ambas estirpes han sido 
secuenciados totalmente (Hoskins et al., 2001; Lanie et al., 2007).  
El regulador MgaSpn de S. pneumoniae 
En el 2002, se identificó una serie de posibles reguladores de virulencia en la 
estirpe TIGR4 (serotipo 4) de S. pneumoniae (Hava and Camilli, 2002). Uno de ellos fue 
la proteína MgrA (Mga-like repressor A), que tiene similitud de secuencia con el 
regulador global Mga de GAS (Hemsley et al., 2003). En modelos murinos, MgrA es 
importante tanto en las etapas de colonización de la nasofaringe como en el desarrollo 
de infección pulmonar. Además, se ha descrito que MgrA actúa, directa o 
indirectamente, como represor transcripcional de genes de virulencia localizados en la 
isla de patogenicidad rlrA (Hava et al., 2003).   
El genoma de la estirpe R6, así como el de su parental D39, carece de la isla de 
patogenicidad rlrA pero posee un gen (spr1622 o mgaSpn) equivalente al gen mgrA de 
TIGR4. Dicho gen codifica una proteína de 493 aminoácidos, denominada por nosotros 
MgaSpn, que difiere de MgrA en dos aminoácidos y que presenta homología de 
secuencia con los reguladores globales Mga (42,6% de similitud) y AtxA (39,9% de 
similitud). Debido a esta homología y a la información disponible sobre el papel de MgrA 
en virulencia, iniciamos este trabajo proponiendo que MgaSpn podría ser un miembro de 
la familia Mga/AtxA de reguladores globales y que, como tal, podría regular la expresión 
de múltiples genes de virulencia en respuesta a señales extracelulares específicas.   
Importancia de este trabajo 
S. pneumoniae continúa siendo una de las principales causas de morbilidad y 
mortalidad a nivel mundial. Para alcanzar un mayor entendimiento de la patogénesis de 
este microorganismo es esencial llegar a desentrañar los mecanismos moleculares que 
controlan la expresión de genes de virulencia en función de estímulos ambientales. En 
los últimos años, se han identificado nuevos reguladores transcripcionales que podrían 
tener un papel importante en la regulación de la virulencia de S. pneumoniae, como es 
el caso de la proteína MgaSpn. A pesar de que se conoce bien el papel de sus 
homólogos Mga y AtxA en la patogénesis de GAS y B. anthracis, respectivamente, los 
estudios a nivel molecular de ambos reguladores son todavía muy limitados. Cuando 
iniciamos este trabajo, se tenía un conocimiento muy escaso de la proteína MgaSpn. Se 
sabía que (i) estaba involucrada en la colonización de la nasofaringe y en el desarrollo 
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de neumonía en modelos de infección murinos, y (ii) era un represor, directo o indirecto, 
de la isla de patogenicidad rlrA. Por tanto, esta Tesis se ha enfocado en la 
caracterización molecular de la proteína MgaSpn, lo que ha servido para ampliar el 
conocimiento que se tenía de la misma como regulador transcripcional de genes 
asociados a la virulencia de neumococo. 
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Objetivos 
Mediante búsquedas realizadas en las bases de datos, encontramos que el genoma 
de S. pneumoniae codificaba un potencial regulador global de la familia Mga/Atxa, el 
cual había sido relacionado previamente con la virulencia de neumococo. La 
investigación realizada durante esta Tesis Doctoral ha estado centrada en la 
caracterización molecular de dicho regulador (denominado MgaSpn por nosotros). Con 
este fin, hemos trabajado en los objetivos siguientes:   
1. Identificación del promotor del gen mgaSpn.  
2. Desarrollo de un procedimiento para la purificación de la proteína MgaSpn a gran 
escala.  
3. Análisis del estado de oligomerización de MgaSpn en solución y determinación 
del contenido de estructura secundaria.  
4. Identificación de los genes diana de MgaSpn: análisis del efecto de MgaSpn en la 
expresión del operón spr1623-spr1626. 
5. Estudio de la interacción de MgaSpn con DNAs lineales de cadena doble.  
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CAPÍTULO 1. Expresión del gen mgaSpn 
En esta Tesis hemos identificado el promotor del gen mgaSpn (Pmga). Mediante 
ensayos de RT-PCR, hemos demostrado que hay transcripción del gen mgaSpn cuando 
las bacterias crecen en las condiciones estándar de laboratorio, aunque los niveles de 
expresión génica son bajos, como hemos confirmado por ensayos de Western-blot. 
Como estrategia para aumentar los niveles del RNA mensajero sintetizado a partir del 
promotor Pmga, clonamos dicho promotor en el plásmido pAS (Ruiz-Cruz et al., 2010), 
justo upstream de un gen gfp reportero que carece de su propio promotor. Utilizando 
dicha fusión transcripcional y mediante ensayos de primer extension, hemos identificado 
el sitio de inicio de la transcripción del gen mgaSpn, que está localizado 39 nucleótidos 
upstream del codón de inicio de la traducción.   
Puesto que la RNA polimerasa (RNAP) de S. pneumoniae no es comercial, como 
primera aproximación para caracterizar el promotor Pmga utilizamos la holoenzima 
comercial de Escherichia coli. Los resultados obtenidos en experimentos de 
transcripción in vitro han demostrado que esta RNAP puede iniciar la transcripción no 
sólo a partir de la coordenada 1598309 (promotor Pmga) sino también en la coordenada 
1598369 (promotor P2). En el laboratorio hemos desarrollado un método para purificar 
la subunidad 43 de la RNAP de neumococo. Esta subunidad es homóloga a la 
subunidad 70 de E. coli y se utilizó para reconstituir una RNAP funcional utilizando el 
core comercial de la RNAP de E. coli. Experimentos de transcripción in vitro 
demostraron que la RNAP reconstituida reconoce el promotor Pmga pero no el promotor 
P2.  
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CAPÍTULO 2. Caracterización biofísica del regulador transcripcional 
MgaSpn 
El primer paso para poder llevar a cabo una caracterización en profundidad del 
regulador MgaSpn fue el desarrollo de un protocolo que nos permitiese su purificación 
en estado nativo. Además, purificamos una versión de MgaSpn que tiene seis histidinas 
adicionales en el extremo C-terminal (MgaSpn-His). En ambos casos, clonamos el gen 
mgaSpn en el vector de expresión pET24b, con lo que obtuvimos estirpes de E. coli 
sobre-productoras de la proteína MgaSpn en sus dos versiones. Para la purificación de 
la proteína MgaSpn-His, empleamos columnas de afinidad de níquel y cromatografía de 
filtración en gel. Además, hemos obtenido anticuerpos policlonales contra esta proteína. 
El procedimiento desarrollado para purificar la proteína MgaSpn en su estado nativo 
consta, esencialmente, de tres etapas: (i) precipitación del DNA y MgaSpn 
(presumiblemente unida al DNA) con polietilenimina (PEI) a baja fuerza iónica, (ii) 
elución de la proteína MgaSpn del precipitado de PEI aumentando la fuerza iónica del 
tampón y (iii) cromatografía de afinidad en columnas de heparina. Además, mediante 
electroforesis en geles de poliacrilamida-SDS (SDS-PAGE), y sobrecargando el gel 
(tinción con Coomassie blue), estimamos que la pureza de la preparación obtenida era 
superior al 95%. 
Mediante ensayos de filtración en gel y ultracentrifugación analítica (equilibrio de 
sedimentación y velocidad de sedimentación), hemos demostrado que, en las 
condiciones ensayadas, la proteína MgaSpn forma principalmente dímeros en solución, 
aunque tiene tendencia a formar especies de mayor masa molecular en función de la 
concentración de proteína. El valor del coeficiente friccional (f/f0) obtenido con estos 
experimentos (1,45) indica que MgaSpn tendría una forma elipsoidal, su 
comportamiento hidrodinámico difiere del de una partícula esférica rígida (f/f0=1).  
Utilizando programas informáticos (Pfam y Phyre2), hemos definido la organización 
de los posibles dominios funcionales de MgaSpn. De acuerdo con estos análisis, 
MgaSpn presenta en su región N-terminal dos posibles motivos HTH de unión a DNA, 
seguidos de dos posibles dominios PRD (región central) y de un motivo tipo EIIB (región 
C-terminal). Mediante ensayos de dicroísmo circular, hemos determinado que la 
proteína MgaSpn posee un alto contenido en hélices (55,3%), datos que 
correlacionan con los obtenidos mediante análisis bioinformáticos (programas SABLE, 
PSIPred, JPred, NPS@, PredictProtein).  
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CAPÍTULO 3. Papel activador del regulador transcripcional MgaSpn 
En este capítulo presentamos un análisis transcripcional detallado del operón 
spr1623-spr1626 de la estirpe R6 de S. pneumoniae y demostramos que MgaSpn 
controla positivamente la expresión de dicho operón. Los resultados de esta 
investigación, publicados en el año 2012 (ver Related publications), pusieron de 
manifiesto, por primera vez, el papel activador del regulador MgaSpn.  
Durante el desarrollo de esta Tesis, hemos construido una estirpe mutante de 
deleción (estirpe R6 mga) en la que el gen mgaSpn ha sido sustituido por el gen cat 
(resistencia a cloranfenicol) del plásmido pC194 (Horinouchi and Weisblum, 1982). Por 
otro lado, hemos construido una estirpe de neumococo sobre-productora de MgaSpn. 
Para ello, clonamos el gen mgaSpn bajo el promotor del gen sulA (dihidropteroato 
sintasa) en el plásmido pDL287 (LeBlanc et al., 1993) que confiere resistencia a 
kanamicina (estirpe R6 mga/pDLPsul::mga). Mediante ensayos de Western-blot, hemos 
detectado MgaSpn en extractos celulares de S. pneumoniae, tanto de la estirpe silvestre 
R6 como de la estirpe sobre-productora (niveles de MgaSpn ocho veces más altos que 
en la estirpe silvestre). Además, hemos confirmado que la estirpe mutante de deleción 
no sintetiza MgaSpn.  
Para estudiar el efecto de MgaSpn sobre la expresión génica global, realizamos 
estudios preliminares de proteómica en colaboración con el Dr. J. A. López (Servicio de 
Proteómica del CNIC) comparando la estirpe silvestre (R6) con la estirpe mutante de 
deleción (R6 mga). Estos estudios dieron como resultado la identificación de 10 
posibles genes diana que estarían regulados directa o indirectamente por MgaSpn. 
Entre ellos cabe resaltar el gen spr1625 (proteína Gls24; posible proteína general de 
estrés), en cuya validación hemos trabajado (ver a continuación). El producto del gen 
spr1625 presenta homología con la proteína de respuesta a estrés Gls24 de 
Enterococcus faecalis, que ha sido implicada en virulencia y resistencia a sales biliares 
(Teng et al., 2005).  
Mediante RT-PCR y utilizando RNA total aislado de S. pneumoniae R6, hemos 
detectado expresión del gen spr1623 en condiciones estándar de crecimiento 
bacteriano. Además, hemos demostrado que los genes spr1623, spr1624, spr1625 y 
spr1626, de función desconocida, constituyen un operón. Este operón está localizado 
upstream del gen mgaSpn y en la cadena complementaria (transcripción divergente). 
Mediante ensayos de primer extension, hemos identificado dos promotores (P1623A y 
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P1623B) del operón spr1623-spr1626. Para estudiar en más detalle el efecto del 
regulador MgaSpn sobre la actividad de los promotores P1623A y P1623B, clonamos un 
fragmento de DNA que incluye ambos promotores en el vector plasmídico pAST (Ruiz-
Cruz et al., 2010), justo upstream de un gen gfp (proteína fluorescente verde) reportero 
que carece de promotor. Mediante ensayos de fluorescencia, comprobamos que dicho 
fragmento tenía actividad promotora. Cuando introdujimos esta construcción en la 
estirpe R6 silvestre (niveles basales de MgaSpn) y en la estirpe R6 mga (ausencia de 
MgaSpn), observamos que MgaSpn activaba uno o ambos promotores. Estos 
experimentos se complementaron con ensayos de primer extension utilizando la estirpe 
R6/pDLPsul::mga, lo que nos permitió observar que MgaSpn codificada en plásmido 
(niveles altos) activaba ambos promotores cromosómicos, P1623A y P1623B, aunque el 
efecto activador fue más marcado sobre el promotor P1623B. El mismo tipo de ensayo 
utilizando la estirpe R6 mga/pDLPsul::mga nos permitió concluir que la estirpe R6 mga 
carece no sólo del gen mgaSpn y su promotor, sino también de una región necesaria 
para la activación del promotor P1623B por la proteína MgaSpn. La identificación de 
dicha región se realizó mediante construcción de fusiones transcripcionales (gen gfp) en 
el plásmido pAST, lo que nos permitió evaluar la actividad promotora de diferentes 
regiones cromosómicas en distintos fondos genéticos (R6 versus R6 mga). 
Combinando ensayos de fluorescencia y primer extension, demostramos que MgaSpn 
activa el promotor P1623B in vivo y que esta activación requiere la presencia de una 
región de 70-pb que hemos denominado “región de activación PB” y que está localizada 
entre los promotores divergentes P1623B y Pmga, exactamente 50 nucleótidos 
upstream del sitio de inicio de transcripción correspondiente al promotor P1623B.  
Para estudiar la posible implicación de MgaSpn en autorregulación, construimos 
una fusión transcripcional entre el promotor Pmga y el gen gfp en el vector pAST2 (Ruiz-
Cruz et al., 2010). Mediante ensayos de fluorescencia, observamos que la actividad del 
promotor Pmga era similar en las estirpes R6 silvestre (niveles bajos de MgaSpn), 
R6 mga (ausencia de MgaSpn) y R6 mga/pDLPsul::mga (niveles altos de MgaSpn), 
por lo que concluimos que, en las condiciones ensayadas, MgaSpn no influye la 
actividad de su propio promotor.  
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CAPÍTULO 4. Propiedades de unión a DNA del regulador MgaSpn 
Durante el desarrollo de esta Tesis, una de las cuestiones que nos planteamos fue 
analizar en detalle cómo era la interacción del regulador MgaSpn con sus DNAs diana. 
Los resultados de este estudio, publicados en el año 2013 (ver Related publications), 
demostraron que MgaSpn genera complejos multiméricos al interaccionar con DNAs 
lineales de cadena doble, una característica que hasta entonces no había sido descrita 
en otros reguladores globales de la familia Mga/AtxA.  
Mediante ensayos de retraso en gel (EMSA), demostramos que MgaSpn se une a 
DNA lineal de cadena doble y determinamos que dicha reacción alcanza el equilibrio 
rápidamente (en menos de 1 min). Además, la formación de complejos MgaSpn-DNA no 
se vio afectada por la concentración de NaCl, al menos en el rango de 20 a 300 mM. La 
interacción de MgaSpn con DNA lineal parece no requerir el reconocimiento de una 
secuencia nucleotídica específica, puesto que la proteína fue capaz de unirse a 
fragmentos de DNA de distinta procedencia. En todos los casos, observamos un patrón 
de complejos proteína-DNA compatible con la formación de complejos multiméricos, en 
los que múltiples unidades de MgaSpn se unirían ordenadamente sobre la misma 
molécula de DNA. La capacidad que tiene MgaSpn de extenderse a lo largo del DNA fue 
comprobada posteriormente mediante ensayos de protección a la digestión con DNasa 
I. Además, mediante EMSA y utilizando DNA de timo de ternera como DNA competidor, 
determinamos que las múltiples unidades de MgaSpn interaccionan con el DNA de 
manera no cooperativa, al menos en la formación de los primeros cuatro complejos.  
Utilizando un fragmento de DNA (222-pb) que contenía la “región de activación PB” 
(70-pb; ver Capítulo 3) en posición interna y mediante ensayos de protección a la 
digestión con DNasa I, encontramos que MgaSpn reconoce preferentemente dicha 
región. Estos resultados fueron confirmados posteriormente mediante ensayos de 
protección frente a corte por radical hidroxilo. Concretamente, MgaSpn interacciona con 
la región comprendida entre las posiciones -60 y -99 del promotor P1623B (sitio 
primario; 40-pb). Es decir, la “región de activación PB”, que es necesaria para que 
MgaSpn active el promotor P1623B in vivo, es reconocida por MgaSpn in vitro, lo que 
demuestra que MgaSpn activa directamente dicho promotor. Sin embargo, 
inesperadamente, observamos que la “región de activación PB” no es reconocida por 
MgaSpn cuando está localizada en un extremo de la molécula de DNA (fragmento de 
224-bp que contiene el promotor Pmga en posición interna). En este caso, y mediante 
ensayos de protección frente a rotura por radical hidroxilo, encontramos que MgaSpn 
Resumen en castellano 
 
 
14 
interacciona preferentemente con la región comprendida entre las posiciones -23 y +21 
del promotor Pmga (sitio primario; 44-pb). Curiosamente, mediante microscopía 
electrónica y utilizando fragmentos de DNA más largos (640-1458 pb) que contenían 
ambos sitios primarios (“región de activación PB” y promotor Pmga) en posición interna, 
demostramos que MgaSpn tiene preferencia por la “región de activación PB”. Los 
ensayos de microscopía electrónica fueron realizados en el Max-Planck Institut für 
Molekulare Genetik (Berlín) y en colaboración con el Dr. R. Lurz. Además, mediante 
microscopía electrónica y utilizando relaciones molares de MgaSpn frente a DNA más 
altas, observamos moléculas de DNA cubiertas parcial o completamente de proteína, sin 
que esta interacción modificase la longitud del DNA. Estos resultados confirman que 
MgaSpn es capaz de reconocer un sitio concreto de la molécula de DNA para, 
seguidamente, extenderse a lo largo de la misma.    
Mediante EMSA y utilizando fragmentos de DNA pequeños (entre 40 y 20-pb), 
delimitamos la longitud mínima de DNA necesaria para la unión de MgaSpn. Esta 
longitud está comprendida entre 20 y 26-pb.  
Hemos analizado la secuencia nucleotídica de los dos sitios reconocidos 
preferentemente por MgaSpn (“región de activación PB” y promotor Pmga) y hemos 
visto que comparten una baja identidad de secuencia: GGT(A/T)(A/T)AATT y 
GA(A/T)AATT. Esta baja identidad de secuencia, junto con el hecho de que MgaSpn 
tiene preferencia por la “región de activación PB” cuando está presente en posición 
interna pero no cuando está en el extremo del DNA, nos llevó a concluir que MgaSpn 
requeriría algo más que una secuencia de bases para reconocer específicamente una 
posición en un DNA determinado. El análisis de los fragmentos de DNA de 222- y 224-
pb utilizando el programa bend.it (Vlahovicek et al., 2003) mostró que los dos sitios 
primarios de MgaSpn se caracterizan por tener una curvatura intrínseca potencial, 
mientras que las regiones adyacentes a los mismos presentan un alto grado de 
bendabilidad. Para analizar si MgaSpn mostraba preferencia por fragmentos de DNA 
curvado, realizamos ensayos de EMSA con el fragmento de 222-pb (“región de 
activación PB” en posición interna) utilizando dos tipos de DNAs como competidores: el 
fragmento C DNA (321-pb; 72,3% de A+T) o el fragmento NC DNA (322-pb; 71.1% de 
A+T). De acuerdo con predicciones de curvatura intrínseca, el grado de curvatura del 
fragmento C DNA es mucho mayor que el del NC DNA. De hecho, el fragmento C DNA 
tiene una movilidad electroforética anómala en geles de poliacrilamida nativos, una 
característica descrita en DNAs curvados (Diekmann, 1987). Además, calculamos la 
afinidad de MgaSpn por cada uno de estos fragmentos de DNA. Los resultados 
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obtenidos en ambos ensayos mostraron que MgaSpn tiene preferencia por DNA 
curvado. Esto nos lleva a concluir que conformaciones locales en el DNA podrían 
contribuir al reconocimiento específico de una determinada región del DNA por MgaSpn. 
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Conclusiones 
Este estudio ha contribuido al conocimiento molecular del regulador transcripcional 
MgaSpn implicado en la virulencia de neumococo. Las conclusiones más importantes 
obtenidas durante la realización de esta Tesis son las siguientes: 
1. El gen mgaSpn se transcribe in vivo a partir del promotor Pmga, que es reconocido in 
vitro por el factor 43 de S. pneumoniae. La transcripción del gen mgaSpn comienza 
39 nucleótidos upstream del codón de inicio de la traducción.   
2. El operón spr1623-spr1626, adyacente al gen mgaSpn, se transcribe in vivo a partir 
de dos promotores, P1623A y P1623B. Estos promotores y el promotor Pmga son 
divergentes.    
3. MgaSpn actúa, de forma directa, como activador del promotor P1623B in vivo y, por 
tanto, activa la transcripción del operón spr1623-spr1626. Esta activación requiere la 
interacción de MgaSpn con un sitio localizado upstream del promotor P1623B 
(posiciones -60 a -99). 
4. El regulador MgaSpn está altamente conservado en las estirpes de neumococo cuyos 
genomas han sido parcial o totalmente secuenciados. La organización de dominios 
funcionales predicha para MgaSpn es similar a la de los reguladores de respuesta 
global Mga y AtxA.  
5. MgaSpn tiene un alto contenido en -hélices (alrededor de un 55%). En solución y en 
las condiciones experimentales utilizadas, MgaSpn se encuentra, mayoritariamente, 
formando dímeros. Sin embargo, tiende a formar especies de mayor masa molecular 
en función de la concentración de proteína. 
6. MgaSpn interacciona con DNA lineal de cadena doble con alta afinidad pero con baja 
especificidad de secuencia.  
7. Conformaciones locales en el DNA (por ejemplo, curvatura intrínseca) podrían 
contribuir a la especificidad de unión de MgaSpn a una determinada región del DNA.      
8. Tras unirse al sitio primario, MgaSpn es capaz de extenderse (probablemente 
mediante oligomerización) a lo largo de las regiones de DNA adyacentes, generando 
complejos proteína-DNA multiméricos.  
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INTRODUCTION: Bacteria usually live in habitats of changing conditions. During 
infection, pathogenic bacteria must be able to survive in different environments 
encountered as the pathogen progresses through its host. This adaptation requires 
sensing the relevant extracellular signals and linking them to a coordinate change in the 
expression of genes, which encode factors appropriate to the given situation. Global 
transcriptional regulators that respond to specific environmental signals are key elements 
in such regulatory networks. Bacteria often use classical two-component signal 
transduction systems (TCSs) to link the environmental signals to adaptive responses 
(Stock et al., 2000). Moreover, in addition to TCSs, stand-alone response regulators 
have been implicated in the global regulation of virulence gene expression. The term 
stand-alone has been used to define global transcriptional regulators that (i) are not 
associated to a membrane-bound sensor histidine kinase, (ii) their activity and/or 
intracellular concentration changes in response to specific external stimuli and (iii) their 
signal transduction components have yet to be fully defined (McIver, 2009).  
The Gram-positive (G+) bacterium Streptococcus pneumoniae, commonly called the 
pneumococcus, is a member of the normal human nasopharyngeal flora, where it exists 
asymptomatically as a commensal. However, when the immune system weakens, it can 
cause serious diseases such as sinusitis, conjunctivitis, otitis media, meningitis and 
bacteremia (Kadioglu et al., 2008; van der Poll and Opal, 2009). S. pneumoniae remains 
as a main cause of morbidity and mortality worldwide as a result of its increasing 
resistance to antibiotics. Recent data estimate that pneumococcal pneumonia kills 
annually around 1.2 million children younger than five years, more than AIDS, malaria 
and tuberculosis combined (www.who.int/mediacentre/factsheets/fs331/en/index.html). 
Understanding the molecular mechanisms that control the expression of pneumococcal 
virulence genes in response to environmental stimuli will offer new insights into the 
pathogenesis of this bacterium.  
Searching for homologies we found that the genome of the pneumococcal R6 
strain (Hoskins et al., 2001), which derives from the D39 clinical isolate (serotype 2), 
encodes a protein (named MgaSpn by us), which is highly conserved in the 
pneumococcal strains whose genomes have been totally or partially sequenced. At 
present, MgaSpn is thought to be a member of the Mga/AtxA family of global response 
regulators, which includes the Mga and the AtxA virulence regulators encoded by the G+ 
pathogens S. pyogenes (the Group A Streptococcus, GAS) and Bacillus anthracis, 
respectively. MgaSpn shares 42.6% of similarity and 21.4% of identity with Mga and 
39.9% of similarity and 20.7% of identity with AtxA. Regarding the Mga regulator, it 
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controls the expression of approximately 10% of the GAS genome during the exponential 
growth phase (Ribardo and McIver, 2006). Mga activates directly the transcription of 
several virulence genes, which encode factors important for adherence and 
internalization into non-phagocytic cells, as well as factors that enable the bacterium to 
evade the host immune responses. Mga also activates the expression of its own gene 
(McIver et al., 1999; McIver, 2009). In vitro studies using a His-tagged Mga showed that 
it binds to regions located upstream of the target promoters with low sequence identity. 
Its ability to interact with DNA resides at the N-terminal region, where it contains two 
helix-turn-helix (HTH) motifs (HTH-3 and HTH-4) that have been shown to be involved in 
DNA binding and transcriptional activation (Vahling and McIver, 2006). The His-tagged 
Mga protein is able to form oligomers in solution and this ability correlates with 
transcriptional activation (Hondorp et al., 2012). Nevertheless, the transcriptional 
regulation mechanism mediated by Mga remains unknown. Concerning the AtxA protein, 
it regulates the expression of numerous genes (chromosomal or plasmid-encoded 
genes), including the three anthrax toxin genes located in plasmid pXO1 (for a review 
see Fouet, 2010). However, studies on the interaction of AtxA with DNA are not 
available. It has been shown that AtxA activity is modulated by the phosphotransferase 
system (PTS) (Tsvetanova et al., 2007). Moreover, its C-terminal region seems to be 
involved in AtxA-AtxA interactions (Hammerstrom et al., 2011). Although the role in 
pathogenesis of both regulators (Mga and AtxA) is well known, studies at a molecular 
level are still very limited.  
When this work was started, we knew almost nothing regarding the 
pneumococcal MgaSpn regulator except that (i) it was involved in nasopharyngeal 
colonization and development of pneumonia in murine infection models (Hava and 
Camilli, 2002), and (ii) it was a repressor of the rlrA pathogenicity islet (Hemsley et al., 
2003). Therefore, this Thesis has been focussed on the molecular characterization of the 
MgaSpn transcriptional regulator.  
 
PRINCIPAL FINDINGS: In this study, we have identified the mgaSpn gene promoter 
(Pmga). By RT-PCR assays we have demonstrated that mgaSpn is transcribed under 
our laboratory conditions. Primer extension experiments were carried out to identify the 
transcription initiation site of the mgaSpn gene, which was found to be located 39 
nucleotides upstream of the translation start codon. The pneumococal 43 factor (gene 
rpoD) is homologous to the housekeeping 70 factor of Escherichia coli. We used the 43 
factor (purified in our laboratory) to reconstitute a functional RNA polymerase (RNAP) 
 Summary  
 
   
 
21 
with the commercial E. coli RNAP core enzyme. In vitro transcription assays using the 
reconstituted RNAP showed that the Pmga promoter is recognized by the 43 factor. 
A remarkable achievement of this work has been the development of a procedure 
to purify the untagged MgaSpn protein. As far as we know, it is the first case within the 
Mga/AtxA family of global regulators. This method involves, essentially, three steps: i) 
precipitation of DNA and MgaSpn with polyethyleneimine (PEI) at low ionic strength; ii) 
elution of MgaSpn from the PEI pellet with higher ionic strength; and iii) chromatography 
on heparin columns. Gel filtration chromatography and analytical ultracentrifugation 
assays (sedimentation velocity and sedimentation equilibrium) showed that MgaSpn 
forms dimers in solution. Moreover, it is able to form higher-order oligomers as its 
concentration increases. The frictional ratio (f/f0) calculated was 1.45, indicating that the 
hydrodynamic behaviour of MgaSpn deviates from that of a rigid spherical particle with a 
frictional ratio value of 1.0. Thus, MgaSpn can be expected to have an ellipsoidal shape. 
The secondary structure content of the MgaSpn regulator determined by far-ultraviolet 
(far-UV) circular dichroism (CD) spectroscopic analyses correlates with the predicted by 
computational methods and revealed that MgaSpn has a high content of -helices 
(around 55%). In silico analyses using the Pfam protein families database (Punta et al., 
2012) and the protein structure prediction server Phyre2 (Kelley and Sternberg, 2009) 
have indicated that MgaSpn exhibits similarity to Mga and AtxA in the domain 
organization. It presents: two putative DNA-binding motifs (HTH-Mga and Mga, 
respectively) within the N-terminal region, two putative PTS regulatory domains (PRDs) 
at the central region and an EIIB-like motif at the C-terminal region. This organization of 
functional domains suggests that the N-terminal region of MgaSpn might participate in 
recognition and binding to DNA whereas the capacity to establish protein-protein 
interactions might reside at the C-terminal region.   
To study the effect of MgaSpn on gene expression, we constructed two 
derivatives of the pneumococcal R6 strain: a deletion mutant strain (R6Δmga) which 
does not synthesize MgaSpn and a strain designed to overproduce MgaSpn (R6Δmga 
/pDLPsulA::mga). The latter strain carries the mgaSpn gene cloned into a plasmid. In 
order to identify the target genes of the MgaSpn regulator, we analysed the effect of the 
absence of MgaSpn on the pattern of global gene expression by proteomics (strain R6 
versus strain R6Δmga). The results obtained showed changes in 10 candidates. One of 
the proteins whose levels decreased (2.3-fold) in the absence of MgaSpn was the 
putative general stress protein 24, encoded by the spr1625 gene. In this work we have 
demonstrated by RT-PCR assays that the spr1625 gene is the third of four genes 
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(spr1623, spr1624, spr1625 and spr1626) of unknown function that are transcribed into a 
polycistronic mRNA molecule. The operon is located upstream of the mgaSpn gene and 
on the complementary strand. Moreover, it is conserved in other pneumococcal strains 
whose genomes have been totally sequenced and several observations suggest that it 
might play a role in virulence. Additionally, primer extension experiments have shown 
that the spr1623-spr1626 operon is transcribed from two promoters named P1623A and 
P1623B. To study in detail the effect of MgaSpn on the activity of the P1623A and 
P1623B promoters, a DNA fragment that contained both promoters was cloned into the 
pAST plasmid (Ruiz-Cruz et al., 2010), just upstream of a promoter-less gfp gene. 
Fluorescence assays combined with primer extension experiments (R6, R6Δmga, 
R6/pDLPsulA::mga and R6Δmga/pDLPsulA::mga as genetic backgrounds) allowed us to 
conclude that MgaSpn activates in vivo the P1623B promoter. Such activation requires a 
region of 70-bp (named PB activation region) located between the Pmga and the 
P1623B divergent promoters. Furthermore, we have shown that MgaSpn does not 
influence the activity of its own promoter under the experimental conditions tested. This 
part of the Thesis was published in 2012 (Solano-Collado et al., 2012). 
We have performed an in-depth analysis of the DNA-binding properties of the 
MgaSpn transcriptional regulator by different techniques (electrophoretic mobility shift 
assays (EMSA), footprinting and electron microscopy). This part of the Thesis was 
published in 2013 (Solano-Collado et al., 2013). By EMSA we have demonstrated that 
MgaSpn binds to linear double-stranded DNA. The binding reaction reaches the 
equilibrium very fast (less than 1 min) and is not affected by the salt concentration used 
in the experiments (20-300 mM NaCl). Using DNA fragments from different sources, we 
found that MgaSpn is able to bind to any tested DNA generating a pattern of complexes 
compatible with the formation of multimeric complexes, in which multiple protein units 
bind orderly on the same DNA molecule. Thus, MgaSpn binds DNA with high affinity, but 
with low sequence specificity. The ability of MgaSpn to spread along the DNA molecule 
was confirmed by DNase I footprinting experiments. Also, EMSA experiments suggested 
that multiple MgaSpn units bind to DNA in a non-cooperative manner.  
By DNase I footprinting assays, we analysed the binding of MgaSpn to a 222-bp 
DNA, which contained the PB activation region at internal position as well as the Pmga 
and the P1623B divergent promoters. This study showed that MgaSpn interacts with 
sequences located between the -52 and -102 positions with respect to the P1623B 
transcription start site. Such a region is included within the PB activation region. 
Therefore, the MgaSpn regulator activates directly the P1623B promoter. These results 
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were further confirmed by hydroxyl radical footprinting experiments. Specifically, MgaSpn 
interacts with a region between the -60 and -99 positions relative to the P1623B 
promoter. Additionally, we used a 224-bp DNA fragment that lacks the P1623B promoter 
but contains the Pmga promoter and the PB activation region. The latter placed at one 
DNA end. Unexpectedly, in such a fragment, MgaSpn does not recognize the PB 
activation region as its primary site. Instead, it recognizes a region between the -23 and 
+21 positions relative to the Pmga promoter. In both DNA fragments (222 and 224-bp), 
upon binding to its primary site, multiple MgaSpn units bind orderly along the DNA 
fragment.  
By electron microscopy experiments, we have analysed the binding of MgaSpn to 
long DNA molecules (640-1485 bp). Such fragments contained both primary sites (the 
PB activation region and the Pmga promoter) at internal positions. The results obtained 
revealed that MgaSpn binds to the PB activation region rather than to the Pmga 
promoter when both sites are located at internal positions on the same DNA. Moreover, 
they supported that MgaSpn is able to spread along the DNA upon binding to a particular 
site.  
Sequence analysis of the two sites recognised preferentially by MgaSpn showed a 
low sequence identity: GGT(A/T)(A/T)AATT and GA(A/T)AATT. Using the bend.it server 
(Vlahovicek et al., 2003) we have shown that both primary binding sites of MgaSpn 
contain a potential intrinsic curvature, which is surrounded by regions with the capacity of 
being easily bent. By EMSA experiments using an intrinsically curved DNA and a non-
curved DNA we have demonstrated that MgaSpn has a higher affinity for the naturally 
occurring curved DNA. Our study suggests that local DNA conformations might 
contribute to the DNA-binding specificity of MgaSpn. 
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1. Global regulation of virulence gene expression in pathogenic bacteria 
Bacteria usually live in habitats of frequently changing conditions and must be able 
to survive in the different environmental and physiological situations encountered during 
their life cycle. The genes necessary to adapt the cell physiology or metabolism to the 
new state are usually organized in a network of interconnected regulons, which are 
expressed differentially (activated and/or repressed) in response to the surrounding 
conditions. The ability to respond to these stimuli involves sensing the relevant signals 
and linking them to a coordinated expression of genes that encode factors suitable for 
the given situation. Virulence of pathogenic bacteria can be understood as a rapid 
adaptive response to different environments encountered as the pathogen progresses 
through its host. Global transcriptional regulators that respond to specific environmental 
signals are key elements in such regulatory networks. Bacteria often use classical two-
component signal transduction systems (TCSs), which are absent in mammals, to link 
environmental stimuli to adaptive responses (Stock et al., 2000). For instance, 13 TCSs 
have been identified in Streptococcus pneumoniae and some of them are known to 
contribute to its virulence. However, such a contribution has been shown to vary 
significantly depending on the pneumococcal strain and/or the infection model used 
(Beier and Gross, 2006; Paterson et al., 2006). A prototypical TCS comprises a sensor 
protein, which is anchored to the bacterial membrane, and a cytoplasmic regulatory 
protein (Figure 1A). Sensor proteins are histidine kinases (HKs) that monitor the external 
stimuli and transmit the signal to their cognate regulatory protein by a phosphorylation 
event. HKs typically present a modular structure composed of a diverse sensing domain 
(N-terminal region) and a highly conserved cytoplasmic kinase domain or kinase core (C-
terminal region), both of them connected by a transmembrane linker region. External 
changes are sensed by the N-terminal domain of the HK and transmitted to the kinase 
core, which is activated to autophosphorylate a conserved histidine residue (Figure 1A). 
HKs usually function as homodimers in which one HK monomer catalyses the 
phosphorylation of the conserved histidine in the second monomer. The phosphorylated 
kinase transfers the phosphoryl group to a conserved aspartate residue of its cognate 
regulatory protein (response regulator; RR). The phosphorylation event promotes 
conformational changes in the RR that allow it to regulate gene expression either at 
transcriptional level (in most of the reported cases) or at post-transcriptional level (for a 
review see Perry et al., 2011).   
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In addition to TCSs, various stand-alone response regulators have been implicated 
in the global regulation of virulence gene expression (Figure 1B). In general, the term 
stand-alone response regulator has been used in the literature to define global 
transcriptional regulators that (i) are not associated to a membrane-bound sensor HK, (ii) 
their activity and/or intracellular concentration changes in response to specific external 
stimuli and (iii) their signal transduction components have yet to be fully defined (McIver, 
2009). To this class of global transcriptional regulators belongs the pneumococcal 
MgaSpn protein, whose molecular characterization has been the main goal of this work. 
At present, MgaSpn is thought to be a member of the Mga/AtxA family of global 
response regulators, which includes the Mga and the AtxA virulence regulators encoded 
by the Gram-positive (G+) pathogens S. pyogenes (the Group A Streptococcus, GAS) 
and Bacillus anthracis, respectively.  
Figure 1. Adaptation to environmental changes. (A) A typical two-component signal transduction system (TCS). 
After detection of the environmental signal by the N-terminal domain of the histidine kinase (HK), it uses ATP to 
autophosphorylate a conserved histidine residue within the cytoplasmic domain. The phosphoryl group is then 
transferred to an aspartate residue on its cognate cytoplasmic response regulator (RR). The phosphorylated RR is 
now able to exert its regulatory function by interaction with promoter regions located upstream of the target 
genes. (B) Stand-alone global response regulators. In general, the signal transduction mechanism remains to be 
defined. The regulator influences positively or negatively the expression of its target genes in response to the 
environment.  
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2. The Group A Streptococcus Mga virulence regulator 
Unlike many other pathogenic bacteria, GAS does not appear to use alternative 
sigma factors to regulate virulence gene expression. Instead, it depends on global 
response regulators, both TCSs and stand-alone response regulators (Kreikemeyer et 
al., 2003; McIver, 2009). GAS is a strict human pathogen that causes a broad spectrum 
of diseases ranging from benign, self-limiting infections to life-threatening invasive 
disorders (Cunningham, 2000). Mga (multiple gene regulator of GAS) was the first 
stand-alone response regulator described in GAS. This protein controls the expression of 
approximately 10% of the GAS genome during the exponential growth phase (Ribardo 
and McIver, 2006), when expression of the mga gene is maximum. Expression of mga 
also increases at elevated levels of CO2, normal body temperature, and increased levels 
of iron or metabolizable sugars. Mga activates the transcription of several virulence 
genes which encode factors important for adherence and internalization into non-
phagocytic cells (M protein: emm, arp; M-family proteins: mrp/fcrA, enn; fibronectin-
binding proteins: fba, sof/sfbX; and collagen-like protein: sclA) and factors that enable 
the bacterium to evade the host immune responses (M protein: emm; M-like proteins: 
mrp, arp, enn; C5a peptidase: scpA; and complement inhibitors: sic, fba). Mga is also 
able to activate the expression of its own gene providing a mechanism to amplify the 
Mga regulon (McIver et al., 1999). In addition, Mga activates or represses, likely in an 
indirect way, the expression of genes involved in the transport and utilization of 
carbohydrates, iron, amino acids, and other metabolites. Thus, Mga is able to regulate 
not only virulence genes but also genes important for the metabolic homeostasis of GAS 
(Hondorp and McIver, 2007; McIver, 2009). Moreover, Mga is able to regulate not only 
genes located adjacent to its own gene but also distant genes (Figure 2). 
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Mga is a large protein (530 amino acids; 62 kDa) with capability to bind directly to 
regions located upstream of its target genes, as was shown by electrophoretic mobility 
shift assays (EMSAs) and DNase I footprinting experiments using Mga fusion proteins 
(either Mga fused to the maltose binding protein (43 kDa) or Mga fused to a His-tag) 
(McIver et al., 1995; McIver et al., 1999). However, a consensus site for Mga binding has 
not been defined (Hondorp and McIver, 2007; Hause and McIver, 2012). The N-terminal 
region of Mga contains two motifs that were shown to be involved in DNA binding and 
transcriptional activation: a classical HTH motif (HTH-3, residues 53-72) and a winged 
HTH motif (HTH-4, residues 107-126). Unlike the HTH-3, the HTH-4 motif is essential for 
Mga binding to all the promoters tested so far. In addition, a small conserved domain 
CMD-1 (conserved Mga domain-1, residues 10-15) also seems to contribute to DNA 
binding and activation (Vahling and McIver, 2006). Two central regions of Mga were 
predicted to have homology to the dual Phosphotransferase System (PTS) Regulation 
Domains (PRDs): PRD-1 (residues 170-287) and PRD-2 (residues 288-390) (Figure 3) 
(Hondorp and McIver, 2007). PRDs are structural domains found generally in 
transcriptional activators and antiterminators involved in the regulation of sugar 
Figure 2. Overview of the Mga regulon in GAS. A compilation of Mga-regulated genes and their products based 
on their known or predicted function in GAS. An arrow indicates transcriptional activation, while repression is 
indicated with a bar. Genes that are activated directly by Mga (Core Regulon Genes) are listed at the top. Genes 
that are activated or repressed by Mga likely indirectly (low-level regulation) are shown at the bottom (Figure 
from Hondorp and McIver, 2007). 
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metabolism (reviewed in Deutscher et al., 2006). The activity of such regulators is 
modulated by phosphorylation of conserved histidine residues within the PRDs in 
response to the utilization of different carbon sources. In a recent study, Hondorp et al. 
(2013) indicated that Mga activity might be modulated (both positively and negatively) by 
PTS-mediated phosphorylation, thereby linking Mga-mediated regulation to the sugar 
status of the cell. Also recently, an EIIB-like domain has been identified at the C-terminal 
region of Mga (residues 407-490). Truncation analyses suggested that the C-terminal 
region of Mga is important for oligomerization in solution, and that the formation of 
oligomers appears to correlate with transcriptional activation (Hondorp et al., 2012). 
Nevertheless, and despite the mentioned findings, the transcriptional regulation 
mechanism mediated by Mga remains unknown. 
 
 
 
 
 
 
3. The Bacillus anthracis AtxA virulence regulator  
The G+ bacterium B. anthracis is the causative agent of anthrax. It carries two 
plasmids that are essential for its virulence: pXO1 and pXO2. Plasmid pXO1 encodes 
the AtxA (Antrax toxin Activator) global transcriptional regulator, which activates directly 
the expression of the three anthrax toxin genes located in plasmid pXO1: pagA 
(Protective Antigen, PA), cya (Edema Factor, EF) and lef (Lethal Factor, LF). Moreover, 
AtxA activates indirectly, through the AcpA and AcpB regulators, the expression of the 
capsule biosynthetic operon (capBCADE), which is located in plasmid pXO2. In addition 
to plasmid-encoded genes, AtxA is able to activate or repress the expression of multiple 
genes located on the bacterial chromosome (reviewed in Fouet, 2010). Expression of the 
Figure 3. Domain organization of Mga and AtxA. The Mga regulator contains three N-terminal motifs involved 
in DNA binding (CMD-1, HTH-3 and HTH-4), two central regions with homology to PTS regulation domains (PRD-
1 and PRD-2) and an EIIB-like domain at the C-terminal region (Vahling and McIver, 2006; Hondorp and McIver, 
2007; Hondorp et al., 2012). AtxA contains two N-terminal DNA binding motifs (WH and Mga), two central PRDs 
and a C-terminal EIIB-like domain involved in AtxA-AtxA interactions (Tsvetanova et al., 2007; Hadjifrangiskou 
and Koehler, 2008; Hammerstrom et al., 2011).  
 
Introduction 
 
 
32 
atxA gene is affected by temperature, carbohydrate availability, growth phase and redox 
conditions. Two independent promoters were shown to govern the expression of atxA 
(Bongiorni et al., 2008). However, the mechanism(s) regulating the activity of these 
promoters are largely unknown. On the other hand, AtxA activity is modulated by 
phosphorylation within the PRDs (presumably by components of the PTS) (see below). 
In addition, the regulator CodY controls indirectly the intracellular levels of AtxA. Schaik 
et al. (2009) have suggested that either CodY represses an unidentified protease that 
degrades AtxA or CodY activates the synthesis of a factor (e.g. a chaperone) that 
influences AtxA stability. The key host-related signal associated with AtxA-regulated 
gene expression is CO2/bicarbonate, which affects AtxA function (Dai and Koehler, 1997; 
Hammerstrom et al., 2011).  
AtxA is a 56 kDa protein (475 amino acids) whose domain organization is similar to 
that mentioned before for the Mga virulence regulator (Figure 3). Its N-terminal region 
contains two DNA binding motifs: a winged-helix (WH) motif (residues 8-67) and a HTH 
motif (residues 75-160). Nevertheless, studies on the interaction of AtxA with DNA are 
not available. It was shown that the promoter regions of several AtxA-regulated genes do 
not exhibit sequence similarities, but in silico and in vitro analyses revealed that the 
anthrax toxin promoter regions are characterized by intrinsic curvature (Hadjifrangiskou 
and Koehler, 2008). The central region of the AtxA regulator contains two PRDs. It was 
reported that the activity of AtxA is influenced by phosphorylation/dephosphorylation 
events within the PRDs. In the current model of AtxA activity, phosphorylation of a 
conserved histidine (H199) in PRD1 results in activation of the regulator whereas 
phosphorylation of a conserved histidine (H379) in PRD2 inhibits the transcription of the 
toxin genes (Tsvetanova et al., 2007). Moreover, the C-terminal region of AtxA, which 
contains an EIIB-like motif (residues 385-475), is involved in AtxA-AtxA interactions and, 
therefore, in the formation of homodimers and higher-order oligomers (Hammerstrom et 
al., 2011).  
4. Virulence factors of Streptococcus pneumoniae 
The G+ bacterium S. pneumoniae, commonly called the pneumococcus, is a 
member of the normal human nasopharyngeal flora, where it exists asymptomatically as 
a commensal. The rate of pneumococcal carriage varies upon age, socioeconomic 
status, environmental factors and geographic area (Bogaert et al., 2004; Weiss-Salz and 
Yagupsky, 2010). S. pneumoniae generally occurs as characteristic diplococci and 
produces α-haemolysis. This bacterium is genetically closely related to other commensal 
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streptococci such as S. mitis and S. oralis. However, S. pneumoniae is a well-known 
human pathogen capable of causing a wide spectrum of diseases. From the 
nasopharynx, the pneumococcus can spread through the airway to the lower respiratory 
tract producing pneumonia. Also, it can invade other places causing diseases such as 
sinusitis, conjunctivitis, otitis media, meningitis and bacteremia (Kadioglu et al., 2008; 
van der Poll and Opal, 2009). The increasing resistance of S. pneumoniae to antibiotics 
has resulted in the pneumococcus remaining as a major cause of morbidity and mortality 
worldwide. Recent data estimate that pneumococcal pneumonia kills annually around 1.2 
million children younger than five years, more than AIDS, malaria and tuberculosis 
combined (http://www.who.int/mediacentre/factsheets/fs331/en/index.html). 
Pneumococci are transmitted from person to person through airborne droplets from 
a cough or sneeze, and in Europe and the United States it is the most common cause of 
community-acquired bacterial pneumonia in adults. In fact, the annual incidence of 
invasive pneumococcal disease ranges from 10 to 100 cases per 100,000 population 
(http://www.who.int/ith/diseases/pneumococcal/en). Genetically, S. pneumoniae is very 
versatile because of its ability to take up DNA from the environment and incorporate it 
into the genome. Pneumococci can obtain exogenous DNA from different sources, such 
as the extracellular matrix of pneumococcal biofilms (Hall-Stoodley et al., 2008) or via 
microbial fratricide (Havarstein et al., 2006), generating a large variety of genetic 
differences among pneumococcal strains. S. pneumoniae is a facultative anaerobe but it 
is able to adapt to conditions of high oxygen tension. This ability is crucial to protect itself 
from the harmful effects of oxygen, as the generation of H2O2 during bacterial 
metabolism. In this study, we have worked with S. pneumoniae R6, a strain that derives 
from the D39 clinical isolate (serotype 2) (Lanie et al., 2007). R6 is avirulent due to the 
lack of a polysaccharide capsule and its genome has been totally sequenced (Hoskins et 
al., 2001). 
As indicated above, the pneumococcus resides asymptomatically and as a 
commensal in the nasopharynx of healthy individuals. However, when the immune 
system weakens, it can cause serious diseases. The pneumococcus produces virulence 
factors that enable the organism to colonize and invade other host niches as well as to 
escape from the host immune response (Figure 4). The role of several pneumococcal 
virulence factors is described in this section. Among them, the polysaccharide capsule is 
probably the most important virulence determinant in pneumococci. Over ninety different 
antigenic types of S. pneumoniae have been identified so far. (Bentley et al., 2006; 
Yother, 2011). Briles et al. (1992) demonstrated that exists a relationship between 
capsular serotype and virulence. Loss of capsule reduces S. pneumoniae virulence in 
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animal models (Morona et al., 2004). In systemic infections such as pneumonia and 
bacteremia the capsule protects pneumococci from the host immune system by 
impeding opsonization and subsequent phagocytosis (van der Poll and Opal, 2009; 
Hyams et al., 2010). The capsule also confers advantages to the pathogen by preventing 
its physical removal by mucus (Nelson et al., 2007). In addition, it restricts autolysis and 
reduces the exposure to antibiotics (Kadioglu et al., 2008).  
 
 
 
 
 
 
The toxin pneumolysin (PLY; haemolysin) has been found in almost all 
pneumococcal clinical isolates. It is produced as a soluble protein that oligomerizes in 
the membrane of target cells forming a transmembrane pore, which finally provokes cell 
lysis. In addition to its citolytic activity, PLY is able to activate the classical complement 
pathway, producing a reduction of serum opsonic activity (Paton et al., 1983). However, 
how PLY is able to prevent complement deposition on the bacterial surface is unknown. 
Its role in diseases such as bacteremia and pneumonia was reported (Hirst et al., 2004; 
reviewed in Mitchell and Mitchell, 2010).  
On the surface of the pneumococcus there are a variety of proteins anchored either 
by the G+ LPXTG attachment motif or by non-covalent interactions with the choline 
present in both the cell wall teichoic acid or in the membrane-associated lipoteichoic acid 
(choline-binding proteins; CBPs). The group of LPXTG-anchored surface proteins 
includes the enzymes hyaluronidase, neuraminidase, and the serine protease PrtA. 
Hyaluronidase degrades hyaluronic acid, a component of the mammalian connective 
tissue, thus acting as a spreading factor during pneumococcal infection and facilitating 
bacterial colonization of new host niches (Hynes and Walton, 2000). The enzyme 
Figure 4. Main pneumococcal virulence 
factors. S. pneumoniae resides as a 
commensal in the upper respiratory 
tract of healthy people. However, it can 
cause several diseases. Important 
virulence factors of the pneumococcus 
include the polysaccharide capsule, 
choline-binding proteins, LPXTG-
anchored proteins, ABC-transporters 
and both, the autolysin (LytA) and the 
pneumolysin (PLY; haemolysin) 
(modified from Kadioglu et al., 2008). 
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neuraminidase cleaves N-acetylneuraminic acid from glycolipids, glycoproteins, 
lipoproteins and oligosaccharides, causing a direct damage to the host. Also, it probably 
favors colonization as a result of its action on glycans. Among all pneumococcal 
enzymes with neuraminidase activity, neuraminidase A (NanA) has been shown to have 
a role in colonization and development of otitis media in animal models (Tong et al., 
2000). The cell wall-associated serine protease PrtA has been reported to be involved in 
virulence in a mouse-peritonitis infection model, since mice infected with a PrtA-deficient 
mutant lived longer than mice infected with the wild-type strain (Bethe et al., 2001). 
Although the exact role of PrtA is unknown, proteases are generally involved in virulence 
as a result of its capability to cleave host proteins such as immunoglobulins, complement 
compounds and proteins of the extracellular matrix. The LPXTG-containing proteins are 
covalently attached to the cell surface by the action of sortase enzymes. In the 
pneumococcus, inactivation of sortase A (SrtA) causes the release of neuraminidase and 
hyaluronidase into the surrounding medium and reduces the adherence of the non-
capsular R6 pneumococcal strain to human cells (Kharat and Tomasz, 2003; Paterson 
and Mitchell, 2006). Regarding the CBPs, it is known that they contribute to 
pneumococcal virulence in different ways. This protein family includes the hydrolytic 
enzymes LytA (autolysin), LytB, LytC, CbpA and CbpE among others. These factors are 
involved in nasopharyngeal colonization and adhesion to host tissues. In addition, LytA 
releases other virulence factors such as the cytoplasmic PLY and cell wall degradation 
components that can provoke inflammatory responses of the host. Moreover, there are 
CBPs that protect the pneumococcus against the host complement system such as 
PspA and PspC (reviewed in Mitchell and Mitchell, 2010).  
Many other proteins related to the transport of different compounds like manganese 
(Mn2+) and iron (Fe2+) have been also involved in pneumococcal virulence. Focused on 
the pneumococcal infection process, Mn2+ is available in the human nasopharynx but it is 
more restricted at internal sites. It has been shown that pneumococci require Mn2+ to 
grow in the presence of Fe2+ under aerobic conditions (Johnston et al., 2004) and it is 
needed for the activity of CpsB, which is involved in the regulation of capsule production 
(Bender and Yother, 2001). Because of its importance and its relative low accessibility 
within the human body, the pneumococcus requires an efficient system of transport and 
utilization of Mn2+. The Mn2+ transport system is an ABC-type permease encoded by the 
psaBCA genes. PsaA is a lipoprotein, which initially binds the metal on the cell surface. 
PsaB (ATP-binding protein) and PsaC (hydrophobic membrane protein) are also 
components of the transport permease. A gene for thiol peroxidase (PsaD) is both 
transcribed separately and also co-transcribed within the psaBCAD transcript. Although 
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S. pneumoniae lacks catalase, the presence of PsaD protects bacteria against oxidative 
damage caused by hydrogen peroxide generated as a product of pyruvate oxidation 
during growth in the presence of oxygen (Tseng et al., 2002; McAllister et al., 2004; Hajaj 
et al., 2012). Fe2+ is an essential element in the metabolism of most bacteria since it is 
used as a cofactor by many proteins. S. pneumoniae has a limited demand for iron 
because it lacks a respiratory chain and it does not possess cytochromes. Nevertheless, 
Fe2+ is required for enzymes such as ribonucleotide reductase, which catalyses the 
formation of deoxyribonucleotides from ribonucleotides and, therefore, is involved in the 
synthesis of DNA. However, the availability of iron in the host is very restricted because 
of its chelation by host iron-binding proteins such as lactoferrin, haemoglobin and 
transferrin (Wooldridge and Williams, 1993). Its low availability constitutes a nutritional 
barrier to infection. In S. pneumoniae, three iron-uptake ABC transporters have been 
identified, termed Pit (pitADBC), Pia (piaABCD) and Piu (piuBCDA). Each one comprises 
four proteins: one iron carrier-binding protein, two heterodimer-forming permeases and 
one ABC ATPase (Brown et al., 2001; Brown et al., 2002). Mutation of both pia and piu 
leads to attenuation of S. pneumoniae virulence in a murine model of septicemia and 
pneumonia (Brown et al., 2001; Jomaa et al., 2005). 
5. The pneumococcal MgaSpn regulator
The genomic sequence of the S. pneumoniae TIGR4 strain (a serotype 4 clinical 
isolate) showed that about 5% of its genome is composed of insertion sequences that 
may contribute to genome rearrangements through uptake of foreign DNA (Tettelin et al., 
2001). Signature-tagged mutagenesis experiments in TIGR4 led to the identification of 
several TCSs and other putative transcriptional regulators that may play a role in the 
ability of the bacterium to adapt to changing environments (Hava and Camilli, 2002). One 
of such putative regulators was named MgrA (Mga-like repressor A) due to its homology 
to the multiple gene regulator Mga of GAS (51% of similarity and 25% of identity) 
(Hemsley et al., 2003). This protein is encoded by the sp1800 gene (mgrA), which is 
highly conserved in the pneumococcal genomes of those that have been partially or 
totally sequenced. Using murine infection models, MgrA was shown to be required for 
both nasopharyngeal colonization and lung infection, but not for the ability of 
pneumococci to cause bacteremia. Microarray experiments carried out comparing the 
transcriptional profile of two mutant strains, one lacking the mgrA gene and another 
overexpressing mgrA, indicated that MgrA acts as a repressor of genes located within 
the rlrA pathogenicity islet (Hemsley et al., 2003). Some of these genes had been 
characterized previously as virulence factors (Hava et al., 2003). However, in contrast to 
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the mgrA gene, the rlrA pathogenicity islet has been found only in a small number of 
pneumococcal strains. These findings suggested that the islet might not be the main 
target of MgrA and, therefore, novel MgrA-regulated genes could be identified in other 
pneumococcal strains and/or under different bacterial growth conditions. In fact, some 
transcriptional regulators can alter the transcriptional profile in a different manner 
depending on the bacterial strain and/or serotype (Hendriksen et al., 2009; Hendriksen et 
al., 2007).  
In 2001, the genome of the pneumococcal R6 strain, which derives from the D39 
clinical isolate (serotype 2), was totally sequenced (Hoskins et al., 2001). Unlike the 
TIGR4 strain, both R6 and D39 lack the rlrA pathogenicity islet (Hoskins et al., 2001; 
Lanie et al., 2007). In 2008, Paterson et al. reported that the R6 strain contains a 
putative mga-like gene (spr1404). It is adjacent to a gene (spr1403) that encodes a 
collagen-like protein (PclA). Both genes are located in the called R6-specific cluster 
(Brückner et al., 2004), a region of 9.6 kb that is absent in TIGR4. The spr1404 gene 
product has homology (40% of similarity) to the Mga virulence regulator of GAS. 
However, single-deletion mutants lacking either spr1404 or spr1403 were not attenuated 
in a mouse model of invasive pneumonia (Paterson et al., 2008). Thus, as pointed out by 
the authors, further work is required to elucidate whether the spr1404 gene has a 
significant role in pathogenesis.  
Searching for homologies, we found another putative mga-like gene in strain R6 
(gene spr1622, from now on named mgaSpn), which is equivalent to the sp1800 (mgrA) 
gene of the TIGR4 strain. MgaSpn (493 residues) differs from MgrA in two amino acid 
residues. EMBOSS needle global sequence alignment (Rice et al., 2000) of the MgaSpn 
protein and the Mga virulence regulator (530 amino acids; encoded by the M6_Spy1720 
gene of S. pyogenes MGAS10394) revealed 42.6% of similarity and 21.4% of identity. 
Similar alignment analyses of the MgaSpn protein and the AtxA virulence regulator (475 
amino acids; encoded by the atxA gene of plasmid pXO1 of B. anthracis) revealed 
39.9% of similarity and 20.7% of identity. Because of its similarity with both regulators, 
we proposed at the beginning of this work that the pneumococcal MgaSpn protein could 
be considered as a member of the Mga/AtxA family of transcriptional regulators, and it 
might act as a global response regulator activating and/or repressing the expression of 
virulence genes.  
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6. Significance of this work
The pneumococcus remains a major cause of morbidity and mortality worldwide. 
Understanding the molecular mechanisms that control the expression of pneumococcal 
virulence genes in response to environmental stimuli offers new insights into the 
pathogenesis of this bacterium, and gives new visions to improve interventions. Due to 
their role in viability and virulence of bacterial pathogens as well as its absence in 
vertebrates, TCSs have received attention as potential antimicrobial targets (Barrett and 
Hoch, 1998). However, novel pneumococcal transcriptional regulators that are emerging, 
as it is the case of the stand-alone regulator MgaSpn, might have important roles in the 
virulence of S. pneumoniae. Therefore, the molecular characterization of MgaSpn may 
reveal new mechanisms used by the pneumococcus to control virulence gene 
expression in response to external stimuli. Although the role in pathogenesis of other 
members of the Mga/AtxA family of regulators (specifically Mga and AtxA) is well known, 
studies of both regulators at a molecular level are still very limited. When this work was 
started, we knew almost nothing regarding the pneumococcal Mga-like regulator except 
that (i) it was involved in nasopharyngeal colonization and development of pneumonia in 
murine infection models (Hava and Camilli, 2002), and (ii) it was a repressor of the rlrA 
pathogenicity islet (Hemsley et al., 2003). Therefore, this Doctoral Thesis has been 
focussed on the molecular characterization of the MgaSpn transcriptional regulator. Our 
findings have contributed to increase the knowledge of this pneumococcal virulence 
regulator.  
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Searching for homologies, we found that the genome of S. pneumoniae encoded a 
potential global response regulator of the Mga/AtxA family. Such a regulator (here 
named MgaSpn) had been previously associated with virulence. The molecular 
characterization of MgaSpn has been the main aim of this Thesis because of its likely 
contribution to fully understand the pathogenic mechanisms of S. pneumoniae. To this 
end, we have worked on the following objectives:       
1. Identification of the mgaSpn gene promoter.
2.
3.
4.
5. Study of the interaction of MgaSpn with linear double-stranded DNAs.
Development of a procedure for large-scale purification of the untagged MgaSpn 
protein.
Analysis of the oligomerization state of MgaSpn in solution and determination of its 
secondary structure content.
Identification of MgSpn-regulated genes: analysis of the effect of MgaSpn on the 
expression of the spr1623-spr1626 operon.
Materials and Methods 
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Materials 
1. Bacterial strains
Table 1. Bacterial strains used in this work 
Strain Features Source 
S. pneumoniae 708 end-1, exo-1, trt-1, hex-4, malM594 
(Lacks and 
Greenberg, 1977) 
S. pneumoniae R6 
Nonencapsulated strain derived from the 
serotype 2 clinical isolate D39 
(Lacks et al., 1986) 
S. pneumoniae R6∆mga 
Strain derived from R6. It lacks the mgaSpn 
gene 
This work 
E. coli BL21 (DE3) 
DE3 (lacI lacUV5-T7 gene 1 ind1 sam7 
nin5) F- dcm ompT hsdS(rB -mB+) gal 
(Studier and 
Moffatt, 1986) 
2. Culture media
S. pneumoniae cells were grown in AGCH medium (Lacks, 1966; Ruiz-Cruz et 
al., 2010) supplemented with 0.2% yeast extract and 0.3% sucrose. In the case of S. 
pneumoniae R6∆mga strain, chloramphenicol (Cm) was added to a final concentration of 
1.5 µg/ml. Plates for bacterial growth in solid medium were freshly prepared as is 
reported in Methods, Section 1. Pneumococcal cells harbouring plasmids were grown in 
media supplemented with tetracycline (Tc; 1 µg/ml) and/or kanamycin (Km; 30-50 
µg/ml). Competent cells were grown in AGCH medium supplemented with 0.2% sucrose 
and 70 M CaCl2. E. coli cells were grown in tryptone-yeast extract (TY) medium (1% 
tryptone, 0.5% yeast extract, 0.5% NaCl) (Maniatis et al., 1982). In the case of plasmid-
harbouring cells, the medium was supplemented with Km (30-50 µg/ml). Plates were 
prepared with TY and 1.5% agar. For competence of E. coli, SOB medium (Hanahan, 
1983) was used. After transformation, cells were incubated in SOC medium (SOB 
medium supplemented with 20 mM glucose). 
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3. Enzymes, chemical products and reactives
Restriction enzymes, T4 DNA ligase, T4 polynucleotide kinase and bovine serum 
albumin (BSA) were acquired from New England BioLabs. DNase I RNase-free, 
isopropyl-β-D-thiogalactopyranoside (IPTG), proteases inhibitor cocktail EDTA-free 
complete, proteases inhibitor cocktail complete, High Pure Plasmid Isolation kit, rNTPs 
and dNTPs were provided by Roche Applied Science. Phusion High-Fidelity DNA 
Polymerase (Finnzymes) was used. ThermoScript reverse transcriptase, RNase inhibitor 
SuperaseIn and protein pre-stained standard SeeBlue Plus were purchased to 
Invitrogen. HyperLadder DNA molecular weight marker was from Bioline. Proteinase K, 
RNase A, lysozyme, tetracyclin (Tc), polyethylenimine (PEI), imidazole, His-select nickel 
affinity gel, and acrylamide:bis-acrylamide 40% solution (29:1 ratio) were from Sigma 
Aldrich. Ethanol absolute, hydrochloric acid, chloroform, isopropanol, aminoacids, 
vitamins, carbohydrates (sucrose and glucose) and magnesium were purchased to 
Merck. The saturated phenol was from AppliChem. Culture media components were 
from Pronadisa, Merck, Sigma, BD and Difco. Low molecular weight protein marker and 
the HiLoad Superdex 200 column were from Amersham Biosciences. DNA sequencing 
kit (Sequenase Version 2.0) was from USB Corporation. Radioactive nucleotides were 
purchased to Perkin-Elmer, Amersham Biosciences or Hartmann. Agarose, 
acrylamide:bis-acrylamide 30% solution (37.5:1 ratio), ammonium persulfate (PSA), -
mercaptoethanol, sodium dodecyl sulfate (SDS), Triton-X100, Bio-Safe Coomassie 
Stain, RNA isolation kit (Aurum Total RNA Mini kit), Immun-blot PVDF membranes, the 
Affi-Gel heparin gel for protein purification and the Econo-Column chromatography 
columns were from Bio-Rad. Acrylamide:bis-acrylamide 40% solution (19:1 ratio) was 
from National Diagnostics. The HiTrap Heparin HP and HisTrap HP columns and Illustra 
MicroSpinTM G-25 columns were from GE Healthcare. For gel extraction or cleanup of 
DNA from enzymatic reactions (PCR or enzymatic digestion) the QIAquick Gel 
Extraction kit from QIAGEN was used. Dialysis membranes were from Spectrum. 
Autoradiography films were acquired from Kodak (X-Omat S). Cronex Lightning Plus 
amplifying x-ray screens were from Dupont. Imaging plates to visualize radioactive 
labelling using the Fujifilm Image Analyzer FLA-3000 were from Fuji. Centrifugal filters 
for protein concentration were from Pall. 96-well plates for fluorescence measurements 
were from Millipore.   
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4. Nucleic acids
4.1. Plasmids 
Table 2. Plasmids used in this work. 
Plasmid 
Size 
(bp) 
Description Source 
pMV158 5,540 
Isolated from S. agalactiae: mobilizable by pAMβ1; 
Tc
R
(Burdett, 
1980) 
pLS1 4,408 
Derivative of pMV158 that lacks the 1,132-bp EcoRI 
restriction fragment; non-mobilizable; Tc
R
(Stassi et al., 
1981) 
pET-24b 5,309 
E. coli expression vector based on the Φ10 promoter 
of phage T7; Km
R Novagen 
pET-mgaSpn 6,821 
Derivative of pET-24b that encodes an untagged 
MgaSpn protein; Km
R This work 
pET-mgaSpn-His 6,790 
Derivative of pET-24b that encodes a His-tagged 
MgaSpn protein; Km
R This work 
pAS 5,210 
Terminator-probe vector. Derivative of pLS1 that 
carries the gfp reporter cassette of the pGreenTIR 
plasmid; Tc
R
(Ruiz-Cruz 
et al., 2010) 
pAST 5,456 
Promoter-probe vector. Derivative of pAS that carries 
the transcriptional termination sites T1T2 of the E. coli 
rrnB ribosomal RNA operon downstream of the tetL 
gene; Tc
R
(Ruiz-Cruz 
et al., 2010) 
pAST2 (pAS-
T2T1rrnB) 
5,456 
Derivative of pAS that carries the transcriptional 
termination sites T1T2 of the E. coli rrnB ribosomal 
RNA operon in the opposite orientation (compared to 
the pAST vector); Tc
R
(Ruiz-Cruz 
et al., 2010) 
pAS-Pmga 5,352 
Derivative of pAS that carries the promoter region of 
the mgaSpn gene (159440-1598305); Tc
R This work 
pAST2-Pmga 5,757 
Derivative of pAST2 that carries the promoter region 
of the mgaSpn gene (1598600-1598304); Tc
R This work 
pAST-PAB 5,757 
Derivative of pAST that carries the promoter region of 
the spr1623-1626 operon (1598304-1598600); Tc
R This work 
pAST-PAB 84 5,672 
Derivative of pAST that carries the promoter region of 
the spr1623-1626 operon (1598388-1598600); Tc
R This work 
pAST-PAB 153 5,602 
Derivative of pAST that carries the promoter region of 
the spr1623-1626 operon (1598457-1598600); Tc
R This work 
pDL287 5,740 Derivative of pVA380-1; Km
R (LeBlanc et 
al., 1993) 
pDLPsulA::mga 7,529 
Derivative of pDL287 containing the PsulA::mga 
PsulA-mga fusion gene into the ClaI site; Km
R This work 
Tc
R
, Km
R
: resistance to tetracycline and kanamycin, respectively
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4.2. Oligonucleotides 
The oligonucleotides used in this work were all synthesized at the CIB-Protein Chemistry Facility (Applied Biosystems 3400 
synthesizer), purified by HPLC and resuspended in water to a final concentration of 100 µM. Oligonucleotides used to obtain dsDNA fragments 
for electrophoretic mobility shifts assays were also purified from polyacrylamide denaturing gels (15-20% PAA, 8 M urea).  
Table 3. Oligonucleotides 
Name Bases Sequence (5´-3´) Applications 
1622Nde 27 GAGAGAAAGATACATATGAGAGATTTA MgaSpn purification 
1622Xho 26 GGTACAGTTCAAACTCGAGATAGCGT MgaSpn purification 
1622XhoHis 30 TTTTGTTATTTTCTCGAGCTCATCTAATCG MgaSpn-His purification 
C1622D 25 CTAAAAAAAGTCATAGGCAATTAGA RT-PCR 
1622A 20 AGTTCCTGATTGTATTCCCT RT-PCR. EMSA. EM 
1622C 20 GATTCTGTATTCACGCCCTC RT-PCR. EMSA. Footprinting 
1622D 26 TTCTAATTGCCTATGACTTTTTTTAG RT-PCR. EMSA. Footprinting 
1622B 20 CACAACACTGCCTACCCTCC EMSA. EM 
1622E 21 TAGATGAAGAAGTTGTTTGCC EMSA 
pUC-Rev 21 TTGTGAGCGGATAACAATTTC EMSA 
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Name Bases Sequence (5´-3´) Applications 
pUC-A 24 GGCTGCGCAACTGTTGGGAAGGGC EMSA 
PrSp1 26 ATAAATTATCGGATCCAACCTCTTGC Construction of pAS-Pmga plasmid 
PrSp2 26 GAATTTGATTCTGGATCCACGCCCTC Construction of pAS-Pmga plasmid 
UpSph 29 CCGTCTATTGAGGGCGTGCATGCAGAATC Construction of R6∆mga 
UpCla 29 TTTGACATATACAATCGATTCGATTTAAC Construction of R6∆mga 
DwSal 33 GTCTCACTCATATACTTGTCGACTGCCATGATG Construction of R6∆mga 
DwCla 34 CTATTCTTTTTCATACATCGATCATAATTATCAG Construction of R6∆mga 
CmSph 32 CTACAGAAAGTAAAGCATGCAAAGAGTAATGC Construction of R6∆mga 
CmSal 34 GCGAAAAAGGAGAAGTCGACTCAGAAAAAGAAGG Construction of R6∆mga 
91G_2 23 GGCTATTTTGATGCACATATCTG EMSA 
92A_2 21 CCCGCCTTCCTTCCCTTGCTC EMSA 
INTgfp 22 CATCACCATCTAATTCAACAAG Primer Extension 
Oligo1 40 TATATTGTCTCCGTAGTGTTATTATACGAAATAAAAGATT EMSA 
Oligo1C 40 AATCTTTTCTTTCGTATAATAACACTACGGAGACAATATA EMSA 
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Name Bases Sequence (5´-3´) Applications 
Oligo4 20 CTCCGTAGTGTTATTATACG EMSA 
Oligo4C 20 CGTATAATAACACTACGGAG EMSA 
Oligo2 20 TATATTGTCTCCGTAGTGTT EMSA 
Oligo2C 20 AACACTACGGAGACAATATA EMSA 
Oligo3 20 ATTATACGAAATAAAAGATT EMSA 
Oligo3C 20 AATCTTTTATTTCGTATAAT EMSA 
Oligo 40p 40 TATATCATGCTATACCTATTCTTTGTGGTATAATTGCAAG EMSA 
Oligo 40pC 40 CTTGCAATTATACCACAAAGAATAGGTATAGCATGATATA EMSA 
Oligo 32A 32 TTCTTTGTGGTATAATTGCAAGAGGTTTAATC EMSA 
Oligo 32B 32 GATTAAACCTCTTGCAATTATACCACAAAGAA EMSA 
Oligo 26A 26 TTCTTTGTGGTATAATTGCAAGAGGT EMSA 
Oligo 26B 26 ACCTCTTGCAATTATACCACAAAGAA EMSA 
1622F 23 CGATGAAACCAACGTTTATGTTC In vitro transcription 
1623A 20 GAGGGCGTGAATACAGAATC RT-PCR 
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Name Bases Sequence (5´-3´) Applications 
1623B 24 CGTAAATTTACATGAACAGTTGGG RT-PCR 
1623C 23 GGAGGGTAGGCAGTGTTGTGATC RT-PCR 
1626A 24 GCACCTTCTACAGCGTCTTTAGCG RT-PCR 
PsulNde 26 CAAGGATTTTCATCATATGATTTTTC Construction of pDLPsulA::mga plasmid 
PsulCla 28 ACTGATTGTTAATCGATTTGCTTTCTGT Construction of pDLPsulA::mga plasmid 
mgaNde 31 TGCAAGAGGTTTCATATGATAATTTATAAAG Construction of pDLPsulA::mga plasmid 
mgaCla 33 GTACATTTTTCTTAATCGATTGAAGGTCTTTTC Construction of pDLPsulA::mga plasmid 
EM1 25 AGTTGAATGTTTAAAGAAATGATGG EM in combination with 1622B 
EM5 27 CAATACAAATATTGTTTTGAAGAAGCC EM in combination with 1622F 
PmgaSac 30 CTTTATAAATTATGAGCTCAAACCTCTTGC Construction of pAST2-Pmga plasmid 
PABSac 31 ATATCAAAAAATCGAGCTCTTTGATTATTAC Construction of pAST-PAB plamid 
PAB∆84Sac 32 ATTTCGTATAAGAGCTCTACGGAGACAATATA Construction of pAST-PAB∆84 plasmid 
PAB∆153Sac 28 GAATACAGAATCGAGCTCAAGTCTAAAG Construction of pAST-PAB∆153 plasmid 
PDA 23 GTGATTTTACCTGCCAAGAGACC Primer Extension 
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Name Bases Sequence (5´-3´) Applications 
PDB 22 GAAAAGTCAATTATTTCGATTG Primer Extension 
PErpoE 23 GCCCAGCAAATACTTCTAATTCC Primer Extension (internal control) 
ASTtetL 23 GAGGGCAGACGTAGTTTATAGGG Primer Extension (internal control) 
1622H 26 CGGATTAAACCTCTTGCAATTATACC EMSA. Footprinting 
1622I 24 CAAATTCTTTAATTGTTGCTATTA EMSA. Footprinting 
a
Restriction sites are in bold, and the base changes that generate restriction sites are underlined. 
 
4.3. Linear double-stranded DNA fragments 
All dsDNA fragments were synthesized during the development of this work. 
Table 4. Linear dsDNA fragments  
Name Size (bp) Coordinates Features Applications 
1622CF 265 1598188-1598452 Includes Pmga promoter In vitro transcription 
1622CD 224 1598229-1598452 Includes Pmga promoter EMSA. Footprinting. In vitro transcription. 
1622HI 222 1598298-1598519 Includes Pmga and PB activation site EMSA. Footprinting. 
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Name Size (bp) Coordinates Features Applications 
1622AE 282 1597232-1597513 From coding region of mgaSpn EMSA 
1622BD 421 1598229-1598649 Includes Pmga promoter EMSA 
91G-92A2 (C) 321 94488-94808 DNA fragment intrinsically curved EMSA 
EM1-26A (NC) 322 1598010-1598331 Control without curvature EMSA 
20 20 1598376-1598395 Small dsDNA EMSA 
26 26 1598306- 1598331 Small dsDNA EMSA 
32 32 1598300-1598331 Small dsDNA EMSA 
40 40 1598310-1598349  Small dsDNA EMSA 
EM1-1622B 640 1598010-1598649 Includes Pmga and PB activation region EM 
1622BA 1418 1597232-1598649 Includes Pmga and PB activation region EM 
EM5-1622F 1458 1598188-1599645 Includes Pmga and PB activation region EM 
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5. Acrylamide solutions
For protein electrophoresis, an acrylamide:bis-acrlylamide 40% solution (40:1) or 
30% solution (37.5:1) was used. For nucleic acids, an acrylamide:bis-acrlylamide 30% 
solution (30:0.8) or 40% solution (29:1) for non-denaturing gels (native gels) and an 
acrylamide:bis-acrlylamide 38% solution (38:2) or 40% solution (19:1) for denaturing 
gels, were used.  
6. Buffer solutions
All buffers and solutions used in this work are listed in Table 5. 
Table 5. Buffers 
Buffer Composition Application 
TE 
10 mM Tris-HCl, pH 8.0 
1mM EDTA 
Storage of DNA 
TAE 
40 mM Tris 
20 mM Acetic acid 
2 mM EDTA 
pH 8.1 
DNA electrophoresis in agarose 
gels 
TBE 
89 mM Tris  
89 mM Boric acid 
2.5 mM EDTA  
pH 8.3 
DNA electrophoresis in 
polyacrylamide gels 
TG 
50 mM Tris-HCl, pH 8.3 
300 mM Glycine  
0.1% SDS  
2 mM EDTA 
Protein electrophoresis: SDS-
PAGE (Tris-Glycine) 
Buffer gel 
3 M Tris-HCl, pH 8.45 
0.3% SDS 
Protein electrophoresis: SDS-
PAGE (Tris-Tricine) 
Cathode buffer 
100 mM Tris-HCl, pH 8.25 
100 mM Tricine 
0.1% SDS 
Protein electrophoresis: SDS-
PAGE (Tris-Tricine) 
Anode buffer 
200 mM Tris-HCl, pH 8.9 
Protein electrophoresis: SDS-
PAGE (Tris-Tricine) 
SLB 5X 
250 mM Tris-HCl, pH 7.2 
10% SDS  
Loading-dye for protein 
electrophoresis (SDS-PAGE) 
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Buffer Composition Application 
3.5 M -mercaptoethanol 
50% Glycerol  
0.5% Bromophenol blue  
BXGE 10X 
0.25% Bromophenol blue 
0.25% Xylene cyanol  
60% Glycerol  
10 mM EDTA  
Loading-dye for gel 
electrophoresis of DNA and DNA-
protein complexes 
V-His 
10 mM Tris-HCl, pH 7.6 
5% Glycerol  
300 mM NaCl  
-mercaptoethanol 
Purification of MgaSpn-His protein. 
Buffer V-His was supplemented 
with imidazole (10 or 250 mM) 
P 
20 mM Tris-HCl, pH 7.6 
5% Glycerol  
250 mM NaCl  
1 mM EDTA  
1 mM DTT 
Storage of MgaSpn-His 
VL 
50 mM Tris-HCl, pH 7.6 
5% Glycerol  
1 mM DTT  
1 mM EDTA  
Purification and storage of 
MgaSpn protein. Buffer VL was 
supplemented with different 
concentrations of NaCl 
FXBE 
80% Formamide  
0.1% Xylene cyanol  
0.1% Bromophenol blue 
10 mM EDTA  
Loading-dye for RNA 
electrophoresis 
AU 
20 mM Tris-HCl, pH 7.6 
1 mM EDTA  
0.1 mM DTT 
5% Glycerol  
250 mM NaCl 
Protein analysis by analytical 
ultracentrifugation 
EB 
200 mM NaCl  
20 mM Tris-HCl, pH8 
2 mM EDTA  
Elution of DNA from native PAA 
(5%) gels 
OEB 
10 mM Magnesium acetate 
200 mM Sodium chloride  
0.1% SDS 
Elution of oligonucleotides from 
denaturing PAA gels 
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Buffer Composition Application 
EM 
20 mM Tris-HCl, pH7.5 
MgCl2 10 mM 
Mica adsorption in electron 
microscopy 
BXF 
80% Deionised formamide 
10 mM NaOH  
0.1% Bromophenol blue  
0.1% Xylene cyanol  
1 mM EDTA  
Loading-dye for DNA 
electrophoresis in denaturing PAA 
gels 
TE (2:0.2)+NaCl 
2 mM Tris-HCl, pH 8.0 
0.2 mM EDTA  
50 mM NaCl 
Oligonucleotides annealing buffer 
STOP DNase I 
2 M Ammonium acetate 
0.8 mM Sodium acetate 
0.15 M EDTA 
Stop solution for DNase I digestion 
Transcription Buffer 5X 
200 mM Tris-HCl, pH 7.5 
750 mM KCl 
50 mM MgCl2
0.05% Triton X-100 
In vitro transcription 
STOP-T 
2% SDS 
100 mM EDTA 
Stop solution for in vitro 
transcription 
LB 
50 mM Tris-HCl, pH 7.6 
1 mM EDTA 
50 mM NaCl  
0.1% Deoxycholate 
Lysis buffer for RNA isolation and 
for total extract preparations from 
S. pneumoniae 
LBP 
20 mM Tris-HCl, pH 8.5 
10 mM DTT 
Lysis of pneumococcal cells for 
Proteomics 
PBS 
10 mM Na2HPO4  
2 mM KH2PO4  
2.7 mM KCl  
137 mM NaCl  
pH 7.4 
Resuspension of pneumococcal 
cells for fluorescence 
measurements.  
Washing buffer for Proteomics. 
Washing buffer in Western-bots 
CD 
10 mM Potassium phosphate 
100 mM Ammonium sulphate 
pH 7.6 
Circular dichroism analysis 
TB 25 mM Tris Western-blot Transfer Buffer 
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Buffer Composition Application 
192 mM Glycine  
20% Methanol 
WB 
PBS  
0.05% Tween20  
Western-blot Washing Buffer 
SB 
PBS 
0.05% Tween20  
0.2% Casein  
Western-blot Saturation Buffer 
 
 
7. Bioinformatics tools 
  Table 6. Bioinformatics tools  
Applications Program Company/Webpage  
Homologies finder BLAST blast.ncbi.nlm.nih.gov/Blast.cgi 
Promoter finder BPROM linux1.softberry.com/berry.phtml 
Open Reading Frame Finder ORF Finder ncbi.nlm.nih.gov/projects/gorf 
Analysis oligonucleotides 
OligoAnalyzer 3.1 
Tm calculator 
eu.idtdna.com 
finnzymes.fi/tm_determination.html 
Restriction maps ApE biology.utah.edu/jorgensen/wayned/ape 
Analysis DNA sequences 
Chromas 
ApE 
mb.mahidol.ac.th/pub/chromas 
biology.utah.edu/jorgensen/wayned/ape 
Sequence alignments  
ClustalW 
Clustal Omega 
ebi.ac.uk/Tools/clustalw2 
ebi.ac.uk/Tools/msa/clustalo 
Primary protein structure 
analysis 
ProtParam web.expasy.org/protparam 
Secondary protein structure 
prediction 
PsiPred 
Jpred 
SABLE 
PredictProtein 
NPS@ 
bioinf.cs.ucl.ac.uk/psipred 
compbio.dundee.ac.uk/www-jpred 
sable.cchmc.org 
predictprotein.org 
npsa-pbil.ibcp.fr 
Deconvolution of CD spectra SELCON3 dichroweb.cryst.bbk.ac.uk 
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Applications Program Company/Webpage 
CONTINLL 
CDSSTR 
K2D 
Prediction of functional domains 
Pfam 
Phyre2 
pfam.sanger.ac.uk 
www.sbg.bio.ic.ac.uk/phyre2 
Sedimentation equilibrium HeteroAnalysis biotech.uconn.edu 
Sedimentation velocity 
SEDFIT 
SEDNTERP 
analyticalultracentrifugation.com 
jphilo.mailway.com 
3D-Strucutres Visualization PyMol pymol.org 
Radiolabelled DNA visualization 
Image-reader 
MultiGauge 
Quantity One 
Fuji 
Fuji 
Bio-Rad 
Radiolabelled DNA visualization 
Image-reader 
MultiGauge 
Quantity One 
Fuji 
Fuji 
Bio-Rad 
Non-labelled DNA visualization Quantity One Bio-Rad 
CD Analysis SpectraManager Jasco 
Data analysis and graphing SigmaPlot SigmaPlot 
DNA bending analysis Bend.it hydra.icgeb.trieste.it/dna 
8. Autoradiography and radioactive material
The radioactive DNA was visualized either by autoradiography using the X-Omat 
S films (Kodak) or using a Phosphor screen scanned with a Fujifilm Image Analyzer FLA-
3000 (Fuji). When autoradiography was used, the radioactive signal was amplified using 
the intensifying screens Cronex Lightning Plus (Dupon).     
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Methods 
1. Bacterial growth conditions  
In liquid medium, E. coli cells were grown at 37°C with rotary shaking in 
Erlenmeyer flasks. The flask volume was 5-times greater than the culture volume in 
order to maintain a constant aeration. In solid medium, cells were spread uniformly over 
TY-agar. In the case of S. pneumoniae, cells were grown under low aeration conditions 
at 37°C. In liquid medium, cells were grown in a static bath in conditions in which the 
volume of the flask was twice the volume of the culture. In solid medium, cells and 
antibiotic (when required) were mixed with a basal layer (20 ml) of AGCH medium 
supplemented with sucrose (0.3%) and yeast extract (0.2%) plus 1% agar. Then, an 
over-layer (8 ml) of AGCH medium plus 0.75% agar was added covering the basal layer. 
In all cases, bacterial growth in liquid medium was followed by turbidity at 600 nm for E. 
coli and at 650 nm for S. pneumoniae using a Braush & Lomb (Spectronic 20D+) 
spectrophotometer.  
For preservation of bacterial strains, cells were grown to an optical density at 650 
nm (OD650) of 0.3 (S. pneumoniae) or to an OD600 of 0.5 (E. coli), which correspond with 
the exponential phase of growth. Then, sterile glycerol was added to 1 ml of culture to a 
final concentration of 10%. The culture was kept at 37°C for 10 min and then on ice for 
10 min. Finally, cultures were stored at -80°C. 
2. Bacterial transformation  
2.1. Preparation of competent cells 
 E. coli electrocompetent cells were prepared from cultures grown with rotary 
shaking in SOC medium to an OD600 of 0.5 (exponential phase). Then, the culture was 
cooled on ice and centrifuged at 5,000 rpm in an Eppendorf F-34-6-38 rotor for 15 min at 
4°C. Cell pellet was washed several times with cool sterile water. Finally, cells were 
resuspended in 10% glycerol, and aliquots (50 µl) were stored at -80°C. S. pneumoniae 
competent cells were prepared as reported previously (Lacks, 1966). Mainly, cells were 
grown in ACGH medium supplemented with sucrose (0.3%) and antibiotic (if required) at 
37ºC to an OD650 of 0.3 (exponential phase). The culture was then diluted 1:40 with pre-
warmed medium and cells were grown under the same conditions to an OD650 of 0.3. 
This dilution step was repeated twice. Finally, glycerol was added to a final concentration 
of 10%, and aliquots of the culture (250 µl) were stored at -80°C. 
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2.2. Transformation   
2.2.1. Electroporation 
E. coli electrocompetent cells were transformed as described previously (Dower 
et al., 1988). DNA in water (5-40µl) was mixed with electrocompetent cells (50 µl) in a 
0.2 cm electroporation cuvette (Bio-Rad) pre-cooled on ice. The pulse was generated 
with a MicroPulser (Bio-Rad) (2.50 kV and 5 ms). After the electric pulse, cells were 
transferred to 0.8 ml SOB medium supplemented with glucose (0.4%) and incubated at 
37°C with rotary shaking for 1 hour. Finally, cells were spread over TY-agar plates with 
the appropriate antibiotic for selection of transformants.  
2.2.2. Natural transformation 
Foreign DNA goes into competent pneumococcal cells by a process of natural 
transformation, which was previously reported (Espinosa et al., 1982). Briefly, cells were 
inoculated in AGCH medium supplemented with sucrose (0.2%) and CaCl2 (70 µM) and 
incubated at 30°C for 20 min before addition of DNA. When strain R6 or derivatives were 
used, 25 ng of CSP-1 (Competence Stimulating Peptide-1) was added at the same time 
as the DNA. After addition of DNA, cultures were incubated at 30°C for 40 min. In 
general, to enable the phenotypic expression (resistance to Tc or Km), cultures were 
incubated at 37°C for 90 min. However, to select transformants resistant to Cm, cultures 
were first incubated at 37ºC for 70 min. Then, Cm was added to a final concentration of 
0.05-0.5 g/ml and cultures were incubated at 37ºC for 20 min. Transformants were 
selected in AGCH plates (described in Section 1) supplemented with the appropriate 
antibiotic.  
3. Construction of bacterial strains  
3.1. Construction of S. pneumoniae R6Δmga strain 
For the construction of the S. pneumoniae R6 mga strain, gene replacement by 
homologous recombination was performed. Briefly, a 1,165-bp DNA fragment (Cm) that 
contained the pC194 cat gene, which confers Cm resistance (Horinouchi and Weisblum, 
1982), was PCR-amplified using the CmSph and the CmSal primers. The PCR product 
was then digested with SphI and SalI. In addition, a 543-bp region (Up) and a 605-bp 
region (Down) that flank the mgaSpn gene (promoter plus coding sequence) were 
amplified using the UpSph and UpCla primers and the DwSal and DwCla primers, 
respectively. Then, the PCR products were digested with the corresponding restriction 
enzymes (SphI and ClaI were used to digest the Up fragment and SalI and ClaI were 
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used to digest the Down fragment). Once all the PCR products had been digested, the 
Up and Down fragments were ligated to the Cm fragment, generating the Up::Cm::Down 
fusion fragment, in which the regions flanking the mgaSpn gene are flanking the cat 
gene. The cassette generated in vitro was then used to transform competent S. 
pneumoniae R6 cells. Selection of transformants resistant to Cm (1.5 µg/ml) led to the 
isolation of the S. pneumoniae R6 mga mutant strain, which lacks the mgaSpn gene 
(including its promoter) (coordinates 1596826-1568431), as confirmed by dye terminator 
sequencing at Secugen (CIB, Madrid). 
4. Fluorescence measurements
Fluorescence assays were carried out as described previously (Ruiz-Cruz et al., 
2010). Briefly, pneumococcal cells harbouring a plasmid that carries the gfp reporter 
gene were grown to an OD650 of 0.3. For these analyses, different volumes of the culture 
(from 25 µl to 1 ml) were used. Cells were harvested by centrifugation at 4ºC and 
resuspended in 200 µl of PBS buffer (see Table 5). Fluorescence was measured on a 
Thermo Scientific Varioskan Flash instrument (Perkin-Elmer) by excitation at 488 nm and 
detection of emission at 515 nm. In all cases, three independent cultures were analysed. 
The fluorescence corresponding to 200 µl of PBS buffer without cells was also measured 
(values around 0.03 arbitrary units). 
5. DNA preparations
5.1. Plasmid DNA isolation 
For small-scale plasmid preparations, the High Pure Plasmid Isolation kit (Roche 
Applied Science) was used for both, E. coli and S. pneumoniae. In the case of S. 
pneumoniae, the kit specifications were modified at two steps: 1) Suspension buffer was 
supplemented with 50 mM glucose and 0.1% deoxycholate (DOC) for cell lysis, 2) Lysis 
buffer was prepared containing 0.170 M NaOH, 1% SDS for chromosomal DNA 
denaturation.  
5.2. Genomic DNA extraction 
To isolate chromosomal DNA from S. pneumoniae, cells were grown in 40 ml 
AGCH supplemented with 0.3% sucrose and 0.2% yeast extract to an OD650 of 0.8. 
Cultures were centrifuged, and cells were resuspended in 1 ml of TE buffer 
supplemented with 0.6 mg proteinase K and 0.6% SDS and incubated at 37ºC for 30 min 
with gentle shaking. Samples were phenol treated, centrifuged and the supernatant was 
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dialyzed against TE buffer. Then, 40 µg RNase A was added and the mixture was 
incubated at 37ºC for 30 min. Finally, samples were phenol treated, ethanol precipitated 
and resuspended in TE. For small-scale genomic DNA isolation, the Bacterial Genomic 
DNA Isolation kit (Norgen) was used as specified by the supplier.   
5.3. Preparation of linear double-stranded DNA fragments  
Linear dsDNA fragments were obtained by digestion with restriction enzymes, by 
Polymerase Chain Reaction (PCR) or by annealing of complementary oligonucleotides. 
5.3.1. Digestion with restriction enzymes 
Digestion of DNA using restriction enzymes was done using the conditions 
specified by the supplier. When needed, 10 g/ml of BSA was included in the digestion 
reaction. In general, the enzyme was inactivated at 65ºC for 10 min.  
5.3.2. Polymerase chain reaction  
All PCR reactions were carried out in an iCycler Thermo Cycler (Bio-Rad). Taq 
DNA polymerase (Invitrogen) was used for analysis of transformants (both E. coli and S. 
pneumoniae) by colony PCR. Essentially, a single colony was inoculated into 100 µl of 
growth medium. Then, 10 µl were added to 90 µl of water and 1 µl of this mixture was 
used as template for PCR. Reactions (25 µl) contained 20 mM Tris-HCl, pH 8.4, 50 mM 
KCl, 2 mM MgCl2, 20 pmol of each primer, 200 μM of each dNTP and 1 unit of Taq DNA 
polymerase. Phusion High-Fidelity DNA polymerase (Finnzymes) was used for the rest 
of the PCR applications. Reaction mixtures (50 µl) contained 5-30 ng of template DNA, 
20 pmol of each primer, 200 μM of each dNTP and 1 unit of DNA polymerase. PCR 
conditions were: initial denaturation step at 94ºC for 3 min (Taq DNA polymerase) or at 
98ºC for 1 min (Phusion DNA polymerase). Then, it was followed by 30 cycles including 
the next steps: denaturation at 94ºC for 45 s (Taq DNA polymerase) or at 98ºC for 10 s 
(Phusion DNA polymerase), annealing of the primers to the DNA template at around 
55ºC (depending on the primer Tm) for 20-30 s followed by an extension at 72ºC for 20-
40 s (depending on the amplicon length). A final extension step was performed at 72ºC 
for 10 min. The QIAquick PCR Purification kit (QIAGEN) was used to purify DNA from 
both restriction endonuclease digestion and PCR. 
 Materials and Methods 
 
 
63 
5.3.3. Annealing of complementary oligonucleotides 
Complementary oligonucleotides were annealed in buffer TE (2:0.2) containing 
50 mM NaCl. For non-radioactive oligonucleotides, equimolar amounts of each 
oligonucleotide were used. The reaction mixtures (150 µl) were incubated at 95ºC for 10 
min and then cooled down slowly to 37ºC. Then, they were kept at this temperature for 
10 min and on ice for 10 min. When preparing radiolabelled dsDNA, one of the 
complementary oligonucleotides was 5´-labelled using [γ-32P]-ATP and T4 PNK. In this 
case, the concentration of the radioactively labelled oligonucleotide in the annealing 
reaction was twice the non-labelled oligonucleotide.  
5.4. DNA purification 
5.4.1. Oligonucleotides 
Oligonucleotides used to obtain small dsDNA fragments (20-bp to 40-bp) were 
purified from PAA (15-20%) denaturing (8 M urea) gels (Maniatis et al., 1982). The 
oligonucleotide solution was mixed with deionised formamide (50% final concentration) 
and heated at 55ºC for 5 min. The sample was cooled down on ice before being loaded 
onto the sequencing gel. After electrophoresis, the gel was placed on a piece of saran 
wrap and then on a Fluor-coated TLC plate (Ambion) and shined with a short wavelength 
UV light. The DNA absorbs the UV light and casts a shadow against the fluorescent 
background allowing the DNA to be visualized. The area of the gel containing the full-
length oligonucleotide was excised. To elute the oligonucleotide, the gel slice was 
incubated in buffer OEB (see Table 5) overnight at 42ºC with continuous shaking. The 
remains of gel in the eluted DNA solution were removed using a Spin-X column (Costar). 
Finally, the eluted oligonucleotide was ethanol precipitated, dissolved in 50 µl of distilled 
water and loaded onto a MicroSpinTM G-25 column (GE Healthcare) to eliminate the 
remains of salt.  
5.4.2. Linear double-stranded DNAs 
Linear dsDNA fragments obtained either by digestion with restriction enzymes or 
by PCR, were purified (when required) from preparative agarose gels or non-denaturing 
polyacrylamide gels. When the DNA fragments were purified from agarose gels, the 
QIAquick gel extraction kit (QIAGEN) was used, following the specifications of the 
supplier. To elute DNA fragments from polyacrylamide, gels were stained with ethidium 
bromide (EtBr) and the band was excised with a clean scalpel. Then, the gel slice was 
incubated overnight in elution buffer (see Table 5) with continuous shaking (450 rpm) at 
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42ºC using a Thermo-shaker (TS-100, Biosan). The eluted DNA was finally precipitated 
with ethanol. When the quality of the DNA preparations was good enough, it was purified 
with the QIAquick PCR purification kit (QIAGEN) without the gel purification step.  
5.5. Ligation  
In general, for ligation of linear DNA fragments, the molar ratio vector to insert 
was between 1:5 and 1:10. The reaction mixture was incubated at 22ºC for 20 min or at 
16ºC overnight for DNAs with sticky ends or at 20ºC for 2 h for DNAs with blunt ends. In 
all cases, 400 units of T4 DNA ligase (New England Biolabs) were added to a final 
reaction volume of 20-40 µl.  
5.6. Construction of recombinant plasmids 
5.6.1. Construction of pET24b-mgaSpn and pET24b-mgaSpn-His plasmids 
The pET24b-mgaSpn and pET24b-mgaSpn-His plasmids were used to 
overproduce and purify the MgaSpn and the MgaSpn-His proteins, respectively (see 
Section 9). In both cases, the pET24b expression vector (Novagen) was used. For 
overproduction of the MgaSpn native protein, a 1,540-bp region of the R6 genome 
containing the mgaSpn gene was amplified by PCR using the 1622Nde and 1622Xho 
primers. These primers contained a single restriction site for NdeI and XhoI, respectively. 
The amplified product was digested with both enzymes, and the 1,512-bp digestion 
product was cloned into the pET24b expression vector. For overproduction of the 
MgaSpn-His protein, the mgaSpn gene was engineered to encode a His-tagged MgaSpn 
protein. Specifically, a 1,512-bp region of the R6 genome was amplified by PCR using 
the 1622Nde and 1622Xho-His primers, generating target sites for NdeI and XhoI 
restriction enzymes, respectively. Then, the amplified DNA fragment was digested with 
both enzymes, and the 1,481-bp digestion product was cloned into the pET24b 
expression vector, which enables a C-terminal His6-tag fusion. 
5.6.2. Construction of pAS-Pmga plasmid 
The pAS-Pmga recombinant plasmid was used to identify the transcription start 
site of the mgaSpn gene. For its construction, a 170-bp region of the R6 chromosome 
containing the Pmga promoter was amplified by PCR using the PrSp1 and PrSp2 
primers, which contained a single restriction site for BamHI. The amplified fragment was 
digested with BamHI, and the 142-bp digestion product was cloned into the BamHI site 
of plasmid pAS (Ruiz-Cruz et al., 2010). In this plasmid, expression of the gfp reporter 
gene remains under the control of the inserted promoter.   
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5.6.3. Construction of the pAST-PAB, pAST2-Pmga pAST-PABΔ84 and 
pAST-PABΔ153 plasmids 
To construct pAST-PAB and pAST2-Pmga, a 333-bp region of the R6 
chromosome was amplified with the PmgaSac and PABSac primers, generating 
restriction sites for SacI. After digestion, the 301-bp restriction fragment, which included 
the P1623A, P1623B and Pmga promoters, was cloned into the SacI site of plasmid 
pAST (Ruiz-Cruz et al., 2010) (pAST-PAB, in which gfp expression is under control of 
the P1623A and P1623B promoters) and pAST2 (Ruiz-Cruz et al., 2010) (pAST2-Pmga, 
in which gfp expression is under control of the Pmga promoter). To construct the pAST-
PABΔ84 plasmid, a 246-bp region of the R6 genome (promoters P1623A and P1623B) 
was amplified with the PABSac and the PABΔ84Sac primers, digested with SacI, and the 
216-bp product was cloned into the pAST plasmid. To construct the pAST-PABΔ153 
plasmid, a 177-bp region of the R6 genome (promoters P1623A and P1623B) was 
amplified with the PABSac and the PABΔ153Sac primers, digested with SacI, and the 
146-bp restriction fragment was cloned into the pAST plasmid. In pAST-PABΔ84 and 
pAST-PABΔ153, gfp gene expression is under control of the P1623A and P1623B 
promoters.  
5.6.4. Construction of the pDLPsulA::mga plasmid 
Plasmid pDLPsulA::mga is a derivative of pDL287, which carries a Km resistance 
gene (LeBlanc et al., 1993). The construction of pDLPsulA::mga involved several steps. 
First, a 189-bp region of the R6 genome, which contained the PsulA promoter (Lacks et 
al., 1995; Ruiz-Cruz et al., 2010), was amplified using the PsulNde and PsulCla primers. 
At the same time, a 1,650-bp region of the R6 chromosome was amplified using the 
mgaNde and the mgaCla primers. This fragment contained a promoter-less mgaSpn 
gene. Both PCR fragments were digested with NdeI (generating fragments of 172-bp 
and 1,636-bp, respectively) and ligated with the T4 DNA ligase, generating the 
PsulA::mga fusion gene. This DNA fragment was then amplified by PCR using the 
PsulCla and mgaCla primers. The amplified product was digested with ClaI, generating a 
1,777-bp restriction fragment that was cloned into the ClaI site of plasmid pDL287 
(LeBlanc et al., 1993).  
5.7. Radioactive labelling of DNA 
Radiolabelled DNA was visualized either by autoradiography or using a Fujifilm 
Image Analyzer FLA-3000 (Phosphorimager). The intensity of the labelled DNA bands 
was quantified using the Quantity One software (Bio-Rad) 
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5.7.1. 5´-end labelling  
Oligonucleotides were radioactively labelled at the 5´-end using [γ-32P]-ATP and the 
T4 PNK. Reactions mixtures (25 µl) contained 25-50 pmol of oligonucleotide, 2.5 µl of 10x 
kinase buffer (provided by the supplier), 40-80 pmol of [γ-32P]-ATP (3,000 Ci/mmol; 10 
μCi/μl) and 10 units of T4 PNK. After incubation at 37ºC for 30 min, additional T4 PNK 
(10 units) was added and the reaction mixture was incubated at 37ºC for 30 min. Finally, 
to inactivate the enzyme, reaction mixtures were incubated at 65ºC for 20 min. Non-
incorporated nucleotide was removed using MicroSpinTM G-25 columns (GE Healthcare). 
The 5´-labelled oligonucleotides were used to obtain labelled-dsDNA either by PCR 
amplification (labelling at the 5´-end of one strand) or by annealing the labelled 
oligonucleotide to the non-labelled complementary oligonucleotide. The 5´-labelled 
oligonucleotides were also used in primer extension reactions and for manual sequencing.  
5.7.2. Internal labelling 
The incorporation of a radiolabelled nucleotide ([α-32P]-dATP, [α-32P]-dCTP, or [α-
32P]-UTP 3,000 Ci/mmol, Hartmann) was used for manual sequencing (using the 
Sequenase v 2.0 kit, following the indications of the supplier), primer extension 
experiments and in vitro transcription assays. 
6. Analysis of DNA 
6.1. DNA quantification 
To quantify non-radiolabelled DNA, agarose or polyacrylamide gels were stained 
with EtBr (1 µg/ml). Bands were visualized using a Gel-doc system (Bio-Rad) and 
quantified using a molecular weight marker (HyperLadder I, Bioline; designed for easy 
size determination) with the Quantity One program. In addition, the concentration of DNA 
samples was determined using a NanoDrop ND-1000 Spectrophotometer (Bio-Rad). For 
5´-labelled DNA, the ionizing radiation was measure with a scintillation counter (Wallac 
1450 MicroBeta, TriLux). Knowing that 125 µCi of [γ-32P]-ATP (41.5 pmol) are equivalent 
to 1.37x108 cpm, we estimated the incorporation of [γ-32P]-ATP in the labelling reaction and 
then the DNA concentration using the total cpm obtained.  
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6.2. DNA electrophoresis 
6.2.1. Agarose gels 
Horizontal agarose gel electrophoresis in TAE buffer was used to analyse 
chromosomal DNA, plasmid DNA and linear dsDNA fragments larger than 100 bp. DNA 
samples were mixed with BXGE buffer (see Table 5) and loaded onto the gel. The 
agarose concentration used (generally 0.8-1%) depended on the size of the DNA 
analysed. After electrophoresis, gels were soaked in a solution of EtBr (1 µg/ml in TAE 
buffer) for 15 min at room temperature. DNA was visualized using a short wavelength UV 
light (254 nm) for analytical agarose gels or a long wavelength UV light (360 nm) for 
preparative agarose gels, using a Gel-doc XR system (Bio-Rad). The image obtained 
was captured with the Quantity One software and quantified when it was necessary.    
6.2.2. Polyacrylamide gels 
4.2.2.1. Native polyacrylamide gels 
Vertical polyacrylamide gels were run using a Mini Protean-III system (Bio-Rad). 
DNA samples were mixed with BXGE buffer and loaded onto the gels. Gels were run at 
100 V and at 4ºC or room temperature in TBE buffer (see Table 5). The concentration of 
acrylamide used (5-15%) depended on the size of the DNA analysed. After 
electrophoresis, gels were stained with EtBr and visualized as described before. When 
the DNA was radioactively labelled, after electrophoresis, gels were fixed with acetic acid 
(10%), dried using a gel dryer (model 583, Bio-Rad) and the DNA was visualized by 
autoradiography or using a Fujifilm Image Analyzer FLA-3000.    
6.2.2.2. Denaturing polyacrylamide gels 
Oligonucleotides were purified (when needed) from denaturing polyacrylamide 
gels in TBE buffer and 8 M urea. The concentration of acrylamide used depended of the 
size of the oligonucleotide: 19% for 15-25 nt and 15% for 25-40 nt. After electrophoresis, 
oligonucleotides were purified as described before (see Section 5.4.1). Sequencing 
reactions, primer extension products, in vitro transcription products as well as footprinting 
reactions (DNase I and OH) were run in sequencing gels (6% PAA, 8 M urea), pre-
heated at 50ºC. A Sequi-Gen GT sequencing system and 21x50 cm gels (Bio-Rad) were 
used. The electrophoresis conditions were 50 W, 50ºC, and the time depended on the 
experiment. After electrophoresis, bands were visualized by autoradiography or using a 
Fujifilm Image Analyzer FLA-3000.  
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6.3. In silico prediction of intrinsic DNA curvature 
The intrinsic curvature of the C and NC DNA fragments was predicted with the 
bend.it server (http://hydra.icgeb.trieste.it/dna/bend_it.html). It was calculated as degrees 
per helical turn (10.5º/helical turn = 1º/basepair). The curvature propensity plot was 
calculated using the consensus scale algorithm (DNase I + nucleosome positioning data) 
with a windows size of 20-bp. 
7. DNA sequencing 
7.1. Manual DNA sequencing 
7.1.1. Dideoxy chain-termination sequencing method (Sanger method) 
In general, the dideoxy chain-termination method was chosen for DNA 
sequencing (Sanger et al., 1977). The Sequenase v2.0 DNA Sequencing kit (USB 
Corporation) was used and some modifications were included when working with linear 
dsDNAs. For plasmid DNA sequencing, 1 µg of alkaline denatured plasmid was 
annealed to a 5´-labelled oligonucleotide (1.5 pmol). Specifically, the reaction mixture 
was incubated at 65ºC for 5 min and then cooled down slowly to 37ºC. Then, Sequenase 
DNA polymerase (6.5 units) was added to the mixture. In reactions with non-
radiolabelled primers, [α-32P]-dATP or [α-32P]-dCTP (3,000 Ci/mmol; Hartmann) was 
added at the same time as the DNA polymerase. In both cases, and after 2-5 min at 
room temperature, the mixture was distributed into four tubes. Each tube contained all 
four dNTPs and one of the four ddNTPs (ddATP, ddCTP, ddGTP or ddTTP) pre-warmed 
at 37ºC. Mixtures were then incubated at 37ºC for 5 min. Reactions were stopped by 
adding the Stop Solution of the kit (95% formamide, 20 mM EDTA, 0.05% bromophenol 
blue, 0.05% xylene cyanol). For linear dsDNA sequencing, 2.5 pmol of a 5´-labelled 
primer were mixed with 0.25 pmol of dsDNA (obtained by PCR). The mixture was heated 
at 95ºC for 3 min and placed on ice. Then, the Sequenase DNA polymerase was added 
and the reactions proceeded as described above.  
7.1.2. Maxam and Gilbert DNA sequencing method 
When necessary, the Maxam and Gilbert DNA sequencing method for cleavage 
at purine residues (G+A) was used (Maxam and Gilbert, 1980). Briefly, 1 µg of tRNA and 
1µl of 0.2 M formic acid were added to 2 µl of labelled dsDNA (30,000-50,000 cpm). The 
reaction mixture (4 µl) was incubated at 65ºC for 30 s. Then, DNA was precipitated by 
adding 30 µl of 1.5 M sodium acetate, pH 7.0, co-precipitant Pellet PaintTM and 150 µl of 
absolute ethanol. The mixture was kept at -80ºC for 10 min followed by centrifugation at 
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4ºC for 10 min (12,000 rpm in a Sigma 12124 rotor). The DNA pellet was dissolved in 30 
µl of water. Then, 150 µl of absolute ethanol was added, and the mixture was incubated 
again at -80ºC for 10 min. After centrifugation at the same conditions, the DNA pellet 
was then washed with 80% ethanol. The DNA pellet was dissolved in 50 µl of water and 
5 µl of 10 M Piperidine. The mixture was then heated at 100ºC for 10 min and the DNA 
was extracted with 1-butanol. Next, DNA was precipitated by mixing with 50 µl of 1% 
SDS and 500 µl of 1-butanol. Finally, DNA was washed twice with ethanol 80%, air-dried 
and dissolved in buffer BXF (see Table 5).   
7.2. Automated DNA sequencing 
All the genetic manipulations performed in chromosomal and extra-chromosomal 
(plasmid) DNAs were confirmed by dye-terminator sequencing at Secugen (Automated 
DNA Sequencing Service, CIB).  
8. RNA techniques 
8.1. Total RNA isolation from E. coli and S. pneumoniae 
To isolate total RNA from either E. coli or S. pneumoniae, either the Aurum Total 
RNA Mini kit (Bio-Rad) or the RNeasy Mini kit (QIAGEN) were used as specified by the 
suppliers. In the case of pneumococcal RNA, cells were concentrated (20X) in LB buffer 
(see Table 5) and incubated at 37ºC for 5-10 min for cell lysis. In both cases, an 
additional DNase I digestion was performed to eliminate residual DNA in the RNA 
preparations. To this end, DNase I recombinant RNase free (Roche) was used and the 
samples were cleaned up by a second purification using the kit columns. Integrity of the 
rRNAs was checked by agarose (0.8%) gel electrophoresis. RNA concentration was 
determined using a NanoDrop ND-1000 Spectrophotometer (Bio-Rad).   
8.2. In vitro transcription 
Blunt-ended dsDNA fragments (obtained by PCR) were used as templates for in 
vitro transcription assays under multiple-round conditions. Two RNA polymerases 
(RNAPs) were used: (i) the commercially available E. coli RNAP holoenzyme 
(Epicentre), and (ii) a reconstituted RNAP composed by the E. coli RNAP core enzyme 
(Epicentre) and the pneumococcal σ43 factor purified in our laboratory. When the E. coli 
RNAP holoenzyme was used, reactions (50 µl) contained 10 nM of template DNA, 10 µl 
of 5x Transcription Buffer (see Table 5), 2 mM DTT, 100 µg/ml BSA (New England 
BioLabs), 10 units of SUPERaseIn (RNase inhibitor, Ambion), 250 µM of each rNTP, 10 
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µCi of [α-32P]-UTP (3,000 Ci/mmol, GE Healthcare) and 1 unit of RNAP holoenzyme. 
After 20 min at 30ºC, reactions were stopped by addition of 50 µl STOP-T buffer (see 
Table 5). Non-incorporated nucleotide was removed using MicroSpinTM G-25 columns 
(GE Healthcare). Then, RNA was ethanol precipitated, dissolved in FXBE buffer, heated 
at 90ºC for 5 min and subjected to electrophoresis on sequencing gels (6% PAA, 8 M 
urea). When the reconstituted RNAP was used, reactions (33.5 µl) contained 1 unit of E. 
coli RNAP core enzyme, 250 ng of the pneumococcal σ43 factor, 2 mM DTT and 6.7 µl of 
5x Transcription Buffer. The mixtures were incubated at 30ºC for 15 min (RNAP 
reconstitution). Then, the template DNA (10 nM) was added. After 15 min at the same 
temperature, transcription was initiated by addition of the rNTPs (including the [α-32P]-
UTP) and the RNase inhibitor. Reaction mixtures were incubated for 15 min at 30ºC, and 
then processed as described above. The sizes of the runoff transcripts were estimated 
by comparison with the sizes of DNA fragments generated by dideoxy-mediated chain 
termination sequencing reactions. In sequencing gels, RNA runs about 5 to 10% more 
slowly than DNA of the same size (Maniatis et al., 1982).     
8.3. Primer extension 
Primer extension reactions were carried out using total RNA isolated as 
described in Section 8.1. The ThermoScript Reverse Transcriptase kit (Invitrogen) was 
used as specified by the supplier. Specific primers were 32P-labelled at the 5´-end as 
described in Section 5.7.1. In experiments with non-radiolabelled primers, [α-32P]-dATP or 
[α-32P]-dCTP was used in the extension reactions. Reaction mixtures (12 µl) contained 1-2 
pmol of primer and 2-15 μg of total RNA. The mixture was incubated at 65ºC for 5 min 
(annealing). Then, 100 µM of each dNTP, 15 units of ThermoScript Reverse 
Transcriptase, 5 mM DTT and cDNA Synthesis buffer (supplied in the kit) were added. 
Extension reactions were carried out at 50-58ºC for 45-60 min (depending on the Tm of 
the primer and the length of the extension product). When non-radiolabelled primers 
were used, 9.75 µM of dATP or dCTP and 0.25 µM of [α-32P]-dATP or [α-32P]-dCTP, 
respectively, were added to the extension reactions. Reactions were stopped by heating 
at 85ºC for 5 min. Finally, samples were ethanol precipitated and dissolved in BXF buffer 
(see Table 5). cDNA products were analysed by sequencing gel electrophoresis. To 
estimate the length of the extension products, sequencing reactions obtained by the 
Sanger method were run in the same gel. Labelled products were visualized using a 
Fujifilm Image Analyzer FLA-3000 or by autoradiography. When necessary, the intensity 
of the bands was quantified using the Quantity One software (Bio-Rad).  
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8.4. Reverse transcription polymerase chain reaction  
RT-PCR assays were carried out using the ThermoScript Reverse Transcriptase 
kit for the synthesis of cDNA. Specifically, 20 pmol of primer were annealed to 1-2 µg of 
total RNA (12 µl) at 65ºC for 5 min. Then, the Thermoscript Reverse Transcriptase (15 
units), 100 µM of each dNTP, 5 mM DTT and cDNA Synthesis buffer (provided by the 
supplier) were added. Reaction mixtures (20 µl) were incubated at 55ºC for 45 min. 
PCRs were then carried out as described in Section 5.3.2 using the cDNA as template 
(10% of the first-strand reaction). To ensure the absence of DNA in the RNA 
preparations, the same reactions were performed without adding reverse transcriptase 
(negative control). As positive control to guarantee the integrity of the primers, PCRs 
were done using chromosomal DNA as template. PCR products were analysed by 
agarose (0.8%) gel electrophoresis. 
9. Protein purification 
In all cases, the commercially available pET24b expression vector (Novagen) 
was used for overproduction and purification of proteins. In this vector, the gene of 
interest is expressed under control of the 10 promoter of phage T7 using the E. coli 
BL21 (DE3) strain. This strain contains a chromosomal copy of the lacI gene and the T7 
RNAP-encoding gene (T7 gene) under control of the lacUV5 promoter. In the absence of 
IPTG, the LacI repressor binds to the operator region of the lacUV5 promoter and 
represses the transcription of the T7 gene. In the presence of IPTG, LacI is blocked and, 
therefore, there is synthesis of the T7 RNAP, which transcribes the gene of interest from 
the 10 promoter. 
9.1. Purification of MgaSpn-His 
E. coli BL21 (DE3) cells harbouring the pET24b-mgaSpn-His plasmid were grown 
at 37ºC with rotary shaking in TY broth containing Km (30 μg/ml) to an OD600 of 0.45. 
Expression of the mgaSpn-His gene was induced by addition of 1mM IPTG. After 25 min 
at 37ºC, rifampicin (200 μg/ml), which specifically inhibits bacterial RNAP, was added 
and the culture was incubated for 60 min. Cells were harvested by centrifugation (9,000 
rpm in an SLA-3000 rotor for 20 min at 4ºC), washed twice with buffer V-His and stored 
at -80ºC. The cell pellet was concentrated (40X) in buffer V-His containing an EDTA-free 
protease inhibitor cocktail (Roche). Cells were lysed by two passages through a pre-
chilled cell-pressure French Press, and the whole-cell extract was clarified by 
centrifugation (9,000 rpm in an Eppendorf F-34-6-38 rotor for 60 min at 4ºC). Then, 
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imidazole (10 mM final concentration) was added to the clarified extract, which was 
subjected to a nickel affinity column (HisTrap HP column, GE Healthcare) pre-
equilibrated with buffer V-His containing 10 mM imidazole. After washing with the same 
buffer, MgaSpn-His was eluted with buffer V-His containing 250 mM imidazole. Fractions 
containing MgaSpn-His were identified by Coomassie-stained SDS polyacrylamide 
(10%) gels, pooled, dialyzed at 4ºC against buffer P (see Table 5) and concentrated by 
filtering through a 10-kDa-cutoff membrane (Macrosep; Pall). The protein sample was 
then loaded onto a HiLoad Superdex 200 gel filtration column (Amersham Biosciences) 
and subjected to fast-pressure liquid chromatography (FPLC; Biologic DuoFlow; Bio-
Rad). Fractions were analysed as described above, pooled, concentrated, and stored at 
-80ºC. 
9.2. Purification of MgaSpn 
E. coli BL21 (DE3) cells carrying the pET24b-mgaSpn plasmid were grown at 
37ºC with rotary shaking in TY medium containing Km (30 μg/ml) to an OD600 of 0.45, 
followed by induction of mgaSpn gene expression with 1 mM of IPTG. After 25 min, 
rifampicin (200 μg/ml) was added and the culture was incubated for 60 min under the 
same conditions. Cells were harvested by centrifugation, and washed twice with buffer 
VL containing 400 mM NaCl. The cell pellet was concentrated (40X) in buffer VL 
containing 400 mM NaCl and a protease inhibitor cocktail (Roche). Cells were disrupted 
by two passages through a pre-chilled French pressure cell, and the whole-cell extract 
was centrifuged to remove cell debris. The clarified extract was mixed with 0.2% 
polyethyleneimine (PEI), kept on ice for 30 min, and centrifuged at 9,000 rpm in an 
Eppendorf F-34-6-38 rotor for 20 min at 4ºC. Under these conditions, MgaSpn was 
recovered in the pellet, which was then washed twice with buffer VL containing 400 mM 
NaCl to eliminate contaminant proteins. MgaSpn was eluted from the pellet with buffer 
VL containing 700 mM NaCl. Then, proteins in the supernatant were precipitated with 
70% saturated ammonium sulphate, which was added slowly. After the addition of 
ammonium sulphate, the mixture was kept on ice with constant stirring for 60 min. After 
centrifugation (9,000 rpm in an Eppendorf F-34-6-38 rotor for 20 min at 4ºC), the 
precipitate was dissolved in buffer VL containing 400 mM NaCl and dialyzed at 4ºC 
against buffer VL containing 100 mM NaCl. The protein preparation was applied to a 
heparin affinity column (HiPrep Heparin, GE Healthcare) equilibrated with the same 
buffer. Bound protein was washed with buffer VL containing 300 mM NaCl and MgaSpn 
was subsequently eluted using a 300-800 mM NaCl gradient. Fractions containing 
MgaSpn were identified by Coomassie-stained SDS-polyacrylamide (10%) gels, pooled 
and dialyzed at 4ºC against VL buffer containing 100 mM NaCl. The protein preparation 
 Materials and Methods 
 
 
73 
was concentrated by filtering through a 3-kDa-cutoff membrane (Macrosep; Pall) and 
stored at -80ºC.  
10. Protein analysis 
10.1. Determination of protein concentration 
For measuring the concentration of a protein in solution, a Nanodrop (ND-1000) 
Spectrophotometer (Bio-Rad) was used. The theoretical molecular weight (Da) and the 
molar extinction coefficient (M-1 cm-1) were calculated from the amino acid sequence of 
the corresponding protein. For circular dichroism experiments (see Section 10.6.2), the 
concentration of MgaSpn was calculated by measuring the absorption spectra at 220 
and 350 nm in a Shimadzu UV-2401PC Spectrophotometer.  
10.2. N-terminal sequencing 
N-terminal sequencing of purified proteins was performed by Edman degradation 
using a Procise 494 Sequencer (Perkin Elmer) (Protein Chemistry Facility; CIB). When 
necessary, proteins were separated by SDS-PAGE. Pre-stained proteins (SeeBlue Plus 
2; Invitrogen) were run in the same gel as molecular weight markers. Then, proteins 
were transferred electrophoretically to Immun-blot polyvinylidene difluoride (PVDF) 
membranes (Mini Trans-Blot; Bio-Rad) at 100 V and 4ºC for 90 min. Finally, membranes 
were stained with a fresh Coomassie solution, de-stained with 50% methanol in water, 
washed with water and air dried. Bands of interest were excised and used for the 
analysis. 
10.3. Protein electrophoresis 
10.3.1. Tris-Glycine SDS-PAGE 
Protein samples were analysed by SDS-PAGE using TG buffer (see Table 5) as 
running buffer and a Mini-Protean III Electrophoresis System (Bio-Rad). The stacking gel 
contained 4% polyacrylamide in 0.125 M Tris-HCl, pH 6.8, and 0.1% SDS. The resolving 
or separating gel contained 10-12% polyacrylamide in 0.374 M Tris-HCl, pH 8.8, and 
0.1% SDS. TEMED and ammonium persulfate (PSA) were used for polyacrylamide gel 
polymerization. Protein samples were mixed with SLB buffer (see Table 5) and heated at 
95ºC for 5 min prior to electrophoresis. Electrophoresis was performed at 80 V until the 
dye (bromophenol blue) migrated down to the bottom of the stacking gel. Then, the 
voltage was increased to 180 V.  
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10.3.2. Tris-Tricine SDS-PAGE 
For the resolution of proteins smaller than 30 kDa, Tris-Tricine SDS-PAGE 
(Schagger and von Jagow, 1987) was commonly used. Gels were prepared in a Mini-
Protean III Electrophoresis System (Bio-Rad). The staking gel (4 ml) contained 4% 
polyacrylamide, and 1 ml Buffer gel (see Table 5). The resolving gel (5 ml) contained 
16% polyacrylamide, 1.65 ml Buffer gel and glycerol (13%). TEMED and PSA were used 
to catalyse polyacrylamide gel polymerization. In this electrophoretic system, cathode 
buffer and anode buffer were used (see Table 5). Electrophoresis conditions were as 
described in Section 10.3.1.  
10.4. Analytical ultracentrifugation 
Analytical ultracentrifugation experiments were carried out at the CIB-Analytical 
Ultracentrifugation and Macromolecular Interactions Facility. These experiments 
provided information about the molecular mass of MgaSpn as well as the hydrodynamic 
behaviour of the protein. All the experiments were done in an Optima XL-A (Beckman-
Coulter) analytical ultracentrifuge equipped with an UV-visible optical detection system, 
using an An60Ti rotor with standard six-channel centrifuge cells (12-mm optical path) 
and centrepieces of epon charcoal.  
10.4.1. Sedimentation velocity 
Sedimentation velocity experiments were performed at 43,000 rpm and 12ºC. 
MgaSpn was equilibrated in buffer AU (see Table 5) and two protein concentrations (5 
and 10 μM; 400 μl) were analysed. The sedimentation coefficient for MgaSpn was 
estimated using the program SEDFIT (version 11.8) (Schuck and Rossmanith, 2000) 
applying a direct linear least-squares boundary modelling of the sedimentation velocity 
data. The sedimentation coefficient was corrected to standard conditions using the 
program SEDNTERP (Laue et al., 1992) to obtain the corresponding S20,w value. The 
translational frictional coefficient (f) of MgaSpn was determined from the molecular mass 
and sedimentation coefficient of the protein (van Holde, 1985), whereas the frictional 
coefficient of the equivalent hydrated sphere (f0) was estimated using a hydration of 0.38 
g H2O/g protein (Pessen and Kumosinski, 1985). With these parameters the translational 
frictional ratio (f/f0) was calculated, which allows an estimation of the hydrodynamic 
shape of MgaSpn.  
Materials and Methods 
75 
10.4.2. Sedimentation equilibrium 
Sedimentation equilibrium experiments were performed at 10ºC. Two protein 
concentrations (5 and 10 μM; 80 μl) were analysed. The samples were centrifuged at 
three successive speeds (8,000, 9,500 and 12,500 rpm) and absorbance readings were 
done after the sedimentation equilibrium was reached. The absorbance scans were 
taken at 250, 280 and 288 nm, depending on the MgaSpn protein concentration used. In 
all cases, the baseline signals were measured after high-speed centrifugation (40,000 
rpm). Apparent average molecular masses of MgaSpn protein were determined using 
the program HETEROANALYSIS (Cole, 2004). The partial specific volume of MgaSpn 
was 0.742 ml/g, determined from the amino acid composition with the program 
SEDNTERP (Laue et al., 1992).  
10.5. Gel filtration chromatography 
Gel filtration chromatography was used to determine the molecular size (Stokes 
radius) of MgaSpn, and was carried out in an Åkta HPLC system (Amersham 
Biosciences) using a HiLoad Superdex 200 gel-filtration column (120 ml; 16 x 600 mm) 
(Amersham Biosciences), equilibrated with buffer VL containing either 100 mM or 250 
mM NaCl. All chromatographic runs were performed at 4ºC with a flow rate of 0.5 ml/min. 
Elution positions of the proteins were monitored at 280 nm. The column was pre-
calibrated by loading a set of standard proteins of known Stokes radius (molecular size), 
as the behaviour of non-globular proteins during gel filtration correlates with the 
molecular size more than with the molecular weight. The standards used were ferritin (F; 
61 Ǻ), alcohol dehydrogenase (ADH; 45 Ǻ), ovalbumin (O; 30.5 Ǻ) and carbonic 
anhydrase (CA; 20.1 Ǻ). Proteins were diluted in buffer VL containing 250 mM NaCl to 
final concentrations of 0.3 mg/ml (F), 5 mg/ml (ADH), 4 mg/ml (O) and 3 mg/ml (CA). 
Purified MgaSpn protein (1 ml, 25 µM) equilibrated in the same buffer was loaded onto 
the column and eluted with a constant flow rate of 0.5 ml/min. Fractions of 2 ml were 
collected, aliquots of the peak fractions were analysed in coomassie-stained SDS-
polyacrylamide (10%) gels. The Kav parameter was calculated for each protein as follows: 
Kav = (Ve-V0)/(Vt-V0) 
where Ve is the elution volume, V0 is de void volume (determined by elution of blue 
dextran) and Vt is the total volume of the packed bed.  
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10.6. Protein secondary structure analysis 
10.6.1. Protein secondary structure prediction 
The prediction of the content and distribution of secondary structures derived 
from the amino acid sequence of the MgaSpn protein was carried out with the following 
bioinformatics programs: SABLE (Adamczak et al., 2005), PsiPred (McGuffin et al., 
2000), Jpred (Cole et al., 2008), NPS@ (Combet et al., 2000) and PredictProtein (Rost 
et al., 2004), that are accessible through the ExPASy Bioinformatics Resource Portal 
(proteomics tools) (Artimo et al., 2012; www.expasy.org). Search of functional domains 
in MgaSpn was done with the Pfam protein families database (Punta et al., 2012) and 
with the Phyre2 protein fold recognition server (Kelley and Sternberg, 2009). 
10.6.2. Circular dichroism analyses 
Circular dichroism (CD) spectra of MgaSpn were acquired in a Jasco J-810 
spectropolarimeter employing a 0.2-mm path length rectangular quartz cuvette. Samples 
were dialyzed against CD buffer (see Table 5) and diluted in the same buffer to a protein 
concentration of 0.71 mg/ml. Spectra were recorded over a wavelength range from 185 
to 260 nm (far-UV) at 4ºC, with a resolution of 1 nm at a scan speed of 50 nm/min. The 
CD spectrum was the average of four accumulations or scans. The final spectrum was 
obtained by subtracting the buffer spectrum measured under identical conditions. The 
results were expressed as mean residue ellipticity (Θ) at a given wavelength. To obtain 
structural information, the CD data were analysed using different algorithms: SELCON3 
(the spectrum of the protein to be analysed is included in the basis set. The resulting 
matrix is solved and the initial guess is replaced by the solution. The process is repeated 
until self-consistency is attained. SELCON3 provides good estimates of the structure of 
globular proteins, however, it gives poor estimates of turns; Sreerama and Woody, 
1993), CONTINLL (compares and fits the CD spectrum of the protein under study with 
the spectra of a database of proteins with known conformations. This method results in 
good estimates of helices and sheets; Provencher and Glockner, 1981), CDSSTR (in 
this method an initial database of standard spectra form proteins with known spectra and 
secondary structure is created and provides superior fits of the conformation of globular 
proteins; Compton and Johnson, 1986); and K2D (an artificial intelligence program is 
used to fin correlations in data. KD2 gives a good estimate of the helical and sheer 
contents, however does not estimate turns; Andrade et al., 1993).  
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10.6.3. Thermal Stability 
CD analyses are also useful as a method to determine the thermal stability of a 
protein, since changes in the ellipticity as a result of protein denaturation (disruption of 
secondary structure) can be detected. Thus, temperature-induced changes in the 
MgaSpn protein secondary structure were measured by increasing the temperature from 
4ºC to 90ºC at two different rates (20 and 50ºC/h). Samples were dialyzed against CD 
buffer and diluted in the same buffer to a protein concentration of 0.35 mg/ml. Changes 
in ellipticity were recorded at 220 nm in a 1-mm optical path length quartz cell. 
Additionally, CD spectra over a wavelength range from 185 to 260 nm were recorded at 
different temperatures (4, 15, 25, 37, 50, 60, 70, 90ºC). The temperature was 
equilibrated for 1 min prior to the acquisition of each spectrum. Finally, the sample was 
cooled to the initial temperature and a spectrum over the same wavelength range was 
recorded. 
10.7. Western blots 
S. pneumoniae R6 cells were grown to an OD650 of 0.3 and cells from 3 ml of 
culture were sedimented by centrifugation. Cell pellets were resuspended in 100 µl of LB 
buffer (see Table 5) and incubated at 30ºC for 5-10 min. Then, 25 µl of 5x SLB buffer 
were added, and the samples were heated at 95ºC for 5 min before being loaded onto 
SDS-polyacrylamide (10%) gels. The SeeBlue Plus 2 pre-stained protein standard 
(Invitrogen) was loaded in the same gel as a molecular weight marker. After 
electrophoresis, the gel was equilibrated with TB buffer. Immun-Blot PVDF membranes 
(Bio-Rad) were used for protein blotting. Methanol was used to pre-wet the membrane 
prior to equilibration in TB buffer. Proteins were transferred electrophoretically to the 
membrane using a Mini Trans-Blot (Bio-Rad) and TB buffer. The transfer was carried out 
at 100 mA at 4ºC for 90 min. Then, the membrane was dried by immersion in methanol 
for 2 min. Membranes were probed with polyclonal antibodies against His-tagged 
MgaSpn, which were diluted 1:1,000 in SB buffer. After 1 h of incubation, the membrane 
was rinsed three times with WB buffer and incubated for 1 h with the secondary antibody 
(anti-rabbit IgG) conjugated with horseradish peroxidase (HRP). The membrane was 
then washed three times with PBS. Antigen-antibody complexes were detected using the 
Immun-StarTM HRP substrate kit (Bio-Rad) in which the peroxidase conjugated with the 
secondary antibody catalyses oxidation of luminol (the substrate) and subsequently 
enhances chemiluminescence when the luminol recovers its original estate (reduction). 
The resulting light was detected with a Luminescent Image Analyzer LAS-3000 (Fujifilm 
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Life Science) or by autoradiography. The intensity of the bands was quantified using the 
Quantity One software (Bio-Rad). 
10.8. Proteomics 
Pneumococcal cells were grown in AGCH medium supplemented with sucrose 
(0.3%), yeast extract (0.2%) and antibiotic (if required) to an OD650 of 0.4. Then, cells 
were sedimented by centrifugation at 8,000 rpm in an Eppendorf F-34-6-38 rotor for 25 
min at 4ºC. Cells were washed twice with pre-cooled PBS buffer and the cell pellet was 
stored at -80ºC. The cell pellet was concentrated (30x) in LBP buffer (Table 5). Bacteria 
were disrupted by two passages through a pre-chilled French pressure cell. The whole-
cell extract was immediately frozen in dry ice and stored at -80ºC. Separation and 
identification of proteins was carried out at the Proteomics Core Facility of the CNIC 
using Difference Gel Electrophoresis (DIGE) (pre-labelling of samples with differential 
fluorochromes and 2-dimensional gel electrophoresis) a MALDI-TOF/TOF and ESI Ion-
Trap spectrometers. 
11. DNA-protein interactions 
11.1. Electrophoretic mobility shift assays  
11.1.1. Standard conditions for EMSA 
In general, standard binding reactions were performed in a volume of 10-20 µl 
containing 40 mM Tris-HCl, pH 7.6, 1.4 mM DTT, 0.4 mM EDTA, 2% glycerol, 50 mM 
NaCl, 10 mM MgCl2, 500 µg/ml BSA, 10 nM of unlabelled DNA or 0.1-2 nM of 5´-labelled 
DNA and varying concentrations of purified MgaSpn (1-480 nM). After 20 min of 
incubation at room temperature, BXGE buffer was added and free and bound DNA forms 
were separated on native polyacrylamide (5 or 8%, depending on the length of the DNA 
used) gels at 100 V and room temperature using TBE buffer. Labelled DNA bands were 
visualized using a Fujifilm Image Analyzer FLA-3000 and the Quantity One software. 
DNA fragments used in EMSA experiments are listed in Table 4.  
When indicated, non-labelled competitor DNA was added to the binding reaction: 
calf thymus DNA or linear dsDNA fragments (containing or not intrinsic curvature). In 
general, 32P-labelled DNA and non-labelled competitor DNA were added simultaneously 
to the reaction mixture. In dissociation experiments, MgaSpn was incubated with the 32P-
labelled DNA under standard conditions (formation of protein-DNA complexes). Then, 
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different amounts of the non-labelled competitor DNA were added and the reaction 
mixtures were incubated for 5 min (dissociation of protein-DNA complexes).  
11.1.2. Determination of the apparent dissociation constant (Kd) 
To estimate the affinity of MgaSpn for different DNA fragments, EMSA 
experiments were performed in which the MgaSpn concentration was varied from 1 to 
150 nM. The concentration of the labelled DNA fragment was 0.1 nM. Free DNA was 
visualized using a Fujifilm Image Analyzer FLA-3000 and was quantified using the 
Quantity One software (Bio-Rad). The protein concentration required to bind half the 
DNA was determined by measuring the decrease in free DNA rather than the increase in 
complexes (Carey, 1991), which gives an indication of the approximate magnitude of the 
dissociation constant, Kd. The data were plotted as fraction of free DNA versus protein 
concentration. The experiments were repeated twice.  
11.2. DNase I footprinting assays  
The DNase I footprinting assay is based on the enzymatic digestion of the DNA 
by DNase I in the presence of a DNA binding protein (Galas and Schmitz, 1978). Prior to 
the footprinting assay, DNase I titration was done to determine the optimum DNase I 
concentration to be used in the experiments. DNase I (stock solution) was diluted in 50% 
glycerol to 1:100, 1:250, 1:500 and 1:1000. Reactions (50 µl) contained 2 nM of the DNA 
fragment, 30 mM Tris-HCl, pH 7.6, 1% glycerol, 1.2 mM DTT, 0.2 mM EDTA, 50 mM 
NaCl, 1 mM CaCl2, 10 mM MgCl2. The digestion reaction was initiated by addition of 2 µl 
of the corresponding DNase I dilution. After incubation for 5 min at room temperature, 
reactions were stopped by adding 25 µl of STOP DNase buffer and 187 µl of absolute 
ethanol. DNA was precipitated, dissolved in BXF buffer, heated at 95ºC for 5 min and 
loaded onto sequencing gels (6% PAA, 8 M urea). A good footprint is obtained when 
approximately 50% of the DNA fragment remains intact. The optimal dilution of the 
DNase I stock was used in the DNase I footprinting assays.  
Binding reactions were performed in a volume of 10-50 µl containing 2-4 nM of 
5´-end labelled DNA, 30 mM Tris-HCl, pH 7.6, 1% glycerol, 1.2 mM DTT, 0.2 mM EDTA, 
50 mM NaCl, 1 mM CaCl2, 10 mM MgCl2, 500 µg/ml BSA and different concentrations of 
MgaSpn. When necessary, heparin (2 µg/ml) was added to the binding reactions. 
Reaction mixtures were incubated for 20 min at room temperature. Then, 0.04 units of 
DNase I was added and the incubation proceeded for 5 min at the same temperature. In 
reactions of 50 µl, DNase I digestion was stopped by adding 25 µl of STOP DNase 
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solution. DNA was precipitated with ethanol, dried and dissolved in 5 µl of BXF buffer. In 
reactions of 10 µl, DNase I digestion was stopped by adding 1 µl of 250 mM EDTA. 
Then, 4 µl of BXF buffer was added. After heating at 95°C for 5 min, samples were 
loaded on sequencing gels (6% PAA, 8 M urea).  
11.3. Hydroxyl radical (OH) footprinting assays 
In the hydroxyl radical (OH) footprinting technique, the DNA is chemically cut for 
the action of hydroxyl radicals generated by reduction of hydrogen peroxide by iron (II) 
(Tullius and Dombroski, 1986). To generate the hydroxyl radicals, equal volumes of 6% 
H2O2, 20 mM sodium ascorbate and a Fe
2+-EDTA solution (equal volumes of 4 mM 
ammonium iron (II) sulphate hexahydrate freshly prepared and 8 mM EDTA) were mixed 
immediately before being used (“Three reagents”). First, 32P-labelled DNA (4-8 nM) was 
incubated with MgaSpn (320-640 nM) in 50 µl of buffer containing 30 mM Tris-HCl, pH 
7.6, 50 mM NaCl, 10 mM MgCl2, 1.2 mM DTT, 0.2 mM EDTA, 0.02% glycerol, 500 µg/ml 
BSA, and incubated at room temperature for 20 min. Then, 20 ng of calf thymus DNA 
was added to enrich the sample in complex C1, and the mixture was incubated for 5 min 
at the same temperature. The cleavage reaction was started by adding 9 µl of the “Three 
reagents”. The OH cleavage was allowed to proceed for 5 min at room temperature. 
Reactions were stopped by the addition of thiourea (9.5 mM). To increase the footprint 
signal, protein-DNA complexes were separated from free DNA by native polyacrylamide 
(5%) gel electrophoresis and visualized by autoradiography. Free and bound DNAs were 
excised from gels and eluted at 42ºC overnight in EB buffer (see Table 5). Finally, DNA 
was precipitated with ethanol, air-dried and dissolved in 5µl of BXF buffer. Samples were 
heated at 95°C for 5 min before being loaded onto sequencing gels (6% PAA, 8 M urea).  
11.4. Analysis of protein-DNA complexes by electron microscopy  
These experiments were carried out using different linear dsDNA fragments (see 
Table 4). First, binding reactions (40-50 µl) were done in buffer containing 30 mM Tris-
HCl, pH 7.6, 1 mM DTT, 0.2 mM EDTA, 1% glycerol, 50-100 mM NaCl, 10 mM MgCl2, 
0.5-1 nM of DNA and MgaSpn (2-40 nM). Reactions were incubated at room 
temperature for 20 min. Then, complexes were adsorbed onto freshly cleaved mica, 
positively stained with 2% uranyl acetate and rotary shadowed. This is the main 
contrasting method for nucleic acids and it is produced by evaporation of a metal (Pt/Ir) 
under high vacuum conditions while the sample is rotating. Finally, the mica sheets were 
covered with a carbon film, which provides homogeneous low noise films of high stability 
under electron bombardment (Spiess and Lurz, 1988). Samples were visualized in an 
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electron microscope (Philips CM100, 100 kV; FEI Company, Hillsboro, Oregon) and 
micrographs of the carbon film replica were taken with a coupled Fastscan CCD camera. 
To determine the protein binding position on a given DNA, the contour length of the DNA 
in the protein-DNA complexes as well as the distance from one end of the DNA to the 
protein-binding site, was measured on projections of 35-mm negatives using a digitizer 
LM4 (Brühl, Nüremberg, Germany).  
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As a consequence of living in habitats of changing conditions, bacteria have 
developed several mechanisms to regulate gene expression. Although genetic regulation 
occurs at different levels, one of the most important mechanisms of adaptation to 
environmental changes is the regulation at a transcriptional level. Bacterial transcription 
is carried out by a multisubunit RNA polymerase (RNAP) holoenzyme. This enzyme is a 
complex of five subunits that constitute the core enzyme ( 2 ´ ) and a factor, which 
confers promoter specificity to the RNAP, interacts with transcription activators, 
participates in promoter DNA opening and influences the early phases of transcription 
(Saecker et al., 2011). In general, bacterial genomes encode different species 
of factors, each of which directs transcription of specific sets of genes (Gruber and 
Gross, 2003). In exponentially growing bacterial cells, most of the genes expressed are 
transcribed by an RNAP containing a housekeeping factor similar to the Escherichia 
coli 70  Promoters that are recognised by this holoenzyme are characterized by two 
main sequence elements: the -35 (5´-TTGACA-3´) and -10 (5´-TATAAT-3´) hexamers 
(relative to the transcription initiation site). The optimum spacer length between them is 
17 nucleotides (nt). In addition, some of these promoters also contain the extended -10 
element, which is more conserved in G+ bacteria (5´-TRTGN-3´) than in E. coli (5´-TGN-
3´), and is located immediately upstream of the -10 element (Figure 5) (Mitchell et al., 
2003; Voskuil and Chambliss, 1998). The presence of an extension within the -10 region 
is generally associated with strong promoters that may lack the -35 element both in S. 
pneumoniae (Sabelnikov et al., 1995) and E. coli (deHaseth et al., 1998). It has been 
shown that sequence-specific interactions between σ70 and the promoter, occur at the -
10 element, the extended -10 element and the -35 element (reviewed by Haugen et al., 
2008). Another element recognised by the RNAP is the UP element. It is located 
upstream of the -35 hexamer and is contacted by the α subunit of the RNAP (Ross et al., 
1993). UP elements have been found upstream of many bacterial promoters and can be 
recognised not only by the RNAP σ70 holoenzyme, but also by RNAPs containing 
alternative σ factors (Fredrick et al., 1995). This interaction facilitates the initial binding of 
the RNAP and enhances transcription (Aiyar et al., 1998). The UP element consists of 
two distinct subsites: the proximal subsite (positions -46 to -38, consensus 5´-
AAAAAARNR-3´) and the distal subsite (positions -57 to -47, consensus 5´-
AWWWWWTTTTT-3´ (Estrem et al., 1999). Promoters that contain a single near-
consensus region (either proximal or distal) are more common than promoters with a 
near-consensus full UP element, and the effect on transcription of these upstream 
sequences generally correlates with the similarity to the consensus (Ross et al., 1998). 
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Although bioinformatics can predict some promoters correctly, definitive 
identification of promoters requires the use of several experimental approaches, both in 
vivo and in vitro (Ross and Gourse, 2009). In this chapter, we show that the 
pneumococcal mgaSpn regulatory gene is transcribed from the Pmga promoter. 
Moreover, we demonstrate that this promoter is recognized by a reconstituted RNAP 
holoenzyme containing the E. coli core enzyme and the S. pneumoniae 43 subunit 
(homologue of the E. coli 70).  
Figure 5. Architecture of bacterial promoters. Schematic representation of the major RNAP holoenzyme and its 
interaction with the different promoter elements. Consensus sequences of the elements recognized by the 
70 
and  ( CTD: carboxy-terminal domain; NTD: amino-terminal domain) subunits are indicated. The optimal UP 
element (  binding site) consists of alternating A- and T- tracts (-57 to -38; 5´- AWWWWWTTTTTAAAAAARNR-3´; 
W = A or T; R = A or G; N = any base) (Estrem et al., 1999). Ext refers to the extended -10 element, whose 
consensus sequence in G+ bacteria is indicated (R = A or G; N = any base). The -35 element, the extended -10 and 
the -10 hexamer are contacted by the 
70 
subunit. +1 (black box) is the transcription start site. 
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1.1. The mgaSpn gene is transcribed from the Pmga promoter  
In the R6 pneumococcal strain, whose complete genome sequence was published 
in 2001 (Hoskins et al., 2001) (GenBank AE007317.1), the spr1622 gene (named 
mgaSpn in this work) encodes an Mga-like regulator. Such a gene is flanked by the 
spr1623 gene (unknown function) and the scrR gene (spr1621), which encodes the 
sucrose utilization system repressor (Figure 6). The four genes located downstream of 
the scrR gene encode an ABC transporter involved in the uptake and metabolism of 
sucrose (genes spr1620, spr1619, spr1618) and a sucrose-6-phospate hydrolase 
(spr1617 or sacA), respectively. According to the National Center for Biotechnology 
Information (NCBI) Entrez Genome Database, translation of the mgaSpn gene starts at 
coordinate 1598327. However, we think that the ATG codon at coordinate 1598270 is 
likely the translation start site of the mgaSpn gene because it is preceded by a putative 
Shine-Dalgarno sequence (5´-AAAGAGAGAAAG-3´) (Figure 6) that matches the 
reported consensus sequence for pneumococcus (Chang Bioscience, San Francisco, 
CA). Translation from this ATG codon would result in a protein of 493 residues 
(MgaSpn).  
 
 
 
 
 
 
To study whether the mgaSpn gene was transcribed under our bacterial growth 
conditions, RT-PCR experiments were carried out (Figure 7). Specifically, the 1622A 
oligonucleotide, which anneals to an internal region of the mgaSpn gene, was used as 
primer for extension on total RNA isolated from R6 cells. It generated a specific cDNA 
extension product, which was further amplified by PCR using either the 1622A and 
Figure 6. Scheme of the pneumococcal R6 genome spanning coordinates 1595432 to 1599526 (Hoskins et 
al., 2001). The spr1622 gene has been named mgaSpn in this work. For each open reading frame (ORF), the 
coordinates of the start and stop codons are indicated. The translation start site (ATG codon) of the mgaSpn 
gene is marked (black box). The putative Shine-Dalgarno sequence (SD) of the mgaSpn gene is indicated 
(bold letters). The main sequence elements of the Pmga promoter (-35 hexamer, -10 box, extended –10 
element and putative UP-element) as well as the transcription initiation site (+1) are shown. 
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C1622D or the 1622A and 1622C primers (Table 3). As controls, PCR reactions were 
performed using total RNA (negative control) or genomic DNA (positive control) as 
template. The resulting PCR products were analysed by agarose gel electrophoresis. 
When primers 1622A and C1622D were used, a PCR product that migrated at the 
position expected for a 1,023-bp DNA was amplified. This product was also detected in 
the positive control but not in the negative control. With the 1622A and 1622C primers no 
PCR products were detected, whereas a PCR product with the mobility expected for a 
1,221-bp fragment was synthesized in the positive control. These results indicated that 
the transcription of the mgaSpn gene was initiated at a site located downstream of 
coordinate 1598452. We then proceeded to analyse the region located between 
coordinate 1598452 and the translation start codon (coordinate 1598270) of the mgaSpn 
gene using the BPROM promoter recognition program (www.softberry.com). This 
sequence analysis led to the identification of a putative promoter (herein named Pmga) 
(Figure 6), which contains a consensus -10 hexamer (5´-TATAAT-3´), a consensus –10 
extension (5´-TGTG-3´) and shows a 3/6 match at the –35 hexamer (5´-aTGctA-3´). In 
addition, the distance between the -35 and the -10 elements is 16 nt, and the -10 
element is located 45 nt upstream of the translation start codon. These features 
indicated that the Pmga promoter might be recognised by a housekeeping  factor 
similar to the E. coli 70 (Haugen et al., 2008). Moreover, according to the consensus 
sequence reported for UP elements (Estrem et al., 1999), the presence of A+T rich 
regions (positions -43 to -64) upstream of the -35 element suggests that the Pmga 
promoter might contain an UP element.   
 
 
 
Figure 7. Transcription of the mgaSpn gene in vivo. RT-PCR assays were performed using total RNA isolated 
from S. pneumoniae R6 strain. The positions of the oligonucleotides used (1622A, 1622C, C1622D) as well as the 
expected DNA fragments (1 and 2) are shown. RT-PCR reaction products (lane R) were subjected to agarose 
(0.8%) gel electrophoresis and visualized using ethidium bromide. RT-PCR reactions without reverse 
transcriptase were performed as negative control (lane N). The size of PCR-amplified DNA fragments (fragments 
1 and 2) using genomic DNA as template (lane P, positive control) is indicated. The size (in bp) of DNA fragments 
(lane M) used as molecular weight markers (HyperLadder I, Bioline) are indicated on the right of the gel. 
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To identify the transcription initiation site of the mgaSpn gene, we carried out primer 
extension experiments. For these experiments we used total RNA isolated from 
pneumococcal R6 cells and the 1622D primer, which is complementary to the C1622D 
oligonucleotide (see Table 3, Figure 7). Nevertheless, we did not detect any cDNA 
extension product (not shown), which suggested that the amount of mgaSpn transcripts 
in the total RNA preparation was too small. As an alternative to amplify the signal, we 
cloned a 136-bp fragment (coordinates 1598440 to 1598305 of the R6 genome), which 
contained the Pmga promoter sequence, into the BamHI site of the pAS vector (pAS-
Pmga recombinant plasmid; Figure 8). Vector pAS (constructed in our laboratory; Ruiz-
Cruz et al., 2010) has a multiple cloning site (including BamHI) upstream of a promoter-
less gfp allele, which encodes a green fluorescence protein (GFP) that carries both the 
F64L mutation (it increases GFP solubility) and the S65T mutation (it increases GFP 
fluorescence and causes a red shift in the excitation spectrum) (Cormack et al., 1996; 
Heim, 1995). Moreover, the gfp allele carries translation initiation signals that are optimal 
for its expression in prokaryotes (Miller and Lindow, 1997). Therefore, the promoter 
activity of the 136-bp DNA fragment was evaluated by monitoring gfp expression. The 
intensity of fluorescence (measured at 515 nm; excitation at 488 nm) in cells harbouring 
the pAS-Pmga recombinant plasmid was slightly higher (1.5 fold) than in cells carrying 
the pAS vector, indicating that the 136-bp region contained a promoter signal. 
Subsequently, we performed primer extension experiments using total RNA from cells 
harbouring the pAS-Pmga recombinant plasmid. In this case, the INTgfp primer, which 
anneals to the gfp transcript, was used for the extension reactions (Figure 8). Two cDNA 
extension products of 120 and 121 nt were detected, indicating that transcription of the 
gfp gene started at a site located 7 to 8 nt downstream of the –10 element of the Pmga 
promoter. These results demonstrated that the Pmga promoter was functional in vivo 
under our experimental conditions. 
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1.2. The Pmga promoter is recognized by the pneumococcal 43 factor 
Unlike the E. coli RNAP holoenzyme (containing the σ70 subunit), the S. pneumoniae 
RNAP holoenzyme is not commercially available. As a first approach to characterize the 
Pmga promoter, we investigated whether the E. coli RNAP holoenzyme was able to 
initiate transcription from the Pmga promoter. To this end, in vitro transcription 
experiments under multiple-round conditions were performed (Figure 9).  
Two linear DNA fragments of 224-bp (coordinates 1598452 to 1598229) and 265-bp 
(coordinates 1598452 to 1598188) were used as templates (see Figure 9A). 
Transcription from the Pmga promoter should generate runoff transcripts of 81 nt or 122 
nt using the 224-bp or 265-bp DNA, respectively. The in vitro transcription products were 
resolved on denaturing gels (6% PAA, 8M urea) (Figure 9B), and their sizes were 
calculated taking into account that an RNA molecule migrates about 5-10% more slowly 
than a DNA molecule of the same size in denaturing gels (Sambrook et al., 1989). When 
the 224-bp DNA fragment was used as a template (lane 1), transcripts of 80-81nt and 
140-141 nt were detected. In the case of the 265-bp DNA fragment (lane 2), transcripts 
Figure 8. The Pmga promoter is functional in vivo. Primer extension reactions were carried out on total 
RNA isolated from pneumococcal cells carrying plasmid pAS-Pmga. The gfp gene carries translation initiation 
signals optimized for prokaryotes (SD) (Miller and Lindow, 1997). The tetL gene confers resistance to 
tetracycline. The main sequence elements of the mgaSpn gene promoter (red boxes) and the ATG initiation 
codon of the gfp gene (black box) are indicated. BamHI sites are underlined. The asterisks indicate the 3′ -
ends of the cDNA products synthesized in the reaction using the INTgfp primer. The sizes of the cDNA 
products (lane R) are indicated in nucleotides on the right of the gel. A, C, G, T sequence ladders were used 
as DNA size markers using DNA from pLS1 plasmid (Lacks et al., 1986) and the F-pLSI primer (5´-
TGCTGGCAGGCACTGGC-3´; coordinates 802 to 818). 
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of 121-122 nt and 182 nt were observed. These results indicated that the E. coli RNAP 
holoenzyme was able to initiate transcription not only at coordinate 1598309 (promoter 
Pmga) but also at coordinate 1598369 (Figure 9A). According to the BPROM prediction 
program there is a promoter sequence (here named P2) just upstream of coordinate 
1598369. Such a promoter has a near consensus -10 element (5´-TATtAT-3´), a near 
consensus -10 extension (5´-aGTG-3´), and a 3/6 match at the –35 hexamer (5´-TTGttt-
3´). Moreover, the -10 and -35 sequence elements are separated by 20 nt.  
43The pneumococcal factor (gene rpoD), which is homologous to the E. coli 70
factor, has been purified in our laboratory by Sofía Ruiz-Cruz. We used the purified 43
factor to reconstitute a functional RNAP holoenzyme with the commercial E. coli core 
enzyme, as described in Methods (section 8.2). The reconstituted RNAP was further 
used for in vitro transcription experiments using again the 224-bp and 265-bp DNAs as 
templates (Figure 9A). As shown in Figure 9C, the reconstituted RNAP was able to 
initiate transcription from the Pmga promoter but not from the P2 promoter. Therefore, 
we conclude that the Pmga promoter is recognized by the pneumococcal 
housekeeping 43 factor. 
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Figure 9. The Pmga promoter is recognized by the 
43
 factor. (A) Scheme showing the 224-bp (coordinates 
1598452 to 1598229) and 265-bp (coordinates 1598452 to 1598188) linear DNA fragments used as templates for in 
vitro transcription assays. In red, runoff transcripts expected to be synthesized from the Pmga promoter using the 
224-bp (81 nt) or the 265-bp (122 nt) DNAs. In grey, runoff transcripts generated from the P2 promoter sequence. 
The Pmga and P2 promoters are separated by 59 nt. The translation start codon (ATG) of the mgaSpn gene is 
indicated. Nucleotide sequence spanning coordinates 1598415 to 1598277 is shown. The main sequence elements 
(-35 element, -10 box and extended -10 element) of the Pmga (red boxes) and P2 (grey boxes) promoters as well as 
the transcription initiation sites (+1) identified in this work are shown. (B) In vitro transcription experiments using 
the E. coli RNAP holoenzyme (Epicentre). Reactions using the 224-bp (Lane 1) or the 265-bp (Lane 2) DNA were 
loaded onto a sequencing gel (6% PAA, 8M urea). The sizes (in nucleotides) of the runoff transcripts are indicated on 
the right of the gel. Sequence ladders were used as DNA size markers (lanes A, C, G and T). They were prepared 
using a PCR-amplified fragment from the pneumococcal R6 genome (1221-bp; coordinates 1597232 to 1598452) 
and the 1622D oligonucleotide (see Table 3). (C) In vitro transcription experiments using a reconstituted RNAP (E. 
coli RNAP core enzyme and the pneumococcal σ
43 
factor). Reactions using the 224-bp (Lane 1) or the 265-bp (Lane 
2) DNA were loaded onto a sequencing gel (6% PAA, 8M urea). The sizes (in nucleotides) of the transcripts are 
indicated on the right of the gel. Dideoxy-mediated chain termination sequencing reactions, using a PCR-amplified 
fragment from the R6 genome (421-bp; coordinates 1598229 to 1598649) and the 1622C primer, were run in the 
same gel, and used as DNA size markers (lanes A, C, G and T).   
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In this chapter, we describe the protocol developed to overproduce and purify an 
untagged form of the MgaSpn regulator. As far as we know, it is the first case within the 
Mga/AtxA family of global regulators. We have also undertaken the study of the 
multimeric state of MgaSpn in solution by gel filtration chromatography and analytical 
ultracentrifugation. The secondary structure content of MgaSpn has also been 
determined by circular dichroism studies.  
2.1. Purification of the native MgaSpn protein 
We have developed a protocol to overproduce and purify an untagged form of the 
MgaSpn protein. This protocol is extensively described in Methods (Section 9.2). 
Basically, the mgaSpn gene was cloned into the E. coli inducible expression vector 
pET24b, which is based on a promoter recognized by the T7 RNAP (Figure 10). The 
recombinant plasmid pET24b-mgaSpn was introduced into the E. coli BL21 (DE3) strain, 
which carries the T7 RNAP-encoding gene (T7 gene) fused to the lacUV5 promoter. In 
this system, expression of the T7 gene and, consequently, expression of mgaSpn is 
induced when IPTG is added to the bacterial culture. Various bacterial growth conditions 
and IPTG concentrations were assayed to define the optimal mgaSpn gene expression 
conditions (TY medium, 37ºC, 1 mM IPTG). The method used for large-scale purification 
of MgaSpn involved essentially three steps (Figure 11): firstly both DNA and MgaSpn 
(presumably bound to DNA) were precipitated with PEI at a low ionic strength, then 
MgaSpn was eluted from the PEI pellet using a higher ionic strength buffer, and finally 
samples were subjected to heparin affinity chromatography. Fractions containing 
MgaSpn were identified using Coomasie-stained SDS-polyacrylamide (10%) gels (Figure 
11). Then, such fractions were pooled, dialyzed and concentrated prior to storage at - 
80ºC. The yield of pure protein was 4-5 mg per litre of cell culture. Coomassie-stained 
overloaded gels showed that the protein preparation was more than 95% pure. Under 
denaturing conditions, MgaSpn migrated between the 45 and 66 kDa bands of the 
molecular weight marker (Figure 11), which agrees with the molecular weight of the 
MgaSpn monomer calculated from its predicted amino acid sequence (58,723.2 Da; 493 
residues). In fact, the quantitative amino acid analysis of MgaSpn (Pharmacia-Biochrom 
20 Amino Acid Analyzer) was in agreement with the amino acid composition predicted 
from the nucleotide sequence. Determination of the N-terminal amino acid sequence of 
MgaSpn by Edman degradation showed that the first Met residue was not processed 
after protein synthesis.  
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Figure 11. Purification of the native MgaSpn protein. Protein fractions of each step were analysed by SDS-
polyacrylamide (10%) gel electrophoresis. Lanes 1 to 3: Induction of mgaSpn gene expression; (1) without 
IPTG; (2) with IPTG for 25 minutes; (3) after treatment with rifampicin for 60 minutes. Lanes 4 to 12: 
Purification steps; (4) supernatant of a whole-cell extract; (5) supernatant of a clear lysate; (6) proteins that 
remained in the supernatant after precipitation with polyethyleneimine (PEI) at low ionic strength; (7-8) 
proteins eluted from PEI pellet using a low ionic strength buffer; (9) proteins eluted from the PEI pellet using a 
higher ionic strength buffer; (10) proteins precipitated with ammonium sulphate; (lane 11) heparin affinity 
chromatography: elution of the proteins retained in the heparin column with a salt gradient (0.3-0.8 M NaCl); 
(lane 12) MgaSpn preparation after heparin affinity chromatography. M indicates the molecular weight 
standards (in kDa) (LMW Marker, GE Healthcare). 
Figure 10. Experimental design to overproduce the MgaSpn protein. The mgaSpn gene was cloned into the 
pET24b expression vector under the control of a T7 RNAP promoter (T7 promoter). The recombinant 
plasmid was introduced into the E. coli BL21 (DE3) strain, which carries the T7 RNAP gene (T7 gene) under 
control of the IPTG-inducible lacUV5 promoter. The host strain also carries a chromosomal copy of the lacI 
gene. In the absence of IPTG, the LacI repressor binds to the operator region (lacO) of the lacUV5 promoter 
and represses the transcription of the T7 gene. When the inductor (IPTG) is added, it displaces the LacI 
repressor from the lacO region, allowing the binding of the E. coli RNAP and, therefore, the expression of 
the T7 gene. The T7 RNAP recognizes the 10 promoter of the phage T7 (T7 promoter) and the mgaSpn 
gene is transcribed. 
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2.2. Domain organization of MgaSpn 
The three-dimensional structure of a putative Mga-like transcriptional regulator 
(EF3013) from Enterococcus faecalis has been resolved by X-ray crystallography 
(Osipiuk et al., 2011). Such a structure has been deposited in the Protein Data Bank 
(PDB 3SQN). With the exception of EF3013, whose function is being characterized in 
our laboratory, structural data are not available for any member of the Mga/AtxA family of 
regulators. However, Mga and AtxA were reported to have a similar organization of 
known or predicted functional domains (Hondorp and McIver, 2007; Tsvetanova et al., 
2007; Hondorp et al., 2013) (see Figure 3). Regarding the MgaSpn regulator, our in silico 
analyses indicated that it exhibits similarity to Mga and AtxA in the domain organization. 
The Pfam protein families database (Punta et al., 2012) revealed the presence of two 
putative DNA-binding motifs within the N-terminal region, the so-called HTH_Mga 
(residues 6 to 65) and Mga (residues 71 to 158) motifs (Figure 12). Both helix-turn-helix 
motifs are also present in the Mga (Hondorp and McIver, 2007) and AtxA (Tsvetanova et 
al., 2007) global response regulators (Figure 3). Moreover, in the central region of 
MgaSpn, the Pfam database predicted a PRD domain that includes amino acids 173 to 
392. Thus, PTS components might modulate the activity of MgaSpn by phosphorylation 
of histidine residues located within such a domain. Analysis of MgaSpn with the protein 
structure prediction server Phyre2 (Kelley and Sternberg, 2009) confirmed the Pfam 
predictions and, in addition, revealed structural homology of the C-terminal region (amino 
acids 399 to 487) to an EIIB-like domain used by the PTS (Figure 12). An EIIB-like 
domain has also been identified at the C-terminal region of the Mga (Hondorp et al., 
2013) and AtxA (Hammerstrom et al., 2011) regulators. 
Figure 12. Predicted domains in the MgaSpn regulatory protein. At the N-terminal region, two putative DNA 
binding motifs are indicated: HTH-Mga (Pfam) or WH (Phyre2) and Mga-like HTH motif. A central domain is found 
to have structural homology to a PTS regulatory domain (PRD). According to Phyre2, the C-terminal region shows 
structural homology to an EIIB-like domain used by the PTS. 
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2.3. Oligomerization state of the MgaSpn protein  
The availability of a method to purify the untagged MgaSpn protein to near 
homogeneity allowed us to study its oligomerization state in solution. To determine the 
molecular size (Stokes radius) of MgaSpn, gel filtration chromatography was performed 
using a running buffer that contained 250 mM of NaCl. The elution profile is shown in 
Figure 13A. At a loading concentration of 25 µM (1.45 mg/ml), most of the MgaSpn 
protein eluted as a symmetrical single peak. The elution volume of MgaSpn was 
obtained from experimental data and its corresponding Kav value was calculated (see 
Methods, Section 10.5). Standard proteins of known Stokes radius were loaded at same 
conditions to obtain a calibration curve. Values of Kav were calculated from the elution 
volume of each protein and plotted against Stokes radii (Figure 13B). The Stokes radius 
of MgaSpn was inferred from the calibration curve and was shown to be 46 Å. This value 
is very close to the Stokes radius of alcohol dehydrogenase standard protein (45 Å), with 
a molecular weight of 150 kDa. The same result was obtained when the running buffer 
contained 100 mM of NaCl. These results indicate that the untagged MgaSpn protein 
appears to be a dimer under our experimental conditions.  
 
 
 
 
 
To further analyse MgaSpn oligomerization, analytical ultracentrifugation 
experiments (sedimentation velocity and sedimentation equilibrium) were carried out at 
different protein concentrations (5 and 10 µM). At 5 µM, the sedimentation velocity profile 
showed a major peak (83.6%) with an S20,w value of 5.7 S, and an average molecular 
mass (Mw,a) of 113,924 Da, which is compatible with the dimer of the protein. When the 
Figure 13. MgaSpn exists as a dimer in solution. (A) Elution profile of MgaSpn on a HiLoad Superdex 200 gel-
filtration column. Inset shows analysis of the eluted protein by SDS-polyacrylamide (10%) gel electrophoresis. 
The molecular weight (in kDa) of proteins used as markers (GE Healthcare) is indicated on the right of the gel. 
(B) Stokes radius of MgaSpn. The column was calibrated by loading several standard proteins of known Stokes 
radius: ferritin (F; 61 Ǻ), alcohol dehydrogenase (ADH; 45 Ǻ), ovalbumin (O; 30.5 Ǻ) and carbonic anhydrase (CA; 
20.1 Ǻ). Each protein was prepared at the concentration recommended by the suppliers, in a final volume of 1 
ml of buffer VL containing 250 mM NaCl. The flow rate used was 0.5 ml/min. 
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protein concentration was increased up to 10 µM, the same major species was found 
(77.7%), but species of higher sedimentation coefficient also appeared in the sample 
(Figure 14A). This indicates that the concentration of MgaSpn may affect its multimeric 
state; nevertheless, the dimeric form appeared to be predominant in the samples. 
Samples were also analysed by sedimentation equilibrium (Figure 14B). Analysis of the 
experimental data obtained at a MgaSpn concentration of 5 µM indicates an Mw,a of 
167,719 ± 894 Da, significantly larger than the value expected for the monomer (58723.2 
Da) and even for the dimer (117,446.4 Da), suggesting that during the sedimentation 
equilibrium, the protein tends to form higher-order molecular species. The Mw,a of 
MgaSpn at 10 µM (194,648 ± 1,233 Da) was even larger than the theoretical mass of the 
MgaSpn dimer (not shown). Analysis of the data using different models indicated no 
improvement in the best-fit parameters. Moreover, the frictional ratio (f/f0) calculated was 
1.45, indicating that the hydrodynamic behaviour of MgaSpn deviates from that of a rigid 
spherical particle with a frictional ratio value of 1.0. Thus, MgaSpn can be expected to 
have an ellipsoidal shape. Taking into account the experimental results, in solution and 
under the conditions tested, MgaSpn is able to establish protein-protein interactions, 
generating molecular species that might be elongated homo-dimers or higher-order 
oligomers. Moreover, the concentration of the protein may favour the formation of homo-
multimers. 
 
 
 
 
 
Figure 14. Analytical ultracentrifugation of MgaSpn. (A) Sedimentation velocity profiles of MgaSpn (5 M and 10 
M) at 43,000 rpm and 12ºC. The lines represent the best fits to a model of a single sedimenting species (3.8 S; 
S20,w = 5.7 S). The arrow indicates a molecular species of higher sedimentation coefficient (5.1 S) that appears at 10 
M and represents a 9.3% of total. (B) Sedimentation equilibrium profile of MgaSpn (5 M) at 9,500 rpm and 10ºC. 
Grey circles represents the experimental data and; the continuous line is the best-fit Mw (167,719 ± 894 Da). 
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2.4. Secondary structure content and thermal stability of MgaSpn 
The secondary structure content of the MgaSpn regulator was analysed by 
computational methods and by far-ultraviolet (far-UV) circular dichroism (CD) 
spectroscopic analyses. According to the prediction programs used (Table 7), MgaSpn 
has a high content of α-helices (57.4-66.3%) and a low content of β-strands (8.1-9.7%). 
The distribution of secondary structure elements predicted by the SABLE program 
(Adamczak et al., 2005) is shown in Figure 15A.  
 
These predictions were further confirmed by CD analyses (Figure 15B). The CD 
spectrum of native MgaSpn (12 µM) was measured in the far-UV region (185-260 nm). It 
is characterized by two minima at 208 and 222 nm, and a maximum at around 192 nm, 
indicative of the presence of α-helical structures. Deconvolution of the CD spectrum by 
different methods (Table 7) gave a consensus average of 55.3% α-helices, 10.5% β-
strands and 37.8% random conformation and turns.  
A 
B 
Figure 15. Secondary structure 
content of MgaSpn. (A) In silico 
prediction of the secondary 
structure content of MgaSpn. The 
amino-acid sequence of MgaSpn 
is shown as well as the 
distribution of secondary 
structure elements predicted by 
the SABLE program (Adamczak et 
al., 2005). α-helices are 
represented by red cylinders 
while β-sheets are represented 
by green arrows. (B) CD spectrum 
of MgaSpn in the far-UV region at 
4ºC. Data were obtained using a 
0.2-mm optical path-length 
quartz cell in CD buffer. 
Experimental data (grey circles) 
and the fitted data using the 
CONTINLL algorithm (continuous 
line) are represented. The spectra 
are expressed as mean residues 
ellipticities (y axis) at given 
wavelength (x axis). 
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Table 7. Secondary structure content of MgaSpn 
CD spectroscopic studies at different temperatures were done to analyse the 
thermal stability of MgaSpn (12 µM). Denaturation of the protein in response to 
temperature produces changes in the ellipticity values. These changes were monitored 
in the far-UV region (190-260 nm) while the temperature was increased from 4ºC to 90ºC 
at the rate of 50ºC/h or 20ºC/h with similar results. CD profiles were recorded from 190 to 
260 nm at 4, 12, 25, 37, 50, 60, 70 and 90ºC (Figure 16). At 50ºC there was a 
progressive loss of ellipticity indicating that denaturation of MgaSpn starts around this 
temperature. Above 50ºC, the ellipticity strongly decreased as the temperature was 
increased. After the maximum temperature (90ºC) was reached, the sample was cooled 
to the initial temperature (4ºC) to study the reversibility of MgaSpn denaturation. The 
spectrum of MgaSpn was not recovered. Similar results were obtained when the 
maximum temperature was limited to 50ºC (not shown) indicating that, once protein 
denaturation starts, MgaSpn is not able to refold its secondary structure to its native 
form.  
Figure 16. Temperature-associated changes in the 
secondary structure of MgaSpn. CD spectra 
measured during thermal denaturing (solid lines) and 
refolding (heated sample re-cooled to 4ºC; dotted 
line) processes. A perceptible loss of secondary 
structure was observed from 50ºC. Re-cooled 
samples did not recover the secondary structure 
once they were denatured, indicating an irreversible 
damage to the MgaSpn secondary structure.   
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In this chapter, we describe an in depth transcriptional analysis of the spr1623-
spr1626 operon and the ability of MgaSpn to activate its transcription. We published this 
study in 2012 (Solano-Collado et al., 2012; see Related publications) and it was the first 
report describing the activator role of the pneumococcal Mga-like regulator.  
3.1. Construction of pneumococcal R6 mutant strains 
To study the effect of MgaSpn on gene expression, we constructed two derivatives 
of the pneumococcal R6 strain: a deletion mutant strain (R6Δmga) which does not 
synthesize MgaSpn and a strain designed to overproduce MgaSpn (R6/pDLPsulA::mga). 
The latter strain carries the mgaSpn gene cloned into a plasmid (Figure 17B). 
Specifically, we first constructed the PsulA::mga fusion gene, in which the Pmga 
promoter of the mgaSpn gene was replaced with the promoter of the pneumococcal sulA 
gene (PsulA) (Lacks et al., 1995). The activity of the PsulA promoter region had been 
tested previously using a promoter-probe vector (Ruiz-Cruz et al., 2010). The 
PsulA::mga fusion gene was then inserted into the pDL287 plasmid (LeBlanc et al., 
1993) generating the pDLPsulA::mga recombinant plasmid. Pneumococcal R6 cells 
either containing or lacking the recombinant plasmid were grown under standard 
laboratory conditions, and the intracellular amount of MgaSpn was estimated by 
Western-blotting (Figure 17C). Compared to R6 cells without plasmid (Figure 17C, lane 
1) or R6 cells carrying pDL287 (not shown), the amount of MgaSpn increased about 8-
fold in cells harbouring the pDLPsulA::mga recombinant plasmid (Figure 17C, lane 3). 
The higher intracellular level of MgaSpn did not affect the bacterial growth rate (not 
shown).  
For the construction of the R6Δmga mutant strain (Figure 17A), the chromosomal 
region that includes the mgaSpn gene and its promoter (Pmga) (coordinates 1596826 to 
1598431) was replaced with the cat gene of the pC194 plasmid, which confers 
chloramphenicol resistance (Horinouchi and Weisblum, 1982). To do this, we first 
constructed a cassette composed of the adjacent regions of mgaSpn flanking the cat 
gene (described in Methods, Section 3.1). Then, competent R6 cells were transformed 
with the cat cassette and by homologous recombination the mgaSpn gene was replaced 
with the cat gene. Cells lacking the mgaSpn gene were selected based on its resistance 
to chloramphenicol (1.5 µg/ml). As expected, the R6Δmga strain did not synthesize 
MgaSpn (Figure 17C, lane 2).   
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3.2. Preliminary proteomic assays 
To identify the target genes of the MgaSpn regulator, we analysed the effect of the 
absence of MgaSpn on the pattern of global gene expression comparing the R6 wild-
type and R6Δmga strains by proteomics. Pneumococcal cells were grown under 
standard laboratory conditions. These experiments were carried out in collaboration with 
Dr. J. A. López at the Proteomics Facility of the Centro Nacional de Investigaciones 
Cardiovasculares (CNIC, Madrid). The results obtained showed significant changes 
(increased or decreased levels in the absence of MgaSpn) in 10 candidates, including 
proteins involved in competence, in metabolism of amino acids, heat shock proteins and 
proteins of unknown function. Interestingly, one of the proteins whose levels decreased 
(2.3-fold) in the absence of MgaSpn was the putative general stress protein 24, encoded 
by the spr1625 gene, indicating that MgaSpn might be acting, directly or indirectly, as a 
positive regulator of the srp1625 gene. This fact, together with the location of spr1625 
Figure 17. Construction of pneumococcal R6 mutant strains and detection of MgaSpn in whole-cell extracts by 
Western-blotting. (A) Construction of the R6Δmga strain. The mgaSpn gene and its promoter were replaced with 
the cat gene (chloramphenicol resistance) of the pC194 plasmid. First, two DNA fragments that flank the mgaSpn 
gene (called Up and Down) were PCR-amplified and ligated to the cat fragment. The cassette generated was used 
to transform competent R6 cells. Finally, two homologous recombination events led to the replacement of the 
mgaSpn gene with the cat gene. Cells that lacked the mgaSpn gene were selected based on their resistance to 
chloramphenicol (1.5 µg/ml). (B) Construction of a mutant strain that overproduces MgaSpn. The Pmga promoter 
of the mgaSpn gene was replaced with the promoter of the sulA gene (Lacks et al., 1995). The fusion PsulA::mga 
gene was then inserted into the ClaI site of plasmid pDL287 (LeBlanc et al., 1993), generating the pDLPsulA::mga 
recombinant plasmid, which was further used to transform pneumococcal R6 cells. (C) Detection of MgaSpn in 
pneumococcal cell extracts by Western-blotting using polyclonal antibodies against the MgaSpn-His protein. Total 
proteins from R6 cells (lane 1), R6Δmga (lane 2), and pDLPsulA::mga-harbouring cells (lane 3) were separated by 
SDS-PAGE (10% polyacrylamide). His-tagged MgaSpn protein (6 ng) (lane 4) and pre-stained proteins (Invitrogen) 
(not shown) were run in the same gel. Cross-reactive bands were used as loading controls.   
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close to mgaSpn on the R6 genome (Figure 18), led us to work on the validation of this 
result. The transcriptional analysis of the spr1625 gene, as well as its regulation by 
MgaSpn is described in the following sections.   
3.3. Transcription of the spr1623-spr1626 operon in pneumococcal R6 cells 
The spr1625 gene is located upstream of the mgaSpn gene and on the 
complementary strand. It is the third of four genes of unknown function that appear to be 
organized in an operon (spr1623-spr1626) (Figure 18). Due to this organization, the 
mgaSpn gene and the putative four-gene operon would be divergently transcribed. The 
ATG codon at coordinate 1598960 is probably the translation initiation codon of the 
spr1623 gene, and it is located at 689-bp from the ATG initiation codon of the mgaSpn 
gene (coordinate 1598270). To investigate whether the putative operon was transcribed 
under our experimental conditions, we performed RT-PCR assays. Initially, the 1623B 
Figure 18. Genetic map of the region spanning the 1596789 and 1600589 coordinates of the pneumococcal R6 
genome (Hoskins et al., 2001). For each gene, the coordinates of the start and stop codons are indicated. The 
nucleotide sequence of the region spanning the start codon (ATG) of the mgaSpn gene (coordinate 1598270) and 
the start codon (ATG) of the spr1623 gene (coordinate 1598960) is shown. The putative Shine-Dalgarno sequence 
(SD) of the mgaSpn gene is indicated (bold letters). The main sequence elements (-35 box, -10 box and extended –
10 box) of the promoters identified in this work (Pmga in red, P1623B in blue and P1623A in yellow), as well as the 
transcription start sites (+1 position, arrows), are indicated. 
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primer, which anneals with the spr1623 transcript, was used for extension on total RNA 
isolated from R6 cells (Figure 19). The cDNA extension product was then amplified by 
PCR using either the 1623B and 1623C or the 1623B and 1623A oligonucleotides. With 
the pair of primers 1623B and 1623C, a PCR product with the mobility expected for a 
695-bp fragment was detected. This product was not visualized in the negative control 
(total RNA as template). When the cDNA product was amplified using the 1623B and 
1623A primers, no PCR products were detected. However, these primers amplified an 
892-bp region when chromosomal DNA was used as template (positive control) (Figure 
19). These results indicate that the spr1623 gene is transcribed under our experimental 
conditions. In addition, we performed RT-PCR experiments to elucidate whether the four 
genes were transcribed as a single polycistronic mRNA. Specifically, the 1626A primer 
was used for the cDNA synthesis (Figure 19). Amplification of the cDNA product with the 
1626A and 1623C primers generated a product with the mobility expected for a 1,917-bp 
fragment. This product was not detected when total RNA was used as template for the 
PCR reactions (negative control) but it was synthesized in the positive control. 
Collectively, these results indicate that the spr1623, spr1624, spr1625 and spr1626 
genes are transcribed into a polycistronic mRNA molecule from a site(s) located between 
the 1598433 and 1598630 coordinates.  
Figure 19. The spr1623-spr1626 genes constitute an operon. RT-PCR experiments were performed using total 
RNA isolated from R6 cells. The positions of the oligonucleotides used (1623A, 1623B, 1623C and 1626A) are 
shown. RT-PCRs (lanes R) were subjected to agarose (0.8%) gel electrophoresis and visualized with ethidium 
bromide. As negative controls (lane N), RT-PCRs were carried out without adding the reverse transcriptase. The 
sizes of the PCR-amplified DNA fragments (1, 2, and 3) using genomic DNA as template (lanes P, positive control) 
are indicated. Lanes M, DNA fragments used as molecular weight markers (in bp) (HyperLadder I, Bioline). 
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Additionally, we carried out a sequence analysis of the region spanning coordinates 
1598960 to 1598270 (intergenic region between spr1623 and mgaSpn) with the BPROM 
program. This analysis predicted a promoter (hereon named P1623A; Figure 18) that 
exhibits a canonical -10 hexamer (5´-TATAAT-3´) and a near consensus -35 hexamer 
(5´-TTGACt-3´). The distance between these two elements is 17 nt, which is the 
optimum spacer length in promoters recognised by an RNAP carrying a housekeeping  
factor similar to the E. coli  (Haugen et al., 2008). To investigate whether the predicted 
promoter P1623A was functional in vivo, we performed primer extension experiments 
using total RNA from R6 cells and the PDA oligonucleotide, which anneals with a 
sequence located downstream of the P1623A promoter (Figure 20). We were able to 
detect two cDNA products of 106 and 191 nt, which may correspond to transcription 
initiation events at coordinates 1598592 (P1623A promoter) and 1598507, respectively. 
Therefore, the pneumococcal RNAP recognised not only the P1623A promoter but also 
a promoter sequence located upstream of the P1623A promoter, which was not 
identified by bioinformatics programs. Such a promoter sequence (termed P1623B) has 
a consensus -10 hexamer (5´-TATAAT-3´) but lacks a -35 element (Figure 18). To 
confirm the functionality of the P1623B promoter in vivo, primer extension experiments 
were performed using the PDB primer. A cDNA product of 60 nt was synthesized, 
indicating that the P1623B promoter was functional (Figure 20). 
70
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3.4. MgaSpn activates the P1623B promoter in vivo  
To investigate whether the MgaSpn protein influenced the activity of a particular 
promoter in vivo, we used the R6/pDLPsulA::mga strain that overproduce MgaSpn (see 
section 3.1 and Figure 17B). Specifically, we analysed the effect of the MgaSpn 
overproduction on the activity of the chromosomal P1623A and P1623B promoters by 
primer extension. For the cDNA synthesis, we used the 5´-labelled PDA oligonucleotide, 
which anneals to the spr1623 transcript (see Figure 21). As a loading control, we 
Figure 20. The spr1623-spr1626 
operon is transcribed from 
promoters P1623A and P1623B. 
Primer extension experiments were 
carried out using total RNA from R6 
cells and either the PDA (left gel) or 
the PDB (right gel) primers. The 
sizes of the cDNA extension 
products (lanes R) are indicated in 
nucleotides on the right of the gels. 
A, C, G, and T sequence ladders 
were used as DNA size markers. 
They were prepared using 
M13mp18 DNA (Yanisch-Perron et 
al., 1985) and the −40 M13 primer 
(5´-GTTTTCCCAGTCACGAC-3´) (left 
gel) or a PCR-amplified DNA 
fragment from the E. faecalis V583 
genome and the Rev primer (5´-
GATTTCTTCAATTTGTTCCATC-3´) 
(right gel). The asterisks in the 
scheme below the gels indicate the 
transcription start sites identified in 
this study. 
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included in the reactions the 5´-labelled PErpoE primer, which anneals to the rpoE 
transcript. The rpoE gene (spr0437 in the R6 genome) encodes the delta subunit of the 
RNAP (Figure 21). When total RNA from R6/pDL287 cells was used as template (Figure 
21, lane 1; low levels of MgaSpn), three cDNA products of 106 nt, 191 nt and 231 nt 
were detected, that correspond with products synthesized from the P1623A promoter, 
the P1623B promoter and the PrpoE promoter, respectively. Unlike the 231 nt product, 
which served as a loading control, the amount of the 106 nt and 191 nt cDNAs increased 
2.6-fold and 4.5-fold, respectively, when total RNA from R6/pDLPsulA::mga cells was 
used (Figure 21, lane 2; overproduction of MgaSpn). Therefore, the overproduction of 
MgaSpn led to the activation of both the P1623A and P1623B promoters, although the 
effect appeared to be greater on the activity of the P1623B promoter.  
 
 
 
 
 
 
 
 
 
We next examined the activity of the chromosomal P1623A and P1623B promoters 
in R6 mga cells carrying either plasmid pDL287 (absence of MgaSpn) (Figure 21, lane 
3) or plasmid pDLPsulA::mga (overproduction of MgaSpn) (Figure 21, lane 4). The 
R6 mga strain lacks the mgaSpn gene and its promoter (Pmga), but conserves the 
P1623A and P1623B promoter sequences (see Figure 18). As before, a mix of the 5´-
labelled PDA and PErpoE primers was used in primer extension assays. Compared to 
R6/pDL287 cells (lane 1; low levels of MgaSpn), the 191 nt product was not detected in 
Figure 21. MgaSpn mediates activation of the P1623B 
promoter. Primer extension reactions were performed 
using total RNA from R6/pDL287 (lanes 1, 5, and 6), 
R6/pDLPsulA::mga (lane 2), R6Δmga/pDL287 (lane 3), or 
R6Δmga/pDLPsulA::mga (lane 4) cells. Used as primers 
were 5´-labelled oligonucleotides: a mix of the PDA and 
PErpoE primers (lanes 1, 2, 3, and 4), primer PDA (lane 5), 
or primer PErpoE (lane 6). The sizes of the cDNA 
extension products are indicated on the left of the gel in 
nucleotides: 106 nt for the P1623A promoter, 191 nt for 
the P1623B promoter, and 231 nt for the PrpoE promoter. 
A, C, G, and T sequence ladders were used as DNA size 
markers. They were prepared using a PCR-amplified DNA 
fragment from the E. faecalis V583 genome and the Fw 
primer (5´-CGTTTGAGCAATATAATCGTTTG-3´).  
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R6 mga/pDL287 cells (lane 3; absence of MgaSpn), although no changes were found in 
the amount of the 106 nt and 231 nt cDNAs. Thus, low intracellular levels of MgaSpn 
resulted in the activation of the P1623B promoter without affecting the activity of the 
P1623A promoter. However, unexpectedly, the activity of the P1623B promoter on the 
R6 mga genome did not change in the presence of the pDLPsulA::mga plasmid (lane 4; 
overproduction of MgaSpn). These results suggest that the genome of the R6 mga 
strain lacks not only the mgaSpn gene (including the Pmga promoter) but also a site 
required for MgaSpn-mediated activation of the P1623B promoter (see below).  
3.5. Mapping the site required for MgaSpn-mediated activation of the 
P1623B promoter 
In order to delimit the region necessary for the activation of the P1623B promoter by 
MgaSpn, we carried out a deletion analysis using the promoter-probe vector pAST 
(Figure 22A) (Ruiz-Cruz et al., 2010). This vector carries a MCS between the T1-T2 
tandem terminators of the E. coli rrnB rRNA operon and a promoter-less gfp gene. The 
presence of the T1-T2 terminators results in an efficient transcriptional termination of the 
tetL gene (tetracycline resistance, Lacks et al., 1986). Plasmid pAST constitutes a useful 
tool for measuring the promoter activity of regions inserted into the MCS. For the deletion 
analyses, three R6 chromosomal regions were inserted independently into the SacI site 
of pAST (Figure 22A): (i) the PAB region (coordinates 1598304-1598600); (ii) the 
PAB 84 region (coordinates 1598388-1598600) and (iii) the PAB 153 region 
(coordinates 1598457-1598600), generating the recombinant plasmids pAST-PAB, 
pAST-PAB 84 and pAST-PAB 153, respectively. In all these constructions, expression 
of the gfp gene is under control of both, the P1623A and P1623B promoters, as shown in 
Figure 22A. Subsequently, each recombinant plasmid was introduced into R6 and 
R6 mga cells, and the promoter activity of each chromosomal region was evaluated by 
measuring gfp expression (fluorescence assays) (Figure 22A). Compared to R6 mga 
cells (absence of MgaSpn), the promoter activity of the PAB and PAB 84 regions was 
twice that observed in R6 cells (low levels of MgaSpn). However, the promoter activity of 
the PAB 153 region was similar in both genetic backgrounds. These results suggest that 
the chromosomal region spanning coordinates 1598388 and 1598457 contains 
sequences that are needed for MgaSpn-mediated activation of the P1623A and/or 
P1623B promoters.  
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We further evaluated the promoter activity of each chromosomal region by primer 
extension (Figure 23). For these assays, we used a mix of the 5´-labelled INTgfp and 
ASTtetL primers, which anneal to the gfp and tetL transcripts, respectively. The tetL 
gene of pAST plasmid was used as internal control. When total RNA from R6 cells (low 
levels of MgaSpn) harbouring plasmid pAST-PAB 84 (Figure 23, lane 2) was used, we 
detected three cDNA extension products of 102 nt, 111 nt and 196 nt, which correspond 
with transcription from PtetL, P1623A and P1623B promoters, respectively. Unlike the 
102 nt and 111 nt cDNAs, the amount of the 196 nt cDNA decreased 5-fold when total 
RNA from R6 cells harbouring plasmid pAST-PAB 153 was used (Figure 23, lane 3). 
Thus, deletion of the region spanning coordinates 1598388 and 1598457 reduced the 
activity of promoter P1623B but not the activity of promoter P1623A. Such a specific 
decrease in the activity of P1623B promoter was also observed in R6 mga cells 
Figure 22. Fluorescence assays. (A) Activity of the P1623A (PA) and P1623B (PB) promoters. The 
promoter-probe vector pAST was described previously (Ruiz-Cruz et al., 2010). The positions of the 
tetL (tetracycline resistance) and gfp (green fluorescent protein) genes are shown. The T1T2 box 
represents the tandem terminators T1 and T2 of the E. coli rrnB rRNA operon. Blue boxes represent 
DNA fragments of the R6 genome used for the deletion analysis. (B) Activity of the Pmga promoter. 
Plasmid pAST2 was described (Ruiz-Cruz et al., 2010). Compared to pAST, it carries the T2T1rrnB 
region inserted in the opposite orientation (box T2T1). The position of promoter Pmga is indicated. 
The intensity of fluorescence (arbitrary units) corresponds to 0.8 ml of culture (OD650 = 0.3). In each 
case, three independent cultures were analysed. 
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(absence of MgaSpn) carrying either PAB 84 (Figure 23, lane 4) or PAB 153 (Figure 
23, lane 5).  
 
 
 
 
 
 
 
 
 
 
These results therefore demonstrate that MgaSpn is able to act, directly or 
indirectly, as a positive regulator of the P1623B promoter in vivo. This activation requires 
a 70-bp region (termed henceforth as the PB activation region; coordinates 1598388 to 
1598457), which maps between the P1623B and Pmga divergent promoters and is 50-
bp upstream of the P1623B transcription start site (coordinate 1598507) (Figure 18 and 
22A).  
Figure 23. Genomic region needed for 
MgaSpn-mediated activation of the P1623B 
promoter. Primer extension reactions were 
carried out using total RNA isolated from 
R6/pAST-PABΔ84 (lanes 1 and 2), R6/pAST-
PABΔ153 (lane 3), R6Δmga/pAST-PABΔ84 
(lane 4), and R6Δmga/pAST-PABΔ153 (lane 5) 
cells. Used as primers were 5´-labelled 
oligonucleotides: a mix of the INTgfp and 
ASTtetL primer (lanes 2, 3, 4, and 5) or the 
ASTtetL primer (lane 1). The sizes of the 
cDNA extension products are indicated on 
the left of the gel in nucleotides: 102 nt for 
the PtetL promoter, 111 nt for the P1623A 
promoter, and 196 nt for the P1623B 
promoter. Dideoxy-mediated chain-
termination sequencing reactions using pAST 
DNA and the INTgfp primer were run in the 
same gel as DNA size markers (lanes A, C, G, 
and T). 
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3.6. MgaSpn does not influence the activity of the Pmga promoter in vivo 
The Mga protein of S. pyogenes regulates positively the expression of its own 
gene during the exponential phase of growth in order to amplify the Mga regulon (McIver 
et al., 1999). Therefore, we investigated whether MgaSpn was able to affect the activity 
of its own promoter in vivo. Moreover, our data showed that the site required for 
MgaSpn-mediated activation of the P1623B promoter is located upstream of the Pmga 
promoter (Figure 18 and 22A). This fact suggested that MgaSpn might also influence the 
activity of its own promoter. To test this hypothesis we constructed a transcriptional 
fusion between Pmga and the gfp gene of plasmid pAST2 (Figure 22B). Compared to 
the promoter-probe vector pAST, plasmid pAST2 (referred to as pAS-T2T1 rrnB in (Ruiz-
Cruz et al., 2010) carries the T1T2rrnB transcriptional terminator region inserted in the 
opposite orientation (T2T1rrnB region). We inserted the PAB chromosomal region 
(coordinates 1598304-1598600) into the SacI site of the pAST2 plasmid, generating the 
pAST2-Pmga plasmid (Figure 22B). Such a region carries the P1623A, P1623B and 
Pmga promoters. In pAST2-Pmga, expression of the gfp gene is under control of the 
Pmga promoter. The T2T1rrnB region functions as a transcriptional terminator signal of 
the tetL gene, although it is less efficient than the T1T2rrnB region (Ruiz-Cruz et al., 
2010). In addition, the T2T1rrnB region ensures an efficient termination of the 
transcription initiated at both divergent promoters, P1623A and P1623B. Plasmids 
pAST2 and pAST2-Pmga were then introduced into R6 (low levels of MgaSpn) and 
R6 mga (absence of MgaSpn) strains, and gfp expression was monitored by 
fluorescence assays. The intensity of fluorescence in R6 cells carrying the pAST2-Pmga 
plasmid was about 2-fold higher than in R6 cells harbouring pAST2, indicating that the 
Pmga promoter was functional. However, the activity of the Pmga promoter was similar 
in both, R6 and R6 mga cells. Thus, MgaSpn did not influence the activity of the Pmga 
promoter placed on the plasmid.  
With this experimental approach we cannot rule out the possibility that the results 
obtained were because of a single chromosomal copy of mgaSpn might not be sufficient 
for regulation of the Pmga promoter placed on a multi-copy plasmid. To test this 
hypothesis, we introduced the pAST2-Pmga recombinant plasmid into cells that 
overproduce MgaSpn (pDLPsulA::mga-harbouring R6 mga cells). It was also introduced 
into cells that do not synthesize MgaSpn (R6 mga carrying the pDL287 plasmid) as 
control. Again, expression of the gfp gene was monitored by fluorescence assays. No 
changes in the activity of the Pmga promoter were observed (not shown). This 
conclusion was further confirmed by primer extension experiments using total RNA 
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isolated from R6 mga/pDL287 and R6 mga/pDLPsulA::mga cells harbouring the 
pAST2-Pmga plasmid. As primers, a mix of the 5´-labelled INTgfp and ASTtetL 
oligonucleotides, which anneal to the gfp and tetL transcripts, respectively, were used 
(Figure 24). The tetL gene of pAST2 plasmid was used as internal control. As shown in 
Figure 24, we detected two cDNA extension products of 102 nt and 110 nt, which 
correspond with transcription from PtetL and Pmga, respectively. No differences were 
observed in the amount of cDNAs independently of the presence of high levels of 
intracellular MgaSpn. These results confirmed our previous findings and supported that 
MgaSpn did not influence the activity of the Pmga promoter under the conditions tested.  
Figure 24. High levels of intracellular 
MgaSpn do not influence the activity of 
Pmga. Primer extension reactions were 
carried out using total RNA isolated from 
R6 mga/pDL287 (lane 1) and 
R6 mga/pDLPsul::mga cells (lane 2). A mix 
of the INTgfp and ASTtetL primers (lanes 1 
and 2) was used for the extension reactions. 
The sizes of the cDNA extension products 
are indicated on the left of the gel in 
nucleotides: 102 nt for the PtetL promoter 
and 110 for the Pmga promoter. Dideoxy-
mediated chain-termination sequencing 
reactions using pAST DNA and the INTgfp 
primer were run in the same gel as DNA size 
markers (lanes A, C, G, and T). 
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In this chapter, we have analysed the DNA binding properties of the MgaSpn 
regulatory protein by gel retardation, footprinting and electron microscopy techniques. 
Electron microscopy experiments were carried out at the Max-Planck Institute für 
molekulare Genetik (Berlín) under the supervision of Dr. Rudi Lurz. We published this 
study in 2013 (Solano-Collado et al., 2013; see Related publications) and, for the first 
time, we showed that a member of the Mga/AtxA family of transcriptional regulators is 
able to generate multimeric complexes on linear double-stranded DNAs.  
4.1. Defining the optimal DNA-binding conditions of MgaSpn 
To study the binding of MgaSpn to linear double-stranded DNAs, we used firstly a 
222-bp DNA fragment (coordinates 1598298 to 1598519), which contains the P1623B 
and Pmga divergent promoters, as well as the PB activation region (coordinates 
1598388 to 1598457) (Figure 25). This region is required for MgaSpn-mediated 
activation of the P1623B promoter in vivo (Results, Chapter 3) (Solano-Collado et al., 
2012). Preliminary EMSA experiments were performed using as binding conditions those 
described in Methods (Section 11.1.1). First of all, we determined the time required for 
the binding reaction to reach equilibrium. The 32P-labelled 222-bp DNA (1 nM) was 
mixed with MgaSpn (25 or 50 nM) in the absence of competitor DNA, and then, after 
different incubation times (1 to 9 min), reaction mixtures were loaded onto native 
polyacrylamide (5%) gels. Since binding and running buffers were different, and to rule 
out a possible re-equilibration of the sample, reaction mixtures were loaded onto the gel 
while the current was turned on (200 V). Under these conditions, the loading process 
itself acts to quench the association reaction, since the free DNA begins to be separated 
from the complexes as soon as the sample is loaded onto the running gel (Carey, 1988). 
When the last sample entered the gel, the voltage was reduced to 100 V. As shown in 
Figure 26, at 25 nM of MgaSpn, free DNA and four protein-DNA complexes were already 
detected at 1 min. The number of complexes observed did not vary at longer incubation 
times, indicating that reaction mixtures already had reached equilibrium at 1 min. When 
the protein concentration used was 50 nM, the time required for equilibrium to be 
reached was the same, although up to seven protein-DNA complexes were detected (not 
shown).  
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Since the interaction between a protein and its target DNA can be affected by salt 
concentration, we also analysed by EMSA the effect of NaCl concentration on the 
binding reaction. In this experiment, MgaSpn (50 nM) was incubated with the non-
Figure 25. Scheme showing the relevant features of the 222-bp and 224-bp DNA fragments. (A) Region spanning 
coordinates 1598229 and 1598519 of the pneumococcal R6 genome. This region includes the P1623B and Pmga 
divergent promoters, as well as the PB activation region (Solano-Collado et al., 2012). The transcription initiation 
site (+1) for each promoter is indicated with an arrow. Location of the 222-bp and 224-bp DNA fragments is 
indicated. The shadowed box on each DNA fragment indicates the primary MgaSpn binding site defined by 
hydroxyl radical footprinting assays in this work. Coordinates of the main elements are indicated. (B) Nucleotide 
sequence of the region spanning coordinates 1598279 and 1598457. It includes the two primary binding sites of 
MgaSpn (shadowed boxes). The two sequence elements (GGT(A/T)(A/T)AAT and GA(A/T)AATT) shared by both 
sites, are indicated. The main elements of the Pmga promoter are marked. 
Figure 26. Time-course formation of MgaSpn-DNA 
complexes. The 
32
P-labelled 222-bp DNA (1 nM) was mixed 
with MgaSpn (25 nM) in the absence of competitor DNA. At 
different time intervals (1 to 9 min), samples were loaded 
onto the running gel. Free (F) and bound DNA bands were 
visualized using a Fujifilm Image Analyzer (FLA-3000). 
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labelled 222-bp DNA (10 nM) in the presence of different NaCl concentrations (from 20 
to 300 mM). Reaction mixtures were incubated for 20 min. The results obtained are 
shown in Figure 27. Independently of the NaCl concentration, similar amounts of the C1, 
C2 and C3 complexes were formed. Thus, binding of MgaSpn to DNA is not affected by 
salt concentration in the range tested.  
 
 
 
 
 
 
4.2. MgaSpn binds to DNA forming multimeric complexes 
To further analyse the interaction of MgaSpn with linear double-stranded DNA, the 
222-bp DNA fragment was 32P-labelled at the 5´-end of the coding strand, and was 
incubated with increasing concentrations of MgaSpn (20 to 480 nM) in the presence of 
non-labelled competitor calf thymus DNA (2 g/ml) (Figure 28A). Free and bound DNAs 
were separated by electrophoresis on native polyacrylamide (5%) gels, and visualized by 
autoradiography. As it is shown in Figure 28A, at 20 nM of MgaSpn, we were able to 
visualize two protein-DNA complexes (C1 and C2) as well as free DNA. Interestingly, as 
the protein concentration was increased, higher-order complexes appeared sequentially 
whereas complexes with greater mobility were observed increasingly less. Moreover, 
protein-DNA complexes moving slower than complex C1 were detected before the total 
disappearance of unbound DNA, suggesting that the first site of interaction was not 
saturated prior to formation of higher-order complexes. This pattern of complexes is 
compatible with the formation of regular multimeric complexes, in which multiple protein 
units bind orderly on the same DNA molecule. To analyse whether cooperativity exists in 
the formation of such complexes, bands of free and bound DNAs were quantified with 
the Quantity One software. The percentage of each protein-DNA complex was calculated 
and plotted against MgaSpn concentration (Figure 28B). The curves obtained suggested 
Figure 27. Effect of NaCl concentration on the 
formation of MgaSpn-DNA complexes. Non-labelled 
222-bp DNA (10 nM) was incubated with MgaSpn (50 
nM). Each binding reaction contained a particular 
concentration of NaCl (20 to 300 nM). Samples were 
subjected to electrophoresis on native polyacrylamide 
(5%) gels. Bands were stained with ethidium bromide 
(1 µg/ml) and visualized using a Gel-doc system (Bio-
Rad). Free DNA (F) and MgaSpn-DNA complexes (C1, 
C2 and C3) are indicated. 
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that several MgaSpn units interact with the DNA molecule in an apparently non-
cooperative manner, at least in the formation of the first four complexes.  
 
 
 
 
 
Additionally, we performed dissociation experiments (Figure 29). Essentially, 
MgaSpn (160 nM) was incubated with 2 nM of the 32P-labelled 222-bp DNA for 20 min. 
Once the complexes were formed, different amounts of non-labelled competitor calf 
thymus DNA (0.5 to 10 g/ml) were added to the binding reactions, which were 
incubated for a further 5 min under the same conditions. Finally, reaction mixtures were 
loaded onto native polyacrylamide (5%) gels. The results obtained showed that, as the 
amount of competitor DNA is increased, higher-order complexes gradually disappear, 
while moving faster complexes appear. Therefore, the protein units dissociate 
sequentially from the higher-order complexes.  
 
 
 
Figure 28. Formation of multimeric MgaSpn-DNA complexes. (A) EMSA analysis of the MgaSpn-DNA complexes. 
The 
32
P-labelled 222-bp DNA fragment (2 nM) was incubated with increasing concentrations of MgaSpn in the 
presence of non-labelled competitor calf thymus DNA (2 g/ml). Reactions were loaded onto a native gel (5% 
polyacrylamide). All the lanes displayed came from the same gel. Bands corresponding to free DNA (F) and to 
several MgaSpn-DNA complexes (C1, C2, C3 and C4) are indicated. (B) The autoradiograph shown in A was 
scanned and the percentage of the indicated complexes was plotted against the concentration of MgaSpn. 
 
Figure 29. Dissociation of MgaSpn-DNA high-order 
complexes. EMSA was carried out incubating MgaSpn 
(160 nM) and 2 nM of 
32
P-labelled 222-bp DNA. The 
indicated amount of non-labelled calf thymus DNA was 
added to pre-formed MgaSpn-DNA complexes. 
Radioactive bands were visualized using a Fujifilm Image 
Analyzer (FLA-3000). 
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By EMSA, we also estimated the affinity of MgaSpn for the 222-bp DNA. In this 
case, the concentration of the 32P-labelled DNA was reduced to 0.1 nM and the MgaSpn 
concentration varied from 1 to 130 nM. Binding reactions were incubated for 20 min. 
Free and bound DNA were visualized using a Phosphorimager system, and the intensity 
of the bands was quantified using the Quantity One software. The protein concentration 
required to bind half the DNA was determined by measuring the decrease in free DNA 
rather than the increase in complexes (Figure 30), giving an indication of the 
approximate magnitude of the dissociation constant, Kd (Carey, 1988). With this 
approach, a Kd value of 50 nM was calculated. However, this value underestimates the 
affinity of MgaSpn for its first binding site on the 222-bp DNA, since, upon binding to this 
site, additional protein units bind sequentially to the same DNA molecule. 
 
 
 
 
 
 
 
 
 
 
 
4.3. Binding of MgaSpn-His and MgaSpn to the PB activation region 
By in vivo experiments (Results, Chapter 3), we demonstrated that the PB activation 
region (Figure 17) is required for MgaSpn-mediated activation of the P1623B promoter. 
To study whether MgaSpn was able to interact with the PB activation region, we 
performed DNase I footprinting experiments. In a first approach, we used a His-tagged 
MgaSpn (MgaSpn-His) protein. This variant of MgaSpn carries six His residues at the C-
terminal end and two additional amino acids (Leu and Glu) between the His-tag and the 
last amino acid of MgaSpn. Previously we had found by EMSA that MgaSpn-His 
Figure 30. Affinity of MgaSpn for the 222-bp DNA. EMSA of the 
32
P-labelled 222-bp DNA (0.1 nM) incubated with 
increasing concentrations of MgaSpn (1 to 130 nM) in the absence of competitor DNA (left panel). Binding 
mixtures were separated by native gel electrophoresis. The percentage of free DNA was calculated and plotted 
against MgaSpn concentration (right panel). From the amounts of unbound DNA the dissociation constant (Kd) 
was calculated (Carey, 1988). 
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generated a pattern of protein-DNA complexes similar to that shown in Figure 28A. For 
the DNase I footprinting experiments, we used the 222-bp DNA fragment, which contains 
the PB activation region at internal position (at a distance of 62-bp and 90-bp from each 
DNA end, respectively) (Figure 25). The DNA fragment was radioactively labelled at the 
5´-end of either the coding (Figure 31A) or the noncoding (Figure 31B) strand with 
respect to the P1623B promoter. Considering the ability of MgaSpn-His to form 
multimeric complexes, the binding reactions were performed in the presence of heparin 
to favour the formation of the complex C1 (Figure 32). As shown in Figure 31A, on the 
coding strand and in the presence of MgaSpn-His, a region from the position -52 to -90 
relative to the transcription start site of the P1623B promoter was protected against 
DNase I digestion. In the case of the noncoding strand (Figure 31B), protections against 
DNase I digestion were observed from -57 to -79 and from -83 to -102. In addition, the -
82 and the -104 positions were slightly more sensitive to DNase I cleavage. These 
results demonstrate that MgaSpn-His interacts with sequences located between the 
positions -52 and -102 with respect to the P1623B transcription start site (Figure 31C). 
Similar results were obtained using the untagged MgaSpn protein (not shown), indicating 
that the His-tag does not affect the DNA-binding activity of MgaSpn. Moreover, the site 
(coordinates 1598405 to 1598455) protected by both proteins (MgaSpn-His and 
MgaSpn) is included within the PB activation region (coordinates 1598388 to 1598457). 
Therefore, the MgaSpn regulator activates directly the P1623B promoter.    
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Figure 31. Analysis of the MgaSpn-His-DNA complexes formed in the presence of heparin by DNase I 
footprinting. The 222-bp DNA fragment (coordinates 1598298 to 1598519) was labelled at the 5´-end of either the 
coding (A) or the non-coding (B) strand. The labelled DNA (4 nM) was incubated with the indicated concentrations 
of MgaSpn-His in the presence of heparin (2 g/ml) and the complexes formed were digested with DNase I. 
Dideoxy-mediated chain-termination sequencing reactions were run in the same gel (lanes A, C, G, and T). 
Densitometer scans corresponding to DNA without protein (black line) and DNA with protein (red line; 240 nM in 
panel A and 200 nM in panel B) are shown. The MgaSpn-His-protected regions are indicated with brackets. 
Arrowheads indicate positions that are slightly more sensitive to DNase I cleavage. Positions are relative to the 
transcription initiation site of the P1623B promoter. All the lanes displayed came from the same gel. (C) 
Nucleotide sequence of the region that spans coordinates 1598509 to 1598380 of the R6 genome. It includes the 
transcription start site of the P1623B promoter (coordinate 1598507), the region required for MgaSpn-mediated
activation of the P1623B promoter (1598457 to 1598388), and the site recognized by MgaSpn-His (brackets). activation of the P1623B pro oter (1598457 to 1598388), and the site recognized by gaSpn-His (brackets).
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Figure 32. MgaSpn-DNA complexes formed in the presence 
of heparin. The 222-bp DNA (2 nM) was radioactively 
labelled and incubated with increasing concentrations of 
MgaSpn (40 to 360 nM) in the presence of heparin (5 
g/ml). Bands corresponding to free DNA (F) and to 
complexes C1 and C2 are indicated on the left of the gel. 
Figure 33. DNase I footprints of complexes formed by MgaSpn on the 222-bp DNA fragment. Coding and 
noncoding strands relative to the P1623B promoter were 
32
P-labelled at the 5´-end. In this assay, the 
concentration of DNA was 4 nM and no competitor was used. All the lanes displayed came from the same gel. 
Densitometer scans corresponding to DNA without protein (black line) and DNA with the indicated concentration 
of protein (red line) are shown. The regions protected at 100 nM of MgaSpn are indicated with brackets. 
Arrowheads indicate positions that are slightly more sensitive to DNase I cleavage. The indicated positions are 
relative to the transcription start site of the P1623B promoter. Dideoxy-mediated chain termination sequencing 
reactions were run in the same gel (lanes A, C, G, T). 
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Binding of MgaSpn to the 222-bp DNA fragment was also analysed by DNase I 
footprinting assays in the absence of heparin (Figure 33). On the non-coding strand and 
at 100 nM of protein, MgaSpn recognised preferentially a site located between the 
positions -56 and -102 relative to the P1623B transcription start site. Such a primary 
binding site (coordinates 1598405 to 1598451) is located within the PB activation region. 
However, at higher protein concentrations (200 to 250 nM), regions flanking the primary 
binding site were also protected against DNase I digestion. On the coding strand and at 
250 nM of MgaSpn, protected regions and hypersensitive sites (-144, -102, -60 and -42) 
were observed along the DNA fragment (Figure 33A). These results indicate that, 
MgaSpn does not bind randomly to the 222-bp DNA. It is able to bind preferentially to the 
PB activation region (primary binding site) and subsequently to spread along the 
adjacent DNA regions. This result is consistent with the pattern of protein-DNA 
complexes observed by EMSA (Figure 28A). 
The specific contacts established by MgaSpn with its primary binding site on the 
222-bp DNA were further analysed by hydroxyl radical footprinting assays (see Methods, 
Section 10.2). Once more, the 222-bp DNA was radioactively labelled at either the 
coding or the noncoding strand relative to the P1623B promoter. The binding reactions 
were performed in the presence of calf thymus DNA to favour the formation of the 
complex C1 (see Figures 28A and 29). To increase the footprint signal, after treatment 
with the hydroxyl radical cleavage reagent, the MgaSpn-DNA complex C1 was separated 
from the unbound DNA by electrophoresis on a native polyacrylamide gel (see Figure 
28A). DNA from complex C1 and unbound DNA were excised from the gel, eluted from 
the acrylamide and loaded onto a sequencing gel (Figure 34A). On the coding strand, 
regions of decreased cutting were observed between the -60 and -96 positions relative to 
the transcription start site of the P1623B promoter. In the case of the noncoding strand, 
the decrease in hydroxyl radical cleavage occurred at regions located between positions 
-65 and -99. Specifically, MgaSpn protected four regions on each DNA strand. Each 
protected region covered three to five nucleotides, and the individual protected regions 
were separated by six to eight nucleotides. Protected regions were represented on a B-
DNA (10.5-bp/helix turn) double helix model. As shown in Figure 34B, MgaSpn 
interacted with one face of the DNA double helix (coordinates 1598407 to 159846). 
Moreover, these results confirm that MgaSpn recognises preferentially the PB activation 
region on the 222-bp DNA.  
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Figure 34. MgaSpn binds preferentially to the PB activation region on the 222-bp DNA. (A) Hydroxyl radical 
cleavage pattern of the 222-bp DNA without protein (F) and with MgaSpn bound to its primary site (complex 
C1). Coding and noncoding strands relative to the P1623B promoter were 
32
P-labelled at the 5´-end and 
incubated with MgaSpn (DNA:protein molar ratio was 1:80). Densitometer scans from lanes F (black line) and 
C1 (red line) are shown. Numbers indicate positions relative to the transcription start site of the P1623B 
promoter. Regions protected by MgaSpn are indicated with brackets. The arrowhead indicates a position (-
67) more sensitive to hydroxyl radical cleavage. All the lanes displayed came from the same gel. Lane C1 
corresponds to a longer exposure time. A+G are products from Maxam-Gilbert adenine- and guanine-specific 
sequencing reactions performed on the respective labelled strands. (B) Schematic representation of the PB 
activation region on a B-DNA double helix. MgaSpn contacts, deduced from hydroxyl radical, are indicated as 
black (coding strand) and grey (noncoding strand) circles. 
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4.4. MgaSpn binds to double-stranded DNA with low sequence specificity 
We decided to study whether MgaSpn was able to interact with DNAs either lacking 
the PB activation region or with it being positioned at one end of the DNA fragment. For 
this study, we used various linear DNA fragments, such as a 253-bp DNA from plasmid 
pUC19 (Yanisch-Perron et al., 1985), a 282-bp DNA from the coding region of the 
mgaSpn gene (1597232 to 1597513 of R6), and a 224-bp DNA (coordinates 1598229 to 
1598452 of R6) which contains the PB activation region (positioned at one DNA end) 
and the Pmga promoter (Figure 25). In all cases (Figure 35), MgaSpn generated a 
pattern of complexes similar to that shown in Figure 28A (222-bp DNA fragment), which 
is compatible with the idea that multiple protein units bind to the same DNA molecule in 
an ordered fashion. Therefore, MgaSpn appears to bind to linear double-stranded DNAs 
with high affinity, but with low sequence specificity. An in-depth analysis of the interaction 
of MgaSpn with the 224-bp DNA fragment (Figure 25) supports this conclusion (see 
following sections).  
 
 
 
 
 
 
 
Figure 35. MgaSpn binds to linear dsDNAs with low sequence specificity. (A) EMSA analysis of the complexes 
formed by MgaSpn and two DNA fragments from the R6 chromosome. The 282-bp DNA came from an internal 
region of the mgaSpn gene (coordinates 1597232 to 1597513). The 224-bp DNA contains the Pmga promoter and 
the PB activation region positioned at one end of the molecule (coordinates 1598229 to 1598452) (Figure 25). The 
non-labelled DNAs (10 nM) were incubated with the indicated concentrations of MgaSpn. Bands corresponding to 
free (F) and several MgaSpn-DNA complexes (C1, C2, C3 and C4) are indicated. (B) Binding of MgaSpn to a dsDNA 
fragment (10 nM) from pUC19 plasmid. Free DNA (F) and MgaSpn-DNA complexes (C1, C2, C3 and C4) are 
indicated. 
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4.5. Binding of MgaSpn to the Pmga promoter region 
Considering that MgaSpn binds to the 224-bp DNA (Figures 25 and 35), which 
includes the Pmga promoter but lacks the P1623B promoter, we also studied in detail the 
characteristics of this interaction. In the 224-bp DNA, the PB activation region is 
positioned at one DNA end (Figure 25). We first performed DNase I footprinting 
experiments labelling the 224-bp DNA at the 5´-end of either the coding or the noncoding 
strand relative to the Pmga promoter. Binding reactions contained 2 nM of 32P-labelled 
DNA and increasing concentrations of MgaSpn (Figure 36). On the coding strand and at 
40 nM of MgaSpn, sites more sensitive to DNase I digestion were observed along the 
DNA fragment (positions -68, -57, -30, -16, +13, +26 and +30 relative to the transcription 
start site of the Pmga promoter). These sites were spaced with a regular frequency of 
alternatively 10-13 and 26-27 nt. On the noncoding strand and at 40 nM of MgaSpn, the 
hypersensitive sites (positions +26 -15, -52 and -94) were spaced 36-41 nt. On both 
strands, the hypersensitive sites were flanking regions protected against DNase I 
digestion; a few unprotected sites were also observed. The pattern of protections and 
hypersensitive sites rules out that MgaSpn bind randomly to the 224-bp DNA and 
suggests a regular positioning of the protein along the DNA molecule. This is consistent 
with the idea of binding to a preferential site and then spreading (ordered positioning) 
along the adjacent DNA regions. 
To identify the primary site recognised by MgaSpn on the 224-bp DNA, protein-DNA 
complexes were formed under conditions that favoured the formation of complex C1. 
These protein-DNA complexes were then subjected to hydroxyl radical treatment. To 
increase the footprint signal of complex C1, DNA complexed to MgaSpn was separated 
from free DNA before being loaded on a sequencing gel. The hydroxyl radical footprint 
pattern of MgaSpn bound to its primary site is shown in Figure 37A. On the coding 
strand, MgaSpn protected four regions within the sequence spanning the -21 and +21 
positions relative to the Pmga transcription start site. Each protected region covered six 
to seven nt, and they were separated by five to six nt. On the noncoding strand, MgaSpn 
protected four regions of five nt within the sequence spanning the +18 and -23 positions. 
The protected regions were separated by six to eight nt. Sites more sensitive to hydroxyl 
radical cleavage were localized between the -25 and -34 positions. This fact indicates 
that the binding of MgaSpn to its primary site might induce a conformational change 
within the -35 element. Therefore, the primary site recognised by MgaSpn on the 224-bp 
DNA is the Pmga promoter region (Figure 37B). Specifically, it interacts with sequences 
that map between the -23 and +21 positions (coordinates 1598332 and 1598289). These 
results demonstrate that MgaSpn does not recognise the PB activation region as the 
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primary binding site when it is positioned at one end of the DNA molecule, but rather it 
shifts to the Pmga promoter.  
Figure 36. DNase I footprints of complexes formed by MgaSpn on the 224-bp DNA. Coding and noncoding 
strands relative to the Pmga promoter were 
32
P-labelled at the 5´-end. In this assay, the concentration of DNA was 
2 nM. Densitometer scans corresponding to free DNA (black line) and bound DNA (40 nM of MgaSpn; red line) are 
shown. Numbers indicate positions relative to the transcription start site of the Pmga promoter. Regions 
protected against DNase I digestion (brackets) and hypersensitive sites (arrowheads) are indicated. Dideoxy-
mediated chain termination sequencing reactions on the non-coding strand were run in the same gel (A, C, G, T). 
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Figure 37. MgaSpn binds preferentially to the Pmga promoter region on the 224-bp DNA. (A) Hydroxyl radical 
digestion pattern of the 224-bp DNA without (F) and with MgaSpn bound to its primary site (complex C1). Coding 
and noncoding strands relative to the Pmga promoter were 
32
P-labelled at the 5´-end and incubated with MgaSpn 
(DNA:protein molar ratio was 1:80). Densitometer scans from lanes F (black line) and C1 (red line) are shown. 
Numbers indicate positions relative to the transcription start site of the Pmga promoter. Regions protected by 
MgaSpn are indicated with brackets. Arrowheads indicate positions more sensitive to hydroxyl radical cleavage. 
All the lanes displayed came from the same gel. Lane C1 corresponds to a longer exposure time. A+G are products 
from Maxam-Gilbert sequencing reactions performed on the respective labelled strands. (B) B- form DNA of the 
Pmga promoter region showing MgaSpn contacts as deduced from hydroxyl radical. Black and grey circles indicate 
protein contacts on the coding and noncoding strand, respectively. 
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4.6. Analysis of the minimum DNA size required for MgaSpn binding 
Hydroxyl radical experiments showed that, in the formation of complex C1, MgaSpn 
interacted with a region of 40-bp (primary binding site) on the 222-bp DNA (Figure 34B). 
Similar results were obtained with the 224-bp DNA (44-bp; Figure 37B). However, EMSA 
with both fragments showed the formation of up to 10 complexes. Therefore, to define 
the minimum DNA length necessary for MgaSpn binding, we performed EMSA 
experiments using small DNA fragments (from 20-bp to 40-bp) (Figure 38). The 40-bp 
fragment contained the -35 and -10 hexamers of the Pmga promoter, whereas the 26-bp 
and 32-bp DNAs contained only the -10 hexamer. The DNA fragments were incubated 
with increasing concentrations of MgaSpn. As shown in Figure 38, two MgaSpn-DNA 
complexes were detected with DNA fragments of 40-bp and 32-bp, whereas only one 
complex was observed with the 26-bp DNA. Similar results were obtained with DNA 
fragments that had the same size but different sequence (not shown). Moreover, no 
complexes were formed with the 20-bp DNA. Therefore, the minimum DNA size required 
for MgaSpn binding is between 20-bp and 26-bp.  
In conclusion, since binding of MgaSpn to a 40-bp DNA fragment generates two 
complexes, and the minimum DNA size required for MgaSpn binding is between 20-bp 
and 26-bp, we propose that two MgaSpn units bound to the primary site of the 222-bp 
could constitute the C1 complex (40-bp, primary site). Sequential binding of additional 
MgaSpn units to complex C1 would then explain the formation of the additional 
complexes (C2 to C10) observed by EMSA (Figure 29).   
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Figure 38. Binding of MgaSpn to small DNA fragments. EMSA analysis of the interaction of MgaSpn with DNA 
fragments of 40-bp (A), 32-bp (B), 26-bp (C) and 20-bp (D). Only the 20-bp DNA was radioactively labelled. The 
indicated concentration of MgaSpn was mixed with 200 nM of the 40-bp DNA, with 200 nM of the 32-bp DNA, 
with 300 nM of the 26-bp DNA or with 2 nM of the 20-bp DNA. Binding reactions were analysed by native gel 
electrophoresis. Bands corresponding to free DNA (F) and to MgaSpn-DNA complexes (C1 and C2) are indicated. 
(E) Nucleotide sequence of the oligonucleotides used to generate the 40-bp, 32-bp and 26-bp dsDNAs. The 20-bp 
DNA was from a region (coordinates 1598376-1598395) located upstream of the Pmga promoter. The main 
elements of the Pmga promoter are shown in bold. 
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4.7. MgaSpn binds to the PB activation region rather than to the Pmga 
promoter on long linear DNAs 
The hydroxyl radical footprinting experiments performed with the 222-bp and 224-bp 
DNAs (Figures 34 and 37) revealed that the requirement for the recognition of the PB 
activation region as the primary binding site is its location internally within the DNA 
molecule. When it was positioned at one DNA end, the primary binding site recognised 
by MgaSpn shifted to the Pmga promoter region (see Figure 25). Since footprinting 
experiments are limited by the length of the DNA molecule, electron microscopy was 
used to further analyse the binding of MgaSpn to longer DNA molecules: 640-bp, 1418-
bp and 1458-bp. The common feature of all these DNAs is the internal location of both 
PB activation region and the Pmga promoter. First, we performed the binding reactions 
at low protein/DNA ratios to favour the formation of complexes formed by one unit of 
MgaSpn bound to the DNA molecule. Electron micrographs of the complexes are shown 
in Figure 39A. We determined the MgaSpn binding position by measuring the DNA 
length in the protein-DNA complexes as well as the distance from the end of the DNA 
fragment to the protein-binding site. The distribution of the MgaSpn binding positions on 
each DNA fragment is represented in Figure 39A. On the 640-bp DNA (coordinates 
1598010 to 1598649), of 171 complexes examined, the majority (80%) showed an 
MgaSpn unit bound to sequences located at a distance of 213-bp from one end of the 
DNA. Thus, MgaSpn bound preferentially either around coordinate 1598223 (MgaSpn 
coding region) or around 1598436 (PB activation region). On the 1418-bp DNA 
(coordinates 1597232 to 1598649), 62% of 156 complexes examined showed MgaSpn 
binding at a peak around 214-bp from the nearest DNA end. This result positioned 
MgaSpn around coordinate 1597446 (MgaSpn coding region) or 1598435 (PB activation 
region). On the 1458-bp DNA (coordinates 1598188 to 1599645), 63% of 182 complexes 
showed MgaSpn binding at a peak around 245-bp from one DNA end. Therefore, 
MgaSpn bound either around coordinate 1598433 (PB activation region) or 1599400 
(downstream of the P1623B promoter). The same experiments were carried out using 
other DNA fragments, giving results (not shown) consistent with those already described. 
Taken collectively, the above results demonstrate that MgaSpn binds to the PB 
activation region rather than to the Pmga promoter when both sites are located at 
internal positions on the same DNA.  
We next performed experiments at high protein/DNA ratios. Under these conditions, 
we detected DNA molecules totally or partially covered by MgaSpn (Figure 39B). The 
contour length of DNA molecules, both naked and covered with protein was measured to 
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find out whether the DNA was compacted. The results obtained show that their lengths 
do not vary as a result of protein binding, indicating that the DNA is not wrap around a 
core of protein molecules, and therefore compaction of the DNA does not occur. Overall, 
the electron microscopy results support that MgaSpn is able to spread along the DNA 
upon preferential binding to a particular site. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 39. Electron microscopy analysis of MgaSpn-DNA complexes. (A) MgaSpn was incubated with different 
DNA fragments (640-bp, 1418-bp and 1458-bp) at low protein/DNA ratios to favour the formation of C1 
complexes (MgaSpn bound to its primary site). The position of the PB activation region is indicated with an 
asterisk. Electron micrographs of the protein-DNA complexes are shown, and representative MgaSpn-DNA 
complexes are indicated with a black arrow. The distribution of the MgaSpn positions on the three DNA fragments 
is shown. Position of the transcription start site of the P1623B (black arrow) and Pmga (grey arrow) promoters is 
indicated. (B) MgaSpn was incubated with the 1418-bp DNA fragment at high protein/DNA ratios. Electron 
micrographs of DNA molecules covered by MgaSpn are shown. Scale bar, 500 bp. 
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4.8. Local DNA conformations might contribute to the DNA-binding 
specificity of MgaSpn 
We have observed that the two sites recognised preferentially by MgaSpn (PB 
activation region and Pmga promoter) share a low sequence identity: the 
GGT(A/T)(A/T)AATT and GA(A/T)AATT sequence elements (Figure 25B). Nevertheless, 
despite this identity, MgaSpn interacted preferentially with the PB activation region rather 
than with the Pmga promoter when both elements were located at internal positions on 
long linear DNAs (see above, Section 4.7). Moreover, when the PB activation region was 
placed at one DNA end, MgaSpn recognised preferentially the Pmga promoter (Figure 
25A). In order to investigate whether both primary sites shared common structural 
features, we calculated the curvature/propensity plots of both the 222-bp and the 224-bp 
DNA fragments with the bend.it server (Vlahovicek et al., 2003). In the case of the 222-
bp DNA (Figure 40), the profile showed a peak of potential curvature at position 102 
(included in the PB activation region; positions 73-112). The magnitude of the curvature 
propensity (9.5) is within the range calculated for experimentally tested curved motifs 
(Gabrielian et al., 1997). Flanking the peak of potential curvature, we found two regions 
of bendability (positions 74-88 and 122-134). In the case of the 224-bp DNA (Figure 40), 
the Pmga promoter region (positions 120-163) contains one peak of potential curvature 
(position 153; magnitude 9.1), which is also flanked by regions of bendability (positions 
105-114 and 174-180). Therefore, the two sites recognised by MgaSpn contain a 
potential intrinsic curvature, which is surrounded by regions with the capacity of being 
easily bent.    
Figure 40. Bendability/curvature propensity plots of the 222-bp and 224-bp DNA fragments according to the 
bend.it program (Vlahovicek et al., 2003). The primary binding sites of MgaSpn are indicated (black boxes). Grey 
boxes indicate regions of bendability. 
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Subsequently, to analyse in greater detail whether MgaSpn interacted preferentially 
with intrinsically curved DNAs, we performed EMSA experiments using the curved (C) 
DNA and the non-curved (NC) DNA. Both DNAs had a similar A+T content. The C DNA 
fragment (321-bp; 72.3% A+T content) came from the E. faecalis V583 genome, while 
the NC DNA fragment (322-bp; 71.1% A+T content) was from the S. pneumoniae R6 
genome. The latter fragment carried the sequence spanning the -22 to +299 positions 
relative to the Pmga transcription start site. According to in silico predictions of intrinsic 
DNA curvature using the bend.it server (Vlahovicek et al., 2003), the C DNA fragment 
showed a potential intrinsic curvature with a magnitude greater than 12 within the region 
spanning the positions 150 to 200. This magnitude of curvature is higher than the 
magnitude of the curvature predicted for the NC DNA fragment (Figure 41B). In addition, 
compared to the NC DNA fragment, the C DNA fragment showed an anomalously slow 
electrophoretic mobility on native polyacrylamide gels (Figure 41B), which is a 
characteristic of curved DNA fragments (Diekmann, 1987). This property is due to the 
higher friction of more curved molecules in the narrow pores of the polyacrylamide gel 
that slows down the rate of migration. We carried out competitive EMSA experiments 
using the radioactively labelled 222-bp DNA fragment. It was incubated with increasing 
concentrations of MgaSpn in the presence of non-labelled competitor DNAs, either C 
DNA or NC DNA (Figure 41A). At all protein concentrations, the amount of labelled DNA 
that remained unbound was higher when C DNA was used as a competitor (Figure 41C). 
These results gave us a first indication that MgaSpn was preferentially interacting with 
the intrinsically curved DNA. 
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Moreover, by EMSA, we estimated the affinity of MgaSpn for both C DNA and NC 
DNA. Specifically, 32P-labelled DNA (0.1 nM) was incubated with increasing 
concentrations of MgaSpn (1 to 130 nM). On both DNAs, MgaSpn generated multiple 
protein-DNA complexes (Figure 42). The DNA that remained unbound was quantified 
with the Quantity One software and plotted against MgaSpn concentration. The half-
maximal binding point was determined by measuring the decrease in free DNA instead 
of the increase of the various complexes. For the C DNA (Figure 42A), the apparent Kd 
was around 12 nM, significantly lower than that obtained for the NC DNA (Figure 42B), 
which was around 95 nM. These results indicate that MgaSpn has higher affinity for the 
Figure 41. Binding of MgaSpn to a naturally occurring curved DNA. (A) Competitive EMSA. The 
32
P-labelled 222-
bp DNA fragment (2 nM) was incubated with the indicated concentration of MgaSpn in the presence of non-
labelled competitor DNA (30 nM), either NC DNA (left) or C DNA (right). Bands corresponding to free DNA (F) and 
to several MgaSpn-DNA complexes (C1, C2, C3 and C4) are indicated. (B) Curvature-propensity plot of the NC DNA 
(grey line) and C DNA (black line). Inset shows the electrophoretic mobility of the NC DNA (lane 1) and C DNA (lane 
2) on a native polyacrylamide (5%) gel. Lane M, DNA fragments used as molecular weight markers (HyperLadder I, 
Bioline). Arrows indicate the position of the 400-bp and 800-bp fragments. (C) The autoradiographs shown in A 
were scanned and the percentage of free DNA was plotted against the concentration of MgaSpn. NC DNA (grey 
squares) and C DNA (white circles) were used as competitors. 
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naturally occurring curved DNA, and are in agreement with the results obtained from the 
competitive gel retardation assay (Figure 41).  
 
Figure 42. Affinity of MgaSpn for the C and NC DNAs. EMSA of either 
32
P-labelled C DNA (0.1 nM) (A) or 
32
P-
labelled NC DNA (0.1 nM) (B) incubated with increasing concentrations of MgaSpn in the absence of competitor 
DNA (left panels). Bands corresponding to free (F) DNA are indicated. The percentage of free DNA was calculated 
and plotted against MgaSpn concentration (right panels). The apparent dissociation constant (Kd) was calculated 
by measuring the decrease in free DNA rather than the increase in complexes (Carey, 1988). 
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Activator role of the MgaSpn virulence transcriptional regulator 
Pathogenic bacteria must be able to survive to different conditions found during the 
diverse stages of infection. This survival depends on the ability to sense and respond to 
external stimuli via global transcriptional regulators whose activity and/or intracellular 
concentration change in response to environmental variations. In combination with 
TCSs, various stand-alone response regulators have been implicated in the regulation of 
virulence gene expression, as it is the case of the Mga global regulator of GAS, whose 
signal transduction components have yet to be fully defined (McIver, 2009). In 2002, 
signature-tagged mutagenesis in S. pneumoniae TIGR4 evidenced the existence of a 
putative virulence transcriptional regulator, which was an Mga orthologue encoded by 
the chromosomal sp1800 (mgrA) gene (Hava and Camilli, 2002; Hemsley et al., 2003). 
In GAS, the mga regulatory gene is located upstream of some of the genes it regulates. 
Nevertheless, in the pneumococcal TIGR4 strain, Hemsley et al. (2003) reported that the 
mgrA gene did not affect transcription of its neighbouring genes. These authors found 
that MgrA was able to repress the expression of the rlrA pathogenicity islet, a cluster 
comprising seven genes some of which had been previously characterized as virulence 
factors (Hava et al., 2003).  
In S. pneumoniae R6, whose genomic sequence was published in 2001 (Hoskins 
et al., 2001), the mgaSpn gene is equivalent to the mgrA gene of the TIGR4 strain. In 
fact, this gene has been found in all the pneumococcal strains whose genomes have 
been totally or partially sequenced. In this work we have analysed 26 pneumococcal 
strains whose genomes have been totally sequenced: R6, D39, TIGR4, Hungary 19A-6, 
670-6B, 70585, A026, AP200, ATCC 700669, CGSP14, G54, INV104, INV200, JJA, 
OXC141, P1031, PCS8235, SPN034156, SPN034183, SPN994038, SPN994039, 
SPNA45, ST556, TCH8431/19A, Taiwan19F-14 and gamPNI0373. According to protein 
sequence database similarity searches, MgaSpn (MgrA in TIGR4) is highly conserved 
among the above-mentioned pneumococcal strains. Compared to R6 and D39, MgaSpn 
has two amino acid changes (I309M and V358I) in the TIGR4, G54, JJA, ATCC 700669, 
P1031, TCH8431/19A, AP200, INV200, gamPNI0373, SPN034156, A026 and CGSP14 
strains, three amino acid changes (C280Y, I309M, and V358I) in the Taiwan19F-14 and 
ST556 strains, three amino acid changes (I309M, V358I, and L362I) in the 670-6B and 
Hungary 19A-6, three amino acid changes (I309M, V358I, and P450S) in the 70585, 
PCS8235, SPN034183, OXC141, INV104, SPN994038 and SPN994039 strains and four 
amino acid changes (S86L, I309M, V358I, and P450S) in the SPNA45 strain. Unlike the 
mgaSpn gene, the rlrA pathogenicity islet has been found only in a small group of 
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pneumococcal strains (e. g. in TIGR4 but not in R6 and D39) (Paterson and Mitchell, 
2006), suggesting that it may has been acquired by horizontal gene transfer, as it is 
flanked by two IS1167 insertion sequences. This fact indicated that the rlrA islet might 
not be the main target of the pneumococcal Mga-like regulator.  
In this work, we have performed an in vivo transcriptional analysis of the region 
spanning coordinates 1596789 to 1600589 of the pneumococcal R6 genome. This 
region includes the mgaSpn regulatory gene and four genes (spr1623, spr1624, spr1625 
and spr1626) of unknown function that are highly conserved in the TIGR4 strain (see 
below). We have identified the promoter of the mgaSpn gene (named Pmga) and its 
transcription initiation site (coordinate 1598308). In addition, we have shown that the 
ATG codon at coordinate 1598270 is likely the translation start site of the mgaSpn gene, 
as it is preceded by a consensus Shine-Dalgarno sequence. Translation from this ATG 
codon, which differs from the one annotated by the NCBI (Results, Chapter 1), generates 
a product of 493 amino acids.   
Regarding the spr1623, spr1624, spr1625 and spr1626 genes, we have shown that 
they constitute an operon, which is transcribed from two promoters (P1623A and 
P1623B). Furthermore, we have demonstrated that, unlike the MgrA regulator of TIGR4 
(Hemsley et al., 2003), MgaSpn is able to act, directly, as a positive regulator of the 
spr1623-spr1626 operon. MgaSpn activates the P1623B promoter in vivo, and therefore 
the expression of the spr1623-spr1626 operon, through direct interaction with sequences 
located upstream of the P1623B promoter (PB activation region). This discrepancy 
between the results presented here and the results previously obtained by Hemsley et al. 
(2003) might be due to the use of different pneumococcal strains and/or the use of 
different bacterial growth conditions. Actually, even though transcriptional regulators 
seem to be conserved among the majority of the S. pneumoniae strains, some of them 
modulate the transcriptional profile differently depending on the bacterial strain and/or 
serotype as well as the environmental conditions (Blue and Mitchell, 2003, Hendriksen et 
al., 2009), (Hendriksen et al., 2007). 
According to the Protein Cluster database (Klimke et al., 2009), the spr1623, 
spr1624, spr1625 and spr1626 products are identical to those encoded by the 26 
pneumococcal genomes mentioned above. However, except in R6 and D39, the operon 
in the other strains contains an additional ORF (sp1801 in TIGR4). It is located upstream 
of the equivalent spr1623 gene and it might encode a product of 54 residues 
(hypothetical protein, putative transglycosylase associated protein). Its absence in both 
R6 and D39 is due to the deletion of one nucleotide between coordinates 1598751 and 
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1598752, which results in a truncated ORF that might encode a product of 20 amino 
acids, which is not contemplated by the NCBI. The function of the genes that constitute 
the spr1623-spr1626 operon is unknown. They encode products of 188 (spr1623; 
hypothetical protein), 56 (spr1624; putative lipoprotein), 202 (spr1625; putative general 
stress protein 24), and 67 (spr1626; hypothetical protein) residues. However, several 
observations suggest that the spr1623-spr1626 operon might play a role in virulence. On 
the one hand, Hemsley et al. (2003) reported the characterization of two transposon 
insertion mutants in TIGR4. One of them (STM206) carries a transposon inserted ~300 
bp upstream of the transcription start site of the sp1800 gene (mgaSpn in R6). The 
authors demonstrated that this mutant strain was attenuated for both nasopharyngeal 
carriage and lung infection and it was much more affected in virulence than a mutant 
strain (AC1272) that carries a transposon inserted within the coding sequence of the 
sp1800 gene. In this work we have shown that the distance between the translation start 
codon of the mgaSpn gene (coordinate 1598270) and the transcription initiation sites of 
the spr1623-spr1626 operon is 323 (from the P1623A promoter; coordinate 1598592) 
and 238 nucleotides (from the P1623B promoter; coordinate 1598507), respectively. 
Hence, the transposon in strain STM206 could be affecting the expression of the 
sp1801-sp1805 operon (spr1623-spr1626 operon in R6). If this were the case, the 
attenuation phenotype of the STM206 mutant strain (Hemsley et al., 2003) would 
indicate an important role of the operon in pneumococcal virulence. In addition, the 
spr1625 product (202 amino acids) has homology (69% similarity) to the product of the 
E. faecalis gls24 gene (EF0080 in strain V583; 186 amino acids). In E. faecalis, the gls24 
gene was shown to be a general stress-inducible gene involved in bile-salts resistance 
(Giard et al., 2000) and its importance in enterococcal virulence using a mouse 
peritonitis model was already reported (Teng et al., 2005). Moreover, in GAS, the levels 
of Gls24 were enhanced when cultures were grown in hyaluronic acid-enriched medium 
(which simulates an infection situation) (Zhang et al., 2007) and during murine soft tissue 
infection (Graham et al., 2006). Additionally, it has been recently reported a direct effect 
of Gls24 in GAS survival in whole-blood and in neutrophil resistance (Tsatsaronis et al., 
2013). Further work has to be done to confirm the role of the spr1623-spr1626 operon in 
pneumococcal virulence.  
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MgaSpn is a member of the Mga/AtxA family of global regulators 
The pneumococcal MgaSpn regulator shares sequence homology with the Mga 
global regulator of GAS (42.6% of similarity and 21.4% of identity) and with the AtxA 
global regulator of B. anthracis (39.9% of similarity and 20.7% of identity). Although no 
structural data are available for Mga or AtxA, both regulators were shown to have a 
similar organization of known or predicted functional domains (Hondorp et al., 2013). 
According to several programs for sequence-based prediction of secondary structures 
(Results, Chapter 2), the MgaSpn regulatory protein has a high content of -helices 
(57.4-66.3%). We confirmed this prediction by CD spectroscopic analyses (average of 
55.3%). Moreover, using the Pfam (protein domain prediction) and Phyre2 (protein 
structure prediction) programs (Punta et al., 2012; Kelley and Sternberg, 2009), we have 
found that the organization of functional domains in MgaSpn is similar to that found in 
Mga and AtxA. 
The N-terminal region of MgaSpn contains two putative HTH DNA binding motifs, 
the so-called HTH-Mga (residues 6-65) and Mga (residues 71-158). HTH motifs are also 
present within the N-terminal region of the Mga and AtxA regulators. At present, studies 
on the interaction of AtxA with DNA are not available. However, in the Mga regulator, the 
HTH-3 and HTH-4 motifs were shown to be involved in the interaction with DNA (McIver 
and Myles, 2002). Moreover, the small CMD-1 motif was shown to be required for Mga-
dependent activation of some promoters (Vahling and McIver, 2006). Sequence 
alignment of the first 150 amino acids of the Mga and MgaSpn regulators reveals the 
existence of several conserved residues within the MgaSpn region that spans the 
positions 74 and 130 (Figure 43). Thus, the most conserved region includes the HTH-4 
motif of Mga. These findings indicate that the N-terminal region of MgaSpn may be 
implicated in the recognition and binding to DNA.  
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Like Mga and AtxA, the central region of MgaSpn contains two putative PRDs, which 
are structural domains found in bacterial transcriptional regulators (antiterminators and 
activators) involved in the expression of catabolic operons. Such regulators are usually 
phosphorylated by components of the PTS on conserved histidine residues located 
within the PRDs. This phosphorylation is known to modulate the activity of the regulator 
(reviewed by Joyet et al., 2013). Amino acid sequence alignment of AtxA and other PRD-
containing proteins led to the identification of two histidine residues (H199 in PRD1 and 
H379 in PRD2) as potential phosphorylation sites (Tsvetanova et al., 2007). By site-
directed mutagenesis, histidine residues were mutated to alanine (mimicking an 
unphosphorylated state) or to aspartate (mimicking a phosphorylated state). These 
experiments indicated that the activity of AtxA is influenced by 
phosphorylation/dephosphorylation events within the PRDs. Indeed, phosphorylation of 
the conserved histidine (H199) in PRD1 increases AtxA activity, whereas 
phosphorylation of the conserved histidine (H379) in PRD2 decreases AtxA function 
(Tsvetanova et al., 2007). The Mga global regulator also contains two PRDs located at 
the central region. Hondorp et al. (2013) showed that phosphorylation of H204 and H270 
(PRD1) inactivates Mga, whereas phosphorylation of H324 (PRD2) increases its 
function. Using the Clustal Omega program (Sievers et al., 2011), we have done an 
amino acid sequence alignment of the PRDs of MgaSpn with the PRDs of some 
transcriptional regulators (Figure 44). Such a multiple alignment includes MtlR 
(Geobacillus stearothermophilus) and LicR (B. subtilis), which are related to carbon 
utilization, and the AtxA and Mga virulence regulators (Figure 44). According to it, 
Figure 43. Sequence alignment of the N-terminal region of Mga and MgaSpn using the Clustal Omega program. 
In Mga, the three motifs (CMD-1, HTH-3 and HTH-4) involved in DNA binding are indicated (McIver and Myles, 
2002; Vahling and McIver, 2006). Identical residues are shown in yellow. For MgaSpn, predicted secondary 
structure elements (SABLE program) are indicated (cilinders: -helices; arrows: -sheets). 
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several histidine residues of MgaSpn (H197 in PRD1 and H320 and H388 in PRD2) are 
potential sites to be phosphorylated by components of the PTS, suggesting that PTS-
mediated phosphorylation of MgaSpn might modulate its activity in response to 
carbohydrate availability.  
 
 
 
 
 
 
In the Mga and AtxA regulators, a motif with structural homology to a region of the 
EIIB component used by the PTS (EIIB-like motif) has been found at their C-terminal 
region. A truncated Mga protein that lacks the last 139 amino acids (including the EIIB-
like motif) was shown to be able to bind DNA with the same affinity as the wild-type 
protein. However it caused a drastic decrease in the transcript levels of two target genes, 
arp (M-like protein) and sof (fibronecting-binding protein). Moreover, co-
immunoprecipitation, gel filtration chromatography and sedimentation equilibrium 
experiments showed that the truncated Mga protein was defective in oligomerization. 
Figure 44. Sequence alignment of some PRDs using the Clustal Omega program. The PRDs of MtlR (G. 
stearothermophilus), LicR (B. subtilis), AtxA (B. anthracis), Mga (S. pyogenes) and MgaSpn are shown. 
Conserved histidine (yellow), arginine (blue) and aspartate (orange) amino acids are pointed out. The 
residues that link the PRD1 and PRD2 domains are indicated in grey. Residues that have been shown to 
increase or decrease the activity of the regulator upon phosphorylation are indicated in green or red, 
respectively.  
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Based on those results, Hondorp et al. (2012) established a correlation between Mga-
mediated transcriptional activation in vivo and the ability of Mga to form oligomers in 
vitro. In the case of AtxA, Hammerstrom et al. (2011) reported that AtxA exists, in vivo, in 
a homo-oligomeric state. Moreover, they found a correlation between AtxA dimerization 
and AtxA activity when bacteria were grown in specific conditions. They also showed that 
AtxA variants lacking the last 91 amino acids (includes the EIIB-like motif) are defective 
in the establishment of AtxA-AtxA interactions. Hence, in Mga and AtxA, the EIIB-like 
motif might play a role in protein-protein interactions. In addition, phosphorylation within 
the PRD1 domain of Mga appears to affects its oligomerization and its ability to regulate 
gene expression in vivo (Hondorp et al., 2013). In this work, we have demonstrated that, 
under our experimental conditions (100 mM and 250 mM NaCl), the untagged MgaSpn 
protein behaves as a dimer in solution. Moreover, it is able to form higher-order 
molecular species in a concentration-dependent manner. Interestingly, the Phyre2 
protein fold recognition server predicts a putative EIIB-like motif at the C-terminal region 
of MgaSpn. Further work is required to elucidate whether the EIIB-like motif is involved in 
protein-protein interactions.  
Collectively, the prediction of functional domains supports that the pneumococcal 
MgaSpn protein is a member of the Mga/Atxa family of global regulators. The predicted 
domain organization indicates that (i) MgaSpn binds DNA presumably through the N-
terminal region, (ii) its activity might be modulated via phosphorylation of conserved 
histidine residues found in the putative PRDs, and (iii) the C-terminal region might be 
involved in its ability to dimerize and/or oligomerize.  
Mga controls the expression of about 10% of the GAS genome (Ribardo and McIver, 
2006) and AtxA influences the expression of more than a hundred genes located on the 
chromosome and the virulence plasmids of B. anthracis (Fouet, 2010). To date, the 
pneumococcal MgaSpn regulator is known to repress, directly or indirectly, the 
expression of several genes located within the rlrA pathogenicity islet (Hemsley et al., 
2003) and to activate directly the expression of a four-gene operon (spr1623-spr1626) of 
unknown function (this work; Solano-Collado et al., 2012). Furthermore, we have 
identified a few putative MgaSpn target genes (metabolism of amino acids, competence 
and heat shock response) in a first proteomic analysis in which bacteria (producing or 
not MgaSpn) were grown under standard laboratory conditions (sucrose as carbon 
source). The low expression level of mgaSpn found in such conditions could explain the 
small number of putative MgaSpn target genes identified. In addition, under the 
conditions used, the MgaSpn regulator might not be fully active. Therefore, it would be 
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interesting to identify the specific external stimuli that influence the intracellular 
concentration and/or activity of the MgaSpn regulator. This knowledge is essential for the 
design of further proteomic and transcriptomic analyses and, consequently, for the 
definition of the MgaSpn regulon.     
MgaSpn likely recognizes particular DNA conformations to achieve DNA-
binding specificity  
The recognition of specific DNA sequences and/or particular DNA structures by 
transcription factors is an essential step in the control of gene expression. In general, 
protein-DNA interactions can be divided in two main categories: those when the protein 
recognizes the unique chemical signatures of the DNA bases (base readout) and those 
when the protein recognizes a sequence-dependent DNA shape (shape readout). 
Nevertheless, it has been argued that any one DNA-binding protein is likely to use a 
combination of readout mechanisms to achieve DNA-binding specificity (Rohs et al., 
2010). Regarding the Mga global transcriptional regulator of GAS, several binding sites 
have been identified. Although a consensus Mga-binding site was initially proposed 
(McIver et al., 1995), new sequence alignments of all established Mga-binding regions 
revealed a very low sequence identity (13.4%) (Hause and McIver, 2012). EMSA and 
DNase I footprinting experiments showed that Mga interacts with large non-palindromic 
DNA regions (45 to 59-bp). Unlike other many regulatory proteins, the regions found 
recognized by Mga did not present discernible symmetry (Hause and McIver, 2012). To 
determine the core nucleotides involved in functional Mga-DNA interactions, Hause and 
McIver (2012) carried out a mutational analysis in some target promoters and 
established that Mga binds to DNA in a promoter-specific manner. In the case of the 
AtxA regulator, two DNA-binding motifs have been predicted but no DNA-binding studies 
have been reported. Although sequence similarities in the promoter regions of AtxA-
regulated genes are not apparent, a detailed analysis of the anthrax toxin genes showed 
a high proportion of A+T in the promoter regions, suggesting that they might exhibit 
intrinsic curvature. This DNA feature was further confirmed by in silico and in vitro 
studies (gel-retardation and circular permutation assays), supporting that AtxA may 
recognize a structural feature of the DNA rather than a specific sequence 
(Hadjifrangiskou and Koehler, 2008). 
Our study (Results, Chapter 4) has shown that MgaSpn is able to interact with linear 
dsDNAs of different sources (e. g. the pneumococcal genome, pUC19 plasmid and the 
enterococcal genome). By gel-retardation assays, MgaSpn was shown to bind to any 
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tested DNA, generating a similar pattern of complexes; thus, it binds DNA with high 
affinity but with low sequence specificity. However, when the DNAs used carried the PB 
activation region at different positions (222-bp and 224-bp DNAs), DNase I and hydroxyl 
radical footprinting assays demonstrated that MgaSpn did not bind randomly at all. When 
the PB activation region was located at internal position on the DNA (222-bp DNA), 
MgaSpn recognized such a region as primary binding site (40-bp; positions -60 to -99 of 
the P1623B promoter). However, when the PB activation region was placed at one DNA 
end (224-bp DNA), MgaSpn interacted preferentially with the Pmga promoter region (44-
bp; positions -23 to +21), which is located at internal position on this DNA fragment. We 
have found that both primary MgaSpn-binding sites, the PB activation region and the 
Pmga promoter region, share a common sequence element: GGT(A/T)(A/T)AAT and 
GA(A/T)AATT (see Chapter 4; Figure 25). Nevertheless, despite this identity, when both 
sites were positioned at internal position on the same DNA molecule (640 to 1458-bp), 
electron microscopy experiments showed that the PB activation region was the preferred 
target of MgaSpn. This observation suggested that MgaSpn might recognize a particular 
DNA conformation rather than a particular DNA sequence to establish specific DNA 
interactions.  
We have analysed the two sites recognized preferentially by MgaSpn with the 
bend.it server (Vlahovicek et al., 2003). This analysis revealed that both sites contain a 
potential intrinsic curvature flanked by regions of bendability. Moreover, we have 
demonstrated that MgaSpn has a high affinity for a naturally occurring curved DNA. Our 
study suggests that local DNA conformations might contribute to the DNA-binding 
specificity of MgaSpn. Therefore, a general feature of the Mga/AtxA family of regulators 
might be their ability to bind DNA with little or no sequence specificity, as it is the case of 
many bacterial nucleoid-associated proteins that are able to influence transcription in 
either a positive or negative manner (Browning et al., 2010; Dillon and Dorman, 2010). 
We suggest that a preference for particular DNA structures might contribute to the 
capacity of the Mga/AtxA family of regulators to control the expression of a wide range of 
genes.  
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Formation of multimeric MgaSpn-DNA complexes  
During this Thesis we have studied in detail the interaction of MgaSpn with linear 
double-stranded DNAs. An interesting finding during the progress of this work has been 
the ability of the untagged MgaSpn protein to generate multimeric protein-DNA 
complexes. Gel retardation assays with different DNAs showed that, before 
disappearance of the free DNA, additional protein units bound sequentially to the 
MgaSpn-DNA complex C1 generating higher-order complexes. The analysis of the 
interaction of MgaSpn with the 222-bp and 224-bp DNAs by DNase I and hydroxyl 
radical footprinting experiments demonstrated that MgaSpn interacted with a particular 
site (PB activation region or Pmga promoter) on both fragments. After this first event, 
MgaSpn was able to spread along the adjacent DNA regions and, therefore, to generate 
multimeric protein-DNA complexes. Considering that MgaSpn occupies a region of ~40-
bp on both primary sites and the minimum DNA region necessary for MgaSpn binding 
has been found to be between 20 and 26-bp, we propose that two MgaSpn units might 
be bound in complex C1.  
At present, formation of multimeric protein-DNA complexes has not been shown for 
other regulators of the Mga/AtxA family, and until 2011 very little was known about the 
biochemical properties of the members of this family. In such a year, Hammerstrom et al. 
(2011) found that the AtxA virulence regulator forms dimers, tetramers and higher 
molecular species under certain conditions (bacterial cultures grown in elevated 
CO2/bicarbonate). In 2012, Hondorp et al. (2012) reported a correlation between the 
capacity of a His-tagged Mga protein to oligomerize in solution (without DNA) and its 
ability to activate transcription. Also, DNA binding was found to be necessary but 
insufficient for fully transcriptional activation. Concerning the MgaSpn protein, under our 
experimental conditions, it forms, in the main, dimers in solution, but it is able to form 
higher-order molecular species during sedimentation equilibrium experiments carried out 
at higher protein concentrations. Moreover, MgaSpn is able to generate multimeric 
protein-DNA complexes in the presence of linear double-stranded DNAs. We propose 
that the spreading phenomenon described in this work might be a useful mechanism 
used by MgaSpn to regulate promoters located at a certain distance from the initial 
protein-binding site. 
There are other examples of regulators with ability to oligomerize, such as several 
bacterial nucleoid-associated proteins. These proteins, which act as both architectural 
proteins and global transcriptional regulators, exist primarily as dimers, but can 
multimerize into higher-order oligomers. It is the case, for instance, of the H-NS protein 
 Discussion 
 
 
 
155 
from enteric bacteria. Depending on different parameters such as protein concentration, 
temperature and monovalent cations, different association states of the protein are 
found. H-NS forms dimers at low protein concentrations but can multimerize into higher-
order oligomers as its concentration increases (Smyth et al., 2000). H-NS has been 
shown to regulate gene expression through a variety of mechanisms (Fang and Rimsky, 
2008), and H-NS oligomerization is essential for its function. As pointed out by Dillon and 
Dorman (2010), one feature of the nucleoid-associated proteins that makes them 
excellent regulators of gene expression at the global level is their promiscuity in their 
interactions with DNA. Initially, H-NS was shown to bind preferentially to DNA containing 
curved regions (Yanisch-Perron et al., 1985). Later on, Lang et al. (2007) identified high-
affinity DNA-binding sites for H-NS in AT-rich regions of the chromosomal DNA. They 
proposed that H-NS binds initially to high-affinity sites (nucleation sites) and then 
spreads along the AT-rich DNA regions. In this model, H-NS spreading from specific 
sites would enable the silencing of extensive regions of the bacterial chromosome. 
Recently, Shin et al. (2012) investigated the H-NS-mediated repression of the LEE5 
promoter. Their results supported a new mechanism by which DNA-bound proteins 
communicate with each other. Basically, H-NS binds to a cluster of A tracks located 
upstream of the LEE5 promoter (position -114) and then spreads, presumably through 
oligomerization, to a site at the promoter where H-NS makes specific contacts with the 
RNA polymerase. Thus, in this model, H-NS spreading on DNA would facilitate 
encounters between distant regulatory elements. 
It has been proposed that sequence-dependent DNA structures may be critical 
components in the assembly of higher-order protein-DNA complexes (Rohs et al., 2010; 
Serrano et al., 1993). Thus, we analysed the nucleotide sequence of the regions 
(stretches of 50-bp) flanking the primary binding sites of MgaSpn. Compared to the 
global A+T content (60.3%) of the pneumococcal R6 genome, such adjacent regions 
display a high A+T content (74-88%), which might facilitate MgaSpn spreading due to 
the potential bendability of the DNA in these regions. Hydroxyl radical footprinting assays 
with the 224-bp DNA suggested that binding of MgaSpn to its primary site (Pmga 
promoter) induces a conformational change within the -35 region. Then, MgaSpn-
dependent changes in the conformation of the DNA may promote sequential binding of 
additional protein units. Therefore, a combination of local variations in DNA structure 
might be directing the specificity of MgaSpn for a particular DNA region. 
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Role of MgaSpn in self-regulation 
It is known that the Mga global transcriptional regulator of GAS is able to activate the 
expression of its own gene in order to amplify the Mga regulon during the first stages of 
infection (McIver et al., 1999). In this work, we have identified the promoter of the 
pneumococcal mgaSpn gene. By RT-PCR, transcriptional fusions and primer extension 
assays we have shown that the mgaSpn regulatory gene is transcribed in vivo from the 
Pmga promoter. In addition, by in vitro transcription experiments, we have demonstrated 
that this promoter is recognized by the pneumococcal housekeeping 43 factor. The PB 
activation region (70-bp), identified in this work between the P1623B and Pmga 
divergent promoters, is located 80 nucleotides upstream of the Pmga transcription 
initiation site. Since MgaSpn interacts with such a region to activate the P1623B 
promoter, we initially proposed that binding of MgaSpn to the PB activation region might 
also influence the activity of its own promoter in vivo. However, we found that it was not 
the case, at least using a Pmga-gfp transcriptional fusion in which the Pmga promoter 
extended to the +6 position. Clearly, the activity of the Pmga promoter did not change in 
response to the intracellular level of MgaSpn. Subsequent to this study, we found that, in 
addition to the PB activation region, MgaSpn is able to recognize the Pmga promoter 
region as primary binding site. Specifically, hydroxyl radical footprinting experiments 
demonstrated that MgaSpn binds to sequences located between the -23 and +21 
positions. Further work is needed to determine whether binding of MgaSpn to such a site 
influences the expression of its own gene in vivo. Interestingly, binding of H-NS to two 
sites located at a distance has been reported for many of its target genes, and in some 
cases one of the binding sites is located downstream of the promoter (Fang and Rimsky, 
2008; Cendra Mdel et al., 2013).  
Possible mechanism(s) of MgaSpn-mediated transcriptional regulation 
In prokaryotes, the strength of a particular promoter can be modulated by 
transcription factors (activator or repressor proteins) that bind to specific DNA sites. 
Different modes of activation and repression by this transcription factors have been 
described (for a review see Browning and Busby, 2004; Minchin and Busby, 2009; van 
Hijum et al., 2009). However, the transcriptional regulation mechanism(s) mediated by 
the Mga/AtxA family of global regulators remains as a key question in the field. 
Regarding the Mga regulator of GAS, several binding sites have been identified using 
either an MBP-tagged or a His-tagged Mga protein (gel retardation and DNase I 
footprinting assays) (McIver et al., 1995; McIver et al., 1999). Based on the number of 
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binding sites and their position with respect to the start of transcription, three categories 
of Mga-regulated promoters have been proposed: category A promoters (the majority of 
the Mga-regulated promoters) contain a single proximal binding site of 45-bp centred at 
the -54 position relative to the start of transcription; category B promoters (PsclA and 
Psof/sfbX) have only a distal Mga-binding site of 45-bp (centred at the -168 position from 
the start of transcription), and category C promoters (Pmga) have two 59-bp binding 
sites (Almengor and McIver, 2004; Hondorp and McIver, 2007; Hause and McIver, 
2012). Although no experimental data are available, the overlapping between the Mga-
binding site and the -35 element in category A promoters suggests that Mga might 
interact with the -subunit of the RNAP, whereas Mga binding to a distal site in category 
B promoters suggests that the interaction with the RNAP might require DNA bending 
(Almengor et al., 2006). Concerning the AtxA regulator, AtxA-DNA interactions have not 
been reported yet, even though it is known that AtxA influences the activity of many 
promoters in vivo and has two putative HTH DNA-binding motifs within the N-terminal 
region.   
The work presented in Chapter 3 has demonstrated that MgaSpn acts as a positive 
regulator of the spr1623-spr1626 operon (Solano-Collado et al., 2012). It activates 
directly the P1623B promoter through interaction with the PB activation region. Such an 
interaction has been extensively studied by EMSA and footprinting techniques (Chapter 
4) (Solano-Collado et al., 2013) showing that MgaSpn binds to a region located between 
positions -60 and -99 of the P1623B promoter. This location could allow its interaction 
with the subunit of the RNAP. If this were the case, such interaction would recruit the 
RNAP to the promoter, stabilize the initiation complex and activate transcription, as it has 
been described for other transcriptional activators (van Hijum et al., 2009). Alternatively, 
MgaSpn might activate transcription initiation at the P1623B promoter by inducing a 
conformational change in the promoter region. Both mechanisms have been reported for 
the nucleoid-associated protein Fis, which binds at hundreds of DNA targets in E. coli 
and affects gene expression (positively or negatively) by at least six different 
mechanisms (reviewed by Browning et al., 2010). Furthermore, the ability of MgaSpn to 
spread on the DNA generating multimeric complexes suggests that MgaSpn spreading 
from specific sites might also play an important role in the regulation of particular 
promoters, as it is the case of the H-NS global modulator (Shin et al., 2012).  
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This study has contributed to the molecular knowledge of a novel pneumococcal 
virulence transcriptional regulator, the MgaSpn protein, and has led to the following 
conclusions:  
1. The mgaSpn regulatory gene is transcribed in vivo from the Pmga promoter, which
is recognized in vitro by the housekeeping 43 factor of S. pneumoniae. The
transcription start site of the mgaSpn gene is located 39 nucleotides upstream of the
translation start codon.
2. The spr1623-spr1626 operon, which is adjacent to the mgaSpn gene, is transcribed
in vivo from two promoters, P1623A and P1623B. These promoters are divergent
from the Pmga promoter.
3. MgaSpn acts directly as a positive transcriptional regulator. It activates the P1623B
promoter in vivo and, therefore, the expression of the spr1623-spr1626 operon. This
activation requires binding of MgaSpn to a site located upstream of the P1623B
promoter (positions -60 to -99).
4. MgaSpn is highly conserved in the pneumococcal strains whose genomes have
been totally or partially sequenced. It is predicted to have the same organization of
functional domains as the Mga and AtxA global response regulators.
5. MgaSpn has a high content of α-helices (around 55%). In solution, and under the 
conditions tested, MgaSpn forms predominantly dimers; however, it tends to form 
higher-order molecular species as a function of protein concentration.
6. MgaSpn binds to linear double-stranded DNAs with high affinity, but with low
sequence specificity.
7. Local DNA conformations (e. g. intrinsic curvature) might contribute to the DNA-
binding specificity of MgaSpn.
8. Upon binding to its primary site, MgaSpn is able to spread (presumably through
oligomerization) along the adjacent DNA regions generating multimeric protein-DNA
complexes.
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